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  Resumo em português 
Contributo da neuropsicologia para o estudo das alterações da 
substância branca: um estudo longitudinal a 10 anos 
A melhoria da saúde e da qualidade de vida constitui um objetivo final de muita da 
investigação que é realizada nas mais variadas áreas e domínios científicos na 
atualidade, com implicações que abrangem aspetos tão diversos como os 
impactos económicos e o desenvolvimento de políticas públicas e sociais. O 
envelhecimento da população constitui um dos pilares das abordagens de 
inovação de cuidados de saúde, já que a diminuição das taxas de natalidade e o 
aumento da esperança média de vida se têm revelado vetores demográficos 
importantes com consequências nos cuidados de saúde. Com efeito, o 
envelhecimento, acompanhado com o aumento de doenças crónicas e doenças 
degenerativas, coloca exigências acrescidas quer na prestação de cuidados 
formais de saúde, quer de cuidados informais. 
A presente investigação enquadra-se neste contexto, inserindo-se num projeto 
longitudinal multinacional de carácter descritivo - o estudo LADIS (Leukoaraiosis 
and Disability Study) financiado pela União Europeia através do 5º Programa 
Quadro ‘Quality of life and management of living resources’. Este projeto procurou 
investigar o significado clínico das alterações da substância branca cerebral 
(ASBC) associadas à idade, em particular, o seu papel enquanto preditor 
independente da transição para a incapacidade, numa amostra de 639 pessoas 
funcionalmente independentes, de idade avançada. O estudo envolveu 11 centros 
Europeus (Amsterdão, Copenhaga, Florença, Graz, Göteborg, Lisboa, Helsínquia, 
Huddinge, Mannheim, Newcastle, Paris), que constituíram uma rede de 
colaboração em 2000, para a investigação em 6 domínios: (1) metodologia, (2) 
incapacidade, (3) neuro-imagem, (4) cognição, (5) humor, e (6) motor. Os 
participantes eram (i) pessoas com idade igual ou superior a 65 anos; (ii) com 
ASBC de qualquer grau (Escala de Fazekas, versão revista), avaliada por 
Ressonância Magnética (RM) e (iii) ausência de incapacidade funcional (nenhum 
ou apenas um item alterado nas atividades de vida diária, avaliadas pela Escala 
de Lawton); (iv) existindo um/a informante regular contactável e (v) detendo 
capacidade de consentimento informado para a participação no estudo. Critérios 
	  de exclusão incluíram a existência de doença grave (hepática, cardíaca, renal, 
oncológica, neurológica, ou imunológica, ou qualquer outra doença sistémica), 
presença de doença mental grave, ou contra-indicações para estudo com RM. 
Uma extensa avaliação clínica, funcional, motora e neuropsicológica ocorreu no 
início do projeto (baseline) e anualmente até o final de um período de 3 anos. A 
sub-amostra investigada no centro de Lisboa (N=66) foi, posteriormente, avaliada 
num follow-up de longo prazo (10 anos), sendo nessa altura submetida a uma 
avaliação clínica, neuropsicológica, e de imagem (RM) com a mesma 
metodologia. Foram também avaliados os cuidadores informais daqueles 
participantes que, no período de 10 anos, se encontravam dependentes em algum 
grau.  
Deste modo, o presente trabalho insere-se no domínio do estudo longitudinal do 
desempenho cognitivo, no âmbito de um projeto internacional, tendo os seguintes 
objetivos principais: 
1. Avaliar o grau em que as alterações da substância branca relacionadas com a 
idade influenciam o desempenho cognitivo e determinar quais os domínios mais 
afetados e que constituem um preditor independente da transição do 
funcionamento autónomo e saudável para a incapacidade funcional relacionada 
com o declínio cognitivo e demência, numa população idosa, num período de 
seguimento de médio (3 anos) e longo prazo (10 anos); 
 
2. Testar o efeito da transição para a dependência na sobrecarga dos cuidadores 
informais, explorando os seus processos de coping. 
Considerando estes objetivos, exploramos as seguintes hipóteses: 
 1. a) Uma bateria neuropsicológica adequada é capaz de diferenciar o 
desempenho cognitivo de indivíduos idosos independentes com alterações da 
substância branca de diferente gravidade, tendo em conta variáveis demográficas 
específicas (idade e educação); 
 1. b) Défices cognitivos subtis são identificáveis no desempenho cognitivo 
global numa população de idosos independentes com alterações da substância 
branca, enquanto preditores de demência a médio prazo (período de 3 anos). 
	   1. c) Uma bateria neuropsicológica adequada permite identificar diferentes 
perfis de desempenho cognitivo numa evolução a longo prazo (10 anos) de uma 
população idosa, inicialmente independente; 
 1. d) A progressão das alterações da substância branca constitui-se como um 
preditor independente de demência num acompanhamento a longo prazo (período 
de 10 anos); 
 
 2. a) Uma mudança de um estatuto independente e autónomo para a 
incapacidade (em qualquer grau) tem um impacto sobre a qualidade de vida do 
cuidador informal; 
 2. b) A sobrecarga do cuidador informal que decorre da progressão da doença 
está relacionada com os mecanismos de coping utilizados para lidar com a 
incapacidade funcional do doente. 
Para testar as hipóteses delineadas, foram desenvolvidos quatro estudos, 
apresentados em diferentes capítulos. 
Num primeiro estudo (Desenvolvimento de uma Bateria Neuropsicológica para um 
Estudo Multinacional: Experiência e dados iniciais), foi desenvolvida a bateria 
neuropsicológica que esteve na base do projeto, de forma a homogeneizar a 
avaliação psicológica nos diversos países envolvidos. Esta incluiu o Mini-Mental 
State Examination (MMSE), uma versão modificada da Vascular Dementia 
Assessment Scale (VADAS-Cog), e os testes Trail Making e Stroop. Os dados 
neuropsicológicos foram analisados para cada teste, bem como para três medidas 
compostas (memória, funções executivas, e velocidade de processamento). 
Verificou-se que os participantes com idade mais avançada tiveram pior 
desempenho nos três domínios. A escolaridade (> 8 anos) revelou-se um preditor 
importante de melhor desempenho cognitivo. Este estudo permitiu o 
desenvolvimento de uma bateria neuropsicológica utilizável em diversos contextos 
culturais e linguísticos, possibilitando comparações do desempenho cognitivo 
entre amostras dos diversos centros.  
O segundo estudo (Identificação dos preditores neuropsicológicos de demência 
num período de acompanhamento de 3 anos) procurou investigar preditores da 
evolução do desempenho cognitivo num acompanhamento a médio prazo. Dos 
	  639 participantes iniciais, 430 foram avaliados no final do projeto (3 anos), dos 
quais 90 foram diagnosticados com demência. Diferenças significativas no 
desempenho cognitivo de baseline foram encontradas entre os grupos de 
participantes que vieram a desenvolver demência ou defeito cognitivo sem 
demência, ou que se mantiveram sem defeito cognitivo. Através de modelos de 
regressão logística, verificou-se que os valores do MMSE e da VADAS-Cog na 
baseline foram preditores significativos da presença de demência após 3 anos. 
Este estudo permitiu a identificação de instrumentos neuropsicológicos sensíveis 
às alterações de substância branca associadas à idade e capazes de prever o 
risco de progressão para demência. 
Num terceiro estudo (Alterações da substância branca num período de 10 anos 
de seguimento: um estudo piloto), feito com a amostra recolhida no centro de 
Lisboa (N=66), foi possível investigar a evolução do desempenho cognitivo deste 
grupo de participantes durante um período de 10 anos. Este estudo procurou 
descrever os perfis de desempenho cognitivo de participantes que, ao final desse 
período, tivessem sido diagnosticados com demência, defeito cognitivo sem 
demência, ou sem defeito cognitivo. Teve ainda como propósito identificar 
preditores neuropsicológicos da ausência de defeito cognitivo a 10 anos de 
seguimento. Dos 41 participantes sobreviventes, 37 foram re-avaliados (15 com 
demência, 12 com defeito cognitivo sem demência, e 10 sem defeito cognitivo). 
Os três grupos de participantes revelaram diferentes perfis de desempenho 
cognitivo em diversas baterias. Valores mais elevados no MMSE na baseline 
constituíram-se como os únicos preditores significativos de pertencer ao grupo 
sem defeito cognitivo ao final de 10 anos. Estes resultados apontam para a 
utilização de pontos de corte elevados em baterias neuropsicológicas globais, 
como o MMSE, como preditores de evolução (ou não) de defeito cognitivo. 
Num quarto estudo (O impacto do declínio funcional nos cuidadores informais: um 
estudo exploratório) procurou-se responder ao segundo objetivo principal 
supracitado, isto é, perceber a relação entre o grau de dependência do 
participante e o grau de sobrecarga subjetiva do cuidador informal, colocando a 
hipótese desta ser mediada pelos mecanismos de coping deste último. Mais de 
metade dos cuidadores informais apresentou sobrecarga subjetiva. Apesar de 
uma associação entre estratégias de coping e perceção de sobrecarga, as 
	  análises de regressão linear permitiram identificar o grau de dependência como o 
preditor independente de sobrecarga. Efeitos na qualidade de vida e saúde dos 
cuidadores foram descritos numa diversidade de domínios. Este estudo permitiu 
explorar os impactos sociais da transição para a dependência, apontando para 
importantes implicações ao nível da prevenção da sobrecarga de cuidadores 
informais. 
Numa tentativa de caracterizar o desempenho a longo-termo de uma população 
idosa com alterações da substância branca, funcionalmente independente, o 
nosso estudo demonstrou que:  
- os níveis de escolaridade mais elevados se associaram a melhor desempenho 
cognitivo, e quanto maior a idade mais dificuldades nas capacidades de memória 
e funcionamento executivo; 
- mesmo numa população com este grau de autonomia funcional, a avaliação 
neuropsicológica permitiu detetar e associar alterações cognitivas subtis na 
avaliação de inclusão com a progressão para demência; 
- pontuações elevadas no MMSE na avaliação de inclusão foram identificadas 
como os únicos preditores de não demência aos 10 anos; 
- mais de metade dos cuidadores informais de participantes que transitaram para 
um estado de dependência apresentou um nível de sobrecarga subjectiva 
substancial. O grau de dependência funcional dos doentes foi identificado como 
único preditor de sobrecarga.  
Com este trabalho confirmamos a importância da avaliação neuropsicológica na 
identificação de diferentes perfis de funcionamento cognitivo em indivíduos com 
alterações da substância branca, e na deteção de défices cognitivos subtis 
independentemente do grau de gravidade das ASBC, que funcionam como 
preditores de declínio cognitivo a médio e longo-prazo. 
 
	  
 GENERAL SUMMARY 
Key words: Neuropsychology, dementia, white matter changes, long term follow-up 
 
This thesis, conceived as a longitudinal, descriptive and analytic observational 
investigation, aims to identify clear profiles of cognitive functioning in patients with 
white matter changes (WMC). The first part, presents the contribution to the 
multinational collaborative research known under the acronym of LADIS 
(Leukoaraiosis and Disability Study) which attempted to investigate the clinical 
significance of white matter changes as an independent predictor of the transition 
to disability in initially non-disabled elderly, to this end selecting and applying an 
appropriate test battery to assess specific domains in cognitive functions. The 
second part introduces the long-term follow-up of the Lisbon Centre group of 
participants in the LADIS study, and identifies the impact of functional and 
cognitive decline on caregivers who accompanied patients up to the state of full 
dependency. The constructed neuropsychological battery proved to be effective in 
identifying cognitive impairment appearing in early stages when comparing 
different evolutionary profiles, as well as in detecting predictors of good cognitive 
functioning in lengthy follow-up research, thus opening space for a renewed 
project to establish intervention programs. Though WMC are exclusively detected 
by imaging, the clinical expression of those changes, particularly as related to 
cognitive function, should become identified through sensitive adapted batteries. 
Neuropsychological assessment allows the definition of the extent of the cognitive 
impairment, as well as the determination of its impact on daily life and adaptation 
of intervention programmes either in early stages, or in later stages of the disease, 
allowing the introduction of non-pharmacologic complementary therapies. The 
identification of changes in cognitive functioning and the corresponding impact on 
patients and on their environment, mostly in the family, allows the adoption of 
broader intervention strategies when introducing future informal caregivers to more 
appropriate coping strategies as mediators of psychological and emotional well-
being. 
  
 RESUMO GERAL 
Palavras-chave: Neuropsicologia, demência, alterações da substância branca, 
seguimento de longo-termo 
 
Esta tese foi concebida como investigação observacional e longitudinal, descritiva 
e analítica, e pretende identificar perfis de funcionamento cognitivo em pacientes 
idosos com alterações da substância branca cerebral. A primeira parte, constitui 
um contributo para a investigação colaborativa multinacional conhecida sob a 
sigla de LADIS (Leukoaraiosis and Disability Study), que analisou o significado 
clínico das alterações de substância branca cerebral (ASBC) como preditor da 
transição para a perda de autonomia em idosos inicialmente sem défice funcional. 
Para o efeito foi aplicada uma bateria neuropsicológica de modo a avaliar 
domínios específicos do funcionamento cognitivo, repetida anualmente ao longo 
de três anos. A segunda parte apresenta o seguimento a longo prazo do grupo 
português de participantes no LADIS e identifica o impacto do declínio funcional e 
cognitivo sobre cuidadores que acompanham os pacientes até o estado de 
dependência total. Quando comparados os diferentes perfis evolutivos, a bateria 
neuropsicológica construída provou ser eficaz na identificação de alterações 
cognitivas nas fases iniciais e permitiu prever níveis de funcionamento cognitivo 
no longo prazo. Assim abriu espaço para um renovado projeto de intervenção. 
Embora as ASBC sejam detetadas exclusivamente por exames de imagem, a sua 
expressão clínica poderá tornar-se identificável através de baterias 
neuropsicológicas mais sensíveis. A avaliação neuropsicológica permite a 
definição de um padrão, bem como a determinação do impacto na vida diária para 
adaptação de programas de intervenção nos estágios iniciais ou em fases mais 
tardias da doença, assim como introduzir terapias complementares não-
farmacológicos, tendo em vista promover a autonomia funcional num maior 
período de tempo possível. A identificação de alterações no funcionamento 
cognitivo e o correspondente impacto sobre os pacientes e o seu ambiente, 
principalmente na família, permite a adoção de estratégias mais amplas de 
intervenção a transmitir aos cuidadores informais para uso no enfrentamento da 
carga emocional e física que os atinge. 
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I - Introduction 
The general decrease in birth rate especially in Western countries and the gradual 
increase of average life expectancy registered in recent decades, brings with it, as 
a consequence, an increasingly elderly population. Globally, according to the 
world population prospects of the United Nations [1], life expectancy at birth is 
projected to rise from 70 years in 2010-2015 to 77 years in 2045-2050 and to 83 
years in 2095-2100, having Europe, Northern America and Oceania a projected 
gain of 10-11 years. It is also pointed out that the number of persons aged 60 and 
above is expected to more than double by 2050 and more than triple by 2100. In 
the same way, the number of persons aged 80 or over is projected to more than 
triple by 2050 and to increase more than seven-fold by 2100. 
 
These numbers explain and justify the current concerns with the quality of life of 
elderly population and the increasing interest in the investigation of age-related 
diseases, being dementia one of the most frequent and disabling. 
 
On the other side, age-related diseases and their respective consequences for the 
level of autonomy and independence of the elderly led to stress the necessity to 
investigate how these patients are cared for and who are the caregivers that 
accompany them throughout the aging process. 
 
Cognitive Decline and Dementia of Vascular Etiology 
One of the most studied facts associated with age has been the decline of 
intellectual capabilities. Descriptions of physical and intellectual loss associated 
with increasing age are found since the Greco-Roman period and, for some 
philosophers, such as Plato, Aristotle, Cicero, and Galen considered an 
inevitability of old age not a disease [2]. 
 
The current concept of dementia linked to changes derives from the definition 
introduced in the early 19th century by Esquirol, disciple of Philippe Pinel, who 
describes dementia as a "brain disease characterized by weakening of sensitivity, 
understanding and will", also affecting the capacity of short-term memory, attention, 
 4 
reasoning, and abstraction [3]. Esquirol identifies three varieties of dementia: the 
acute, related to an identified cause (fever, hemorrhages) which may be cured; 
chronic resulting from certain behaviors (alcoholism, masturbation) or from 
pathology (mania, epilepsy) which is rarely curable; and senile, a form described 
as “resulting from the advancement of age, beginning as a weakening of memory, 
specially recent remembrance, and making the act of attention impossible” [2]. 
 
New forms of study and approach to mental illness, developed by Emil Kraepelin 
in the early 20th century, resulted in the distinction between senile and pre-senile 
forms of dementia and dementia caused by arteriosclerosis. This was based on 
Binswanger’s and Alzheimer's work correlating anatomical - clinical - pathological 
facts. These authors appear as pioneers in identifying the earliest forms of 
dementia with vascular cause, which are grouped into four entities [2, 4]: 1) post-
apoplexia dementia or dementia after stroke; 2) cerebral degeneration 
arteriolosclerosis, characterized by multiple strokes lacunes, étatcriblé and 
atherosclerosis; 3) cortical vascular senile atrophy characterized by perivascular 
gliosis and, granular atrophy and laminar necrosis; 4) subcortical atherosclerotic 
encephalopathy,  or Binswanger disease [5]. The latter was initially characterized 
by Binswanger as subcortical white matter lesions not affecting the U-fibres, 
ventricles much extended, in particular the horns, and normal brain cortex. 
Binswanger found in these cases marked atrophy of the white substance, confined 
to one or more sections of the hemisphere. In the most serious cases, the white 
substance seemed to have disappeared altogether, more marked changes being 
in the occipital and temporal lobes. These changes were accompanied by severe 
cerebral artery atheromatous plaques, so the loss of subcortical fibres was related 
to poor blood supply caused by atherosclerosis [6]. 
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White Matter Changes: Clinicopathological considerations 
The concept of White Matter Changes 
The development of new observation techniques in vivo, particularly the imaging 
techniques such as Computerized Tomography (CT) and, later, the Magnetic 
Resonance Imaging (MRI), allowed that white matter changes (WMC) initially 
described in anatomical and pathological examinations and related to 
arteriolosclerosical dementia, could receive imaging correspondence. The term 
Leuko-araiosis (white rarefaction, derived from the Greek), was introduced with the 
aim of pointing out the signs observed on the CT (as decreased density areas) or 
MRI (high density areas) scans, which were limited to periventricular areas or 
encompassing the whole white matter substance, though without indicating a 
specific clinical or pathogenic meaning [7]. 
 
The increasing use of both imaging techniques, allowed the identification of WMC, 
described as bilateral periventricular or subcortical areas of hypodensity (when 
observed in CT scans) or hyperintensity (when observed in MRI scans), in a 
growing number of adults and the association with vascular risk factors, cognitive 
changes and vascular dementia [7-10]. The anatomical and pathological 
examinations of these patients have established a correlation between WMC 
signaled in CT scans and demyelinated areas, white matter infarcts, lacunes or 
dilated perivascular spaces and, in most cases, arteriolosclerosis. However, some 
cases have been associated with other types of pathologies such as Alzheimer's 
disease [11] and the absence of vascular disease and atherosclerosis led to 
question the diagnosis of Binswanger disease and brought up the question of 
being confronted by a different pathology. 
 
Indeed, the first studies which used more sensitive imaging techniques such as 
MRI, revealed that 80% to 90% of healthy subjects with more than 60 years 
showed changes in white matter substance [12, 13]. However, the relationship 
between white matter changes (WMC) and cognitive deficits was not clearly 
identified [14-16]. In the last decades, the clinical impact of WMC have been highly 
discussed with controversial results being published [17, 18]. 
 6 
The type of imaging technique used proved to be important in identifying the 
changes in white matter substance and might also explain some of the 
discrepancies in the studies’ results. Correlation studies between images and the 
changes in post-mortem examinations show that the CT has a sensitivity of 72% 
and a specificity of 100%, while the MRI has a sensitivity of 100% but a specificity 
of 88% [19, 20]. The high degree of sensitivity of MRI permits the differentiation of 
periventricular changes from hyperintensities in deep white matter substance; and 
to classify different levels of white matter rarefaction severity. 
 
Over these last decades, the title WMC (white matter changes) has been 
progressively replaced by white matter lesions (WML) or white matter 
hyperintensities (WMH). The adoption of these terms is directly linked to the 
increasingly frequent use of MRI, and the resulting description of the neuroimaging 
findings. Consequently, in the course of the present study, those different terms 
have been used, corresponding to an effort of appreciating the chronological 
evolution of the concept and the type of technique used in the mentioned studies 
 
Clinical Significance of White Matter Changes 
The occurrence of WMC in healthy individuals varies between 10% and 100% [21, 
22], being age an important factor for its increase [21, 23]. Some longitudinal 
studies reported a prevalence of 11% to 90% in subjects between 65 to 69 years, 
as well as 54% to 98% in subjects with more than 80 years. The difference of 
values depends on the design of the studies, the population under study, and the 
classification scales selected to differentiate severity of WMC. A few authors 
indicate a significantly greater degree of severity in women [21, 23], while other 
researches show no relationship with gender [24]. 
 
When correlated with cognitive changes, the alterations of white matter substance 
ceased to be synonyms of dementia, as they could be present in subjects not 
revealing cognitive defect, as stated above. 
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The nineties were a decade of intense work in this field (for a revision, Pantoni and 
Garcia, 1995 [18]). A series of studies revealed that white matter changes were 
also present among normal individuals with more than 60 years of age [24-26], the 
same occurring in sick individuals suffering from various degrees of dementia [27]. 
In patients with dementia of vascular origin, periventricular and subcortical WMC 
were observed in 80% and 50% of cases, respectively. In patients affected by 
Alzheimer's disease, 26% to 70% were described as presenting periventricular 
WML, as well as 20% to 25% presenting subcortical WMC [25, 28]. 
 
White Matter Changes: Risk factors and Pathogenesis 
Risk Factors 
Hypertension seems one of the more important factors associated to WMC, 
especially in younger subjects [21] and even in subjects under medication without 
adequate control [24]. Other factors, such as atheroesclerosis, hipercolestrolemia 
[21], smoking [23], cardiac disease [21, 29] and previous stroke [21, 23, 30] have 
been associated to WMC, but there is yet little consistency found in data. Diabetes 
has also been associated with higher risk of WMC, although evidence is lower 
than for hypertension [31-33]. 
 
Pathogenesis 
Despite the growth of research in WMC, it is still not clear what are the specific 
mechanisms related with WMC formation and progression. However, recent 
studies have provided some evidence that extensive forms of WMC are an 
expression of small vessel disease [34]. 
 
Lesion of small size vessels of the brain (arteries and arterioles) is classically 
originated by thickening of the arterial media, occlusion of arterial lumen and 
obstruction of the origins of the penetrating arteries [35]. 
 
Localization of the lesions can help as an indicator of etiology. Smooth 
periventricular hyperintensities, including caps around the ventricular horns, 
periventricular lining and halos are likely to be of non-vascular origin [36]. They 
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relate to a disruption of the ependymal lining with subependymal widening of the 
extracellular space and have to be differentiated from subcortical and deep white 
matter abnormalities [36]. For the latter, with presumed ischemic origin, a 
distinction needs to be made between punctate, early confluent and confluent 
types. Punctate white matter lesions often represent widened perivascular spaces 
without substantial ischemic tissue damage, early confluent and confluent lesions 
correspond to incomplete ischemic destruction, although extensive etiology of 
white matter changes remains controversial [35]. Punctate abnormalities on MRI 
show a low tendency for progression, while early confluent and confluent changes 
progress rapidly. Several theories have been proposed, including recurrent 
ischemia and edema, chronic leakage of fluid related to increased vascular 
permeability, and contribution of venous pathology [35]. The causative and 
modifying pathways involved in the occurrence of sporadic age-related white 
matter changes are still incompletely understood, but recent microarray and 
genome-wide association approaches can potential help on the pathogenic links 
[36]. 
 
Neuropsychology of White Matter Changes 
The presence of white matter changes and lacunar infarcts have been identified as 
the in vivo most detectable consequences of the Small Vessel Disease (SVD) on 
the brain parenchyma and thus related with cognitive impairment and dementia. 
For this reason, neuropsychology features of WMC will be explored within SVD 
findings. 
 
SVD and Global Cognitive Measures 
Since SVD is an insidious disease, early subtle cognitive changes are difficult to 
detect, especially in the absence of other clinical complaints. Some recent 
longitudinal studies, performed within the general population and reporting data 
from cognitively intact participants, have demonstrated that increasing volume and 
extension of WMC are related with lower global cognitive measures, such as Mini 
Mental State Examination (MMSE) [37], and with conversion to mild cognitive 
impairment [38, 39]. Nevertheless, in both studies, MMSE mean scores at 
baseline were over the cut-off point for cognitive impairment (total baseline score 
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29 and 28, respectively. Global cognitive decline associated with progression of 
WMC was also found in the Rotterdam Study [40]. Using both MMSE and a 
composed cognitive score (cognitive index) based on the performance in 
information processing speed, executive functions and verbal memory tests, the 
authors found a significant decline with increasing periventricular WMC. Decline 
on global functioning was mainly caused by impairment in speed (Stroop naming 
colors) and efficiency of processing (letter-digit substitution test) [40]. 
 
Decrease in global cognitive functioning associated with SVD has been more 
clearly observed in studies reporting the evolution of cognitive status in persons 
with cognitive complaints or vascular risk factors. In a study that compared the 
evolution of cognitive decline in three distinctive groups - subjective memory 
complaints, Mild Cognitive Impairment of amnestic type (MCI-A), and normal 
controls -, WMC volume was associated with an annual change in the Cambridge 
Cognitive Examination (CAMCOG) global score [41]. 
 
It is to be noted that changes in global cognitive scales are usually associated with 
the progression and / or severity of the disease, when a global compromise is 
already installed. For instance, in a cohort of patients with acute lacunar infarcts, 
MMSE failed to identify 30% of the patients diagnosed with cognitive deficits [42]. 
 
The same occurs with other global cognitive scales or batteries such as CAMCOG 
[43] or Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) 
[44]. This might be explained by the lack of sensitivity of these instruments in 
identifying subtle changes or deficits in other cognitive domains either than 
orientation, memory, language or visual constructional praxis. For instance, 
memory functioning seems to be less vulnerable to the presence of WML, unless 
that increasing WML represents a significant loss of brain volume [45]. 
 
To decrease the risk of under diagnosing cognitive impairment in the initial phases 
of the disease, it is generally recommended to add more specific tests to well 
studied and known batteries in order to improve their sensitivity to executive, 
attentional and speed processing deficits. An example of such a combination is the 
Vascular Dementia Assessment Scale-cognitive subscale (VADAS-cog battery) 
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[46], that resulted from the addition of five tests to assess working memory, 
psychomotor speed, attention and executive functions (namely, digit span 
backwards, maze simple task, digit-symbol, digit cancellation and verbal fluency) 
to the ADAS-Cog battery. 
 
The Montreal Cognitive Assessment scale (MoCA) [47] is another global cognitive 
screening tool that has been recently developed and recommended by the NINDS-
CNS [48] as a more sensitive instrument than MMSE, in detecting Mild Cognitive 
Impairment (MCI) and vascular cognitive impairment (VCI).The inclusion of 
executive functioning tasks (such as trail-making B or phonemic verbal fluency), 
make this screening battery more sensitive to cognitive deficits observed in 
vascular disease. MoCA has been used in different clinical populations and 
different countries, where its validity has been explored [49-53]. However, except 
for one study reporting that MoCA was a useful instrument differentiating a small 
group of SVD patients from controls [54], there is still a lack of data regarding its 
sensitivity and specificity to detect subtle cognitive changes in SVD patients. 
 
SVD and Executive Functions 
The effect of SVD on the decline of global cognitive measures is mainly due to the 
compromise and decrease of specific cognitive functions and not, at least in the 
initial and intermediate stages of the disease, to a diffuse cognitive impairment 
pattern. Executive dysfunction - mainly characterized by deficits in set shifting, 
verbal fluency, abstract problem solving and attention -, and decrease on speed of 
information processing might be detectable even in the initial stages of the disease. 
Multiple lacunes located in the subcortical structures and confluent and extensive 
WMC can result in a disconnexion of frontal-subcortical circuits (in particular, the 
dorsolateral prefrontal circuit) interrupting the central cholinergic pathway [55] and 
causing this pattern of frontal-lobe dysfunction. 
 
For this reason, tailored instruments should be used in the clinical assessment of 
patients with SVD. The NINDS-CSN group [48], proposed the use of standard 
neuropsychological protocols to assess vascular cognitive impairment. The 
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importance given to measures of executive, attention and speed processing 
functioning is well established, even in the short-form protocols. 
 
Executive and activation functions are frequently assessed using timed tests with 
a variety of set shifting, mental flexibility and response inhibition tasks. Both 
executive functions and speed of processing are frequently impaired in patients 
with SVD. Lower scores on verbal fluency (both semantic and phonemic), Stroop 
reading and colour naming tasks [56], and trail making tests[57], have been 
repeatedly associated with SVD [40, 58-60]. On other non-timed instruments used 
to assess mental flexibility and conceptualization such as Wisconsin Card Sorting 
Test [61], changes on scores were also associated to progression of WMC, in a 
healthy community-dwelling elderly volunteers [45]. 
 
When employing a brief assessment battery used to differentiate patients with 
ischaemic leukoaraiosis from normal controls, the best individual tests identifying 
cognitive impairment were trail-making and digit-symbol substitution tasks [29]. 
Also in other studies, a decline in the Symbol-Digit substitution test performance 
was associated with worse scores of leukoaraiosis [62]. Tests sensitive to 
reductions in psychomotor speed, mental flexibility, working memory and attention 
are useful instruments to detect early subtle changes in SVD patients. 
 
Slowing and Motor skills 
Decrease on speed of mental processing and attention have been frequently 
associated with the presence and progression of WMC, either in healthy elderly 
populations [40, 62, 63] or in elderly population with high risk for vascular disease 
[64-66]. Changes in attention and processing speed due to SVD are explained by 
a disruption in brain structures involving the frontal-subcortical pathway circuits 
causing a frontal lobe related cognitive impairment pattern. 
 
In studies reporting an association between cognitive functions and WMC 
localization, impairment in speed of mental processing is usually related to WMC 
located in periventricular regions rather that in subcortical deep areas [40, 63, 66]. 
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A recent study performed by Dueringet. al. [67], with a cohort of 215 patients with 
CADASIL – a disease that best reflects the mechanisms of small vessel disease 
on VCI –, tried to explore the role of strategic lesions, detected for both lacunar 
and white matter lesions, on different patterns of cognitive decline, including 
mental processing speed. Using a voxel-based approach the authors were able to 
report an association between decrease in processing speed and volume of WML 
and lacunar lesions located on the anterior thalamic radiation and forceps minor. 
These findings are in accordance with the previously described involvement of 
these structures in executive functions[68-70], as they are composed by white 
matter tracts that project between the thalamus, prefrontal cortex and striatum that 
play an important role in the prefrontal-subcortical circuits. 
 
However, results are still controversial concerning the strategic locations for 
cognitive symptoms related with SVD. Different results might be explained by 
differences in imaging techniques, in cohorts of participants and also in the 
different instruments used in the neuropsychological evaluation. In the majority of 
the studies, tests used to assess processing speed are usually complex since they 
require multiple cognitive capacities to perform the task. Instruments such as trail 
making and symbol-digit modalities are dependent on attention, memory, and 
motor skills, and require the involvement of different cerebral structures. The role 
of corpus callosum on processing speed and executive functions was also 
addressed in previous studies [71]. 
 
It is still difficult to identify if slowing is an effect of compromised executive 
functioning or impairment in sensory motor ability. Wright et al. [72], using the 
Grooved pegboard test, confirmed the association between volume of WMC and 
poorer performance on sensory-motor tasks. The authors emphasized the use of 
the Grooved Pegboard as a robust marker of white matter damage since it is 
sensitive to slow neural transmission or conduction of integrative rostral-caudal 
pathways. Still, the majority of the studies do not use such specific tests to assess 
sensoriomotor skills. However, the inclusion of Pegboards tests on the evaluation 
of patients with SVD, as recommended for the assessment of vascular cognitive 
impairment [73], would help in differentiating measures of psychomotor speed 
from those more dependent on executive/activation abilities. 
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SVD and Memory Performance 
Memory deficits observed in SVD are distinctive from those observed in other 
pathologies such as MCI and AD. Studies comparing patients with MCI, with and 
without SVD, tried to identify different cognitive profiles [60, 74, 75]. Zou et al. [60] 
reported a non specific profile in non-specified MCI-SVD patients since they found 
extensive cognitive deficits on these patients. Comparatively, patients with MCI-
AD had a more specific pattern characterized by a significantly worse performance 
on verbal and visual delay recall and recognition measures with a relatively 
preserved performance on processing speed tasks. 
 
MCI (non defined type) patients with severe WMC were compared with MCI 
patients with severe hippocampal atrophy using a comprehensive 
neuropsychological battery [76]. The authors found that patients with hippocampal 
atrophy exhibited a specific episodic memory impairment while patients with WMC 
exhibited deficits on episodic memory (assessed by a 36-item object color 
association task), working memory (were tested on two verbal working memory 
tasks and a spatial working memory task), and attention control tasks (continuous 
performance test), suggesting that the episodic memory deficit was secondary to a 
more general impairment of executive control. In fact, working memory 
performance requires an ability to hold, manipulate and quickly access information 
that is dependent on mental flexibility and speed. The mediation effect of executive 
functions on verbal and visual memory performance of SVD patients was already 
described [58]. 
 
Distinctive patterns can be observed in relation to memory impairment. Ability to 
storage information is mainly dependent on the limbic and hippocampal structures, 
while retrieval and short term memory capacities are more related with the integrity 
of frontal-subcortical structures and temporo-parietal lesions, respectively. In SVD 
patients, episodic memory impairment is usually absent or mild in the initial 
phases, being the most frequent deficit characterized by difficulty in recall 
information that improves in the presence of cues. However, these findings are 
frequently associated to other variables such as medial temporal lobe atrophy [77] 
and corpus callosum atrophy [78]. Poorer episodic memory has been associated 
 14 
with age-related differences in central white matter regions [79]. Recent studies 
with SVD patients have explored the relationship of microstructural integrity of the 
hippocampus – not detected with conventional MRI – and verbal memory 
impairment [80, 81]. These authors found that deficits in verbal memory 
(immediate, delayed recall and delayed recognition), but not in psychomotor 
speed, were related with changes in the hippocampus microstructure. These 
results might lead us into a new perspective in the understanding of memory 
impairment related with SVD. 
 
Language 
Impairment in language functions is not frequent in SVD. Comparing patients with 
initial dementia, Kertesz et al. [82] found that patients with periventricular 
hyperintensities performed worse on comprehension and attention tasks, 
compared with those with no hyperintensities that showed worse performances on 
memory and conceptualization tasks. However, other studies performed within the 
general population and with high risk non-demented patients with WMH, did not 
find a relationship between presence of WML or lacunes and language deficits 
(see Debette et al. [83], for a review). Nevertheless, lexical and semantic fluency 
measures should be included in the assessment of SVD patients. Impairment in 
lexical tasks is more frequent and prominent than semantic difficulties, showing a 
different pattern of MCI or AD patients. As occurs in other cognitive functional 
deficits observed in patients with SVD, the type of impairment found in verbal 
functions seems to be related with the decrease in speed of processing and 
access to information which affects word generation tasks. 
 
Visuospatial construction and visuopractical functions 
Previous studies with healthy elderly or community-dwelling populations did not 
find any relationship between visuoconstructional impairment and the presence of 
WMC [14, 15, 62, 84]. 
 
Similar results were also reported in patients with vascular risk factors [64] or initial 
dementia [82]. On the contrary, in a cohort with more severe dementia, impairment 
in visuospatial abilities measured by the Wechsler Adult Intelligence Scale- 
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Revised (WAIS-R) Object Assembly subtest was associated with the volume of 
WML located on the posterior periventricular regions [85]. Other motor 
performance subtests were also found to be important contributors to discriminate 
between groups of severe Vascular Dementia and Alzheimer’s Disease [86]. 
Nevertheless, both WAIS-R subtests used in the two studies are sensitive to 
constructional abilities and visuospatial organization skills, while they are also 
time-dependent and highly sensitive to frontal lobe dysfunction. 
 
Results from the Austrian Stroke Prevention Study [45], also show an association 
between visuopractical skills decline assessed by the Purdue pegboard [87] and 
the progression of WMC and related loss of brain volume. Again, the performance 
on this test is highly dependent on the speed of motor response. 
 
More recently, decline in spatial organization and visuo constructional skills, 
measured by the Benton Visual Retention Test (BVRT) and the Consortium to 
Establish a Registry in Alzheimer’s Disease’s (CERAD) geometric design copying 
test, were found to be uniquely associated with progression of posterior WML [88]. 
Murray et al. [89] investigated the impact of WM hyperintensities (WMH) on 
cognitive impairment and motor dysfunction in a cohort of neurologically intact 
elderly subjects. Measuring the percentage of WMH in well-defined cerebral 
regions (frontal, temporal, parietal, occipital, periventricular and subcortical) and 
the performance in memory, language, executive functions and visuospatial 
reasoning domains, the authors found only a trend toward worse performance in 
visuospatial abilities (measured by the WAIS-R picture completion and block 
design subtests) with greater percentage of WML. Interestingly, in this study, a 
higher percentage of WMH in all regions except occipital lobe was associated with 
worse performance in executive tasks (measured by Trailmaking B and Digit 
Symbol). No significant relationship was found between WMH and memory or 
language standard scores. These findings support the importance of the integrity 
of white matter fibers in anterior brain regions for global cognitive functioning, and 
might reflect the contribution of executive functions on visual reasoning, as both 
tests – picture completion and block design – depend also on subjects’ abilities of 
reasoning and judgment about practical and conceptual relevancies, and problem 
solving techniques. 
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Different expressions of SVD and its impact on cognition 
As previously referred, WML are the most detectable consequences of SVD. 
However, other forms of SVD, such as lacunes, cerebral microbleeds and brain 
atrophy [90], may play an important and still not yet completely identified role in 
cognitive performance. 
 
Lacunes 
Lacunes can be detected on MRI T2 and FLAIR sequences and defined as small 
subcortical infarcts (3 to 20mm of diameter) that occur in cerebral regions supplied 
by the small perforating arteries [91]. The most frequently affected regions are 
basal ganglia, internal capsule, thalamus, paramedian and lateral regions of 
brainstem, corona radiate and centrum semiovale. Depending on the number and 
localisation, lacunes can be clinically silent or very expressive. Among cognitively 
normal elderly subjects, the total number of subcortical lacunes was an 
independent predictor of executive functioning [92], speed and motor control [93]. 
Thalamic and basal ganglia lacunes were independent predictors of cognitive 
decline in elderly subjects [94]. Progression of lacunes was also associated with 
cognitive function, particularly in processing speed and executive functions, along 
with WMC progression [63, 95]. 
 
Among individuals with Alzheimer’s disease (AD) a marked influence of thalamic, 
basal ganglia, and deep white matter lacunes on cognitive function was cleared 
identified in neuropathological study [96]. However, in other studies, lacunes were 
present in approximately one-quarter of elderly cases without a relationship with 
psychiatric or neurological disease [97], or did not predict any of the cognitive tests 
outcomes when adjusting for age and medial temporal atrophy [98]. Thus, the 
independent role played by lacunes in cognition and / or progression for dementia 
is still not well identified. 
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Cerebral microbleeds 
Cerebral microbleeds (CMB) – are small rounded lesions detected on more 
sensitive MRI sequences (T2*-weighted gradient-recalled echo, GRE, and 
susceptibility-weighted imaging, SWI) composed of small collection of blood 
breakdown products [91] - have been recently identified as other forms of SVD, 
accompanying WML and lacunes [99]. The prevalence of CMB is variable 
depending on the MRI techniques used [100]. 
The impact of CMB on cognition has been progressively and consistently reported. 
A recent meta-analysis [101] evidenced that patients with CMBs had higher 
incidence of cognitive dysfunction and lower scores of cognitive function. There 
was also a correlation between the number and specific localizations of CMB 
(lobar regions, deep areas, basal ganglia, and thalamus regions) with cognitive 
impairment. Rhian et al. [101] did not find evidence of a correlation between 
infratentorial CMBs and cognitive performance. 
 
However, previous studies have reported associations between deep CMB and 
motor speed [102], processing speed and executive functions [103]. Infratentorial 
CMB have been also associated with motor speed, attention [103] and visual 
memory [104]. 
 
Nonetheless, besides an increasing evidence of the influence of other SVD 
markers on cognitive performance, it is still difficult to identify the direct impact of 
these different expressions, either because they are consistently associated with 
each other or because they come with a varied type of vascular risk factors. 
 
WMC: Unsolved issues 
In the beginning of this study, and aside the increasing interest and research on 
white matter lesions and their impact on cognitive performance, there were still a 
number of unsolved issues to address. 
 
The first one was the most simple and yet the most important: what should we tell 
an independent elderly person, regarding a neuroimaging examination that 
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detected the presence of white matter changes, in the absence of other expressive 
clinical complaints? 
 
It became important to know how WMC would evolve in a medium and long-term 
period and what cognitive implications they could have. A strong relationship 
between the presence of WMC and progression to disability had been reported 
[105], but the long-term evolution of the disturbance and its relationship with 
cognitive performance along with its impact on the transition to a functionally 
dependent status, was still not clear. 
In the same way, there was still a lack of information regarding the contribution of 
neuropsychology on detecting predictors of disability and on identifying different 
profiles of evolution. 
 
At this point, what stood up was the need to better identify those 
neuropsychological instruments which were most useful in detecting subtle 
cognitive deficits and changes in the long-term follow-up of elderly subjects with 
WMC. 
 
Equally important when considering the hypothesis that WMC could have a direct 
impact on the transition from an autonomous status to a gradual cognitive loss and 
consequent dependency, is to explore the impact of this outcome on informal 
caregivers. 
 
Thus, the present thesis took form as an effort to construct and validate a 
neuropsychological battery to better identify predictors of dementia and non 
impaired cognitive status in a long-term longitudinal approaches. It further 
encompassed the study of the impact of the disease on informal caregivers who 
accompanied patients up to the state of possible full dependency. 
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II - Objectives and hypotheses under study 
The objectives and hypotheses under study are summarized as follows: 
 
1. To evaluate the extent to which age-related cerebral white matter changes 
(WMC) influence cognitive performance and constitute an independent 
determinant of cognitive decline. 
We aimed to identify how cognitive functioning was related with the presence of 
WMC, which cognitive domains were mainly affected by them, and which are the 
most sensitive to decline. In order to explore these questions, we had to determine 
the best instruments to evaluate these cognitive changes to be able to identify 
neuropsychological predictors of dementia on a long-term follow-up. Considering 
these purposes, we explored the following hypotheses: 
 
a) A properly designed neuropsychological battery is able to differentiate the 
cognitive performance of independent elderly subjects with different degrees of 
WMC, in association with specific demographic variables (age and education); 
b) Subtle deficits on global cognitive performance and specific cognitive domains 
observed at baseline, are predictors of dementia on a 3 year period, in a 
functionally independent elderly population with WMC. 
 
These hypotheses are studied and discussed in Chapters IV and V of the present 
thesis. 
 
2. To evaluate the extent to which WMC influence cognitive performance at a 10-
year follow-up period and to identify predictors of non-disability. 
We hypothesized that: 
 
a) The neuropsychological battery was able to identify different profiles of cognitive 
performance on a long-term evolution of a sample of initially independent elderly 
people with WMC. Higher performance in global measures and specific cognitive 
domains are predictors of no cognitive impairment at 10 years; 
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b) Progression of WMC was an independent predictor of dementia among elderly 
people on a long-term follow up. 
This study is presented and discussed in Chapter VI of the present thesis. 
 
3. To explore and characterize informal caregivers’ burden and needs as they 
follow the elderly subjects’ process of transition from an independent to a condition 
of disability. For this purpose we established the following hypotheses: 
 
a) Progressive change from an independent and autonomous status to a disabled 
functioning have an impact on the quality of life of caregivers; 
b) The way in which caregivers are affected by the progression of the disease is 
related with their own coping mechanisms. 
 
The results of this study are presented and discussed in Chapter VII.
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III - Methodology 
The research here submitted is conceived as a longitudinal, descriptive and 
analytic observational investigation. The present Chapter is divided in two main 
parts: A) The first part presents the multinational collaborative study known under 
the acronym of LADIS (Leukoaraiosis and Disability Study), which attempted to 
investigate the clinical significance of white matter changes (WMC) as an 
independent predictor of the transition to disability in initially non-disabled elderly 
(64 to 84 years). It was supported by the European Union through the 5th 
European Framework Program ‘Quality of life and management of living 
resources’; B) The second part of the Chapter introduces the long-term follow-up 
of the Portuguese group of participants in the LADIS study, and identifies the 
impact of functional and cognitive decline on caregivers. 
 
The LeukoAraiosis and DISability (LADIS) study 
The Leukoaraiosis and Disability (LADIS) study was an European multicentre 
collaborative research established in 2000, with the support of the European Union 
(5th European Framework Program ‘Quality of life and management of living 
resources’),which aimed to identify the impact of white matter changes (WMC) in 
the transition from an independent functional status to disability in elderly subjects. 
It had two main purposes: 1) to assess the role of WMC as an independent 
predictor of the transition from an autonomous functional status to disability; 2) to 
identify the role of WMC progression in this transition [106]. 
 
The LADIS study was conducted in 11 European centres that were previously 
involved in the investigation of the clinical consequences of cerebrovascular 
diseases (Amsterdam, Copenhagen, Florence, Graz, Göteborg, Lisbon, Helsinki, 
Huddinge, Mannheim, Newcastle-upon-Tyne and Paris, see Appendix 1 for a 
complete list of participants), and had the staff and structure to carry out this novel 
multidimensional research [106]. 
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The study was designed to cover a full range of clinical implications and focused 6 
main work packages (WP): (1) methodology, (2) disability, (3) neuroimaging, (4) 
cognition, (5) mood, and (6) gait. Each WP was responsible for the justification 
and implementation of procedures and harmonization of instruments and 
techniques of clinical assessment, given the cultural and language differences 
between groups. Work package’s coordination also involved the control of data 
report and analysis. A handbook was constructed to guide the use of all clinical, 
cognitive, functional, imaging, behavioural and motor assessment instruments, 
and several meetings were held in order to validate the procedures before 
enrolment of participants. 
 
The Lisbon centre was responsible for the coordination of work package 4 
(cognition), designed to select the neuropsychological battery, to harmonize 
cognitive assessment procedures, to plan the statistical approach of cognitive data 
and to definite parameters of cognitive decline. The construction of the 
neuropsychological battery and the difficulties related with this task, will be 
properly explored in Chapter IV. 
 
Participants 
Inclusion criteria 
Participants in the LADIS study were: a) subjects between 65–84 years of age; b) 
with WMC of any degree indicated on MRI, according to the revised version of 
Fazekas’ scale [107]; and c) with no disability (no impairment or only 1 item 
compromised of those included in the Instrumental Activities of Daily Living scale 
(IADL) [108]; d) with a regularly contactable informant; (e) that agreed to sign an 
informed consent. 
 
To reduce the impact of cultural differences across countries (for example, gender 
social roles) in the IADL scale, the protocol included an extra score (score 9, not 
applicable) to distinguish between activities never performed during her/his lifetime 
from those that were not done at that moment. It also included a specific question 
to determine if activities not done at the moment were due to reasons apparently 
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independent of the subject’s willingness or capabilities (e.g. the subject did not 
have a home phone or never took public transportation because he/she did not 
need it), the interviewer formulated the question in the following way: ‘Suppose 
that he/she has to make a phone call, take public transportation etc. do you think 
he/she would be able to do it?’ and scored the item accordingly. At least 4 out of 
the 8 items of the IADL scale had to be applicable to be included in the study. 
 
Reasons for referral in the study were minor neurological, cognitive, mood or 
motor complaints with no impact on daily activities, and incidental findings on 
cranial imaging performed for a non-specific event. Some participants were 
volunteers from other studies or people who came to accompany their relatives or 
friends, and asked to be included in the study. 
 
Exclusion criteria 
Subjects with severe illnesses that might compromise their presence during the 
follow-up period (cardiac, hepatic or renal failure, cancer or other relevant 
systemic diseases), severe unrelated neurological diseases, other etiologies for 
leukoencephalopathy (immunological demyelinating, metabolic, toxic, infectious, 
other), severe psychiatric disorders, inability to give an informed consent or refusal 
to undergo cerebral MRI, were excluded. 
 
Procedures and instruments 
Participants were submitted to a wide-ranging clinical, functional, motor and 
neuropsychological examination that was repeated yearly during a 3-year follow-
up period. The protocol comprised three main assessment parts: 1) a social 
background and medical history assessment; 2) a functional and clinical 
assessment; 3) a Magnetic Resonance Imaging (MRI) Study (see Table 1). 
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Table 1: Clinical, Functional and Imaging Assessment 
 
Protocol Assessment Instruments 
Social Background and 
medical history 
Standard interview following a comprehensive and structured questionnaire. 
Registry of demographic data, vascular risk factors, age-related co-
morbidities  
Functional and Clinical 
Assessment 
1. Standard cardiovascular and neurological examination;  
2. Functional status and disability  
a. Instrumental Activities of Daily Living scale (IADL) [108] 
b. Disability assessment of dementia scale (DAD) [109] 
3. Quality of Life 
a. Euro QoL EQ-5D [110] 
4. Depression 
a. Diagnostic and Statistical Manual of Mental Disorders 
(DSM) IV criteria [111] 
b. Geriatric Depression Scale (GDS) [112] 
c. Cornell scale for depression in dementia [113] 
5. Motor performance 
a. Short Physical Performance Battery [114]; 
b. Single leg stance and gait velocity [115] 
6. Neuropsychological assessment 
a. Mini-Mental State Examination (MMSE) [37] 
b. Alzheimer’s Disease Assessment Scale (ADAS-Cog) [44] 
plus delayed recall, symbol digit, digit span, mazes, digit 
cancellation and verbal fluency (VADAS-Cog) [116] 
c. Stroop Test [56] 
d. Trail-Making Test [57] 
e. Telephone Interview for Cognitive Status (TICS) [117] 
Magnetic Resonance 
Imaging (MRI) Study 
MRI Protocol 
Axial/coronal T1, T2, PD, 
FLAIR sequences 
Diffusion tensor 
Magnetization transfer 
techniques 
1. WMC severity grade:  
a. Fazekas Scale[107] 
b. Scheltens Scale [118] 
c. European Task Force WMC Scale [119] 
2. Volumetry (semiquantitative measurement) [120] 
3. Atrophy 
a. Scheltens Visual Scale (medial temporal lobeatrophy) 
[121] 
4. Presence of infarcts and lacunes 
a. Visual assessment of number and location and side-by-
side comparison [122, 123] 
5. WMC progression 
a. Rotterdam Progression Scale modified [124] 
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Social background and medical history were assessed with a comprehensive 
and structured questionnaire performed by the trained practitioner, and designed 
to obtain the registry of: a) demographic characteristics, that included information 
on education (years of schooling), occupational status, longest job in life, marital 
status, living conditions, past and current lifestyle habits (alcohol consumption, 
smoking), type of leisure and physical activities; b) specific vascular risk factors 
such as: previous hypertension, determined according to the World Health 
Organization guidelines for the management of hypertension[125]; diabetes 
mellitus, defined based on previous diagnosis and/or current treatment with insulin 
or oral hypoglycaemic medications, or when measured, according to established 
criteria [126]; hyperlipidaemias defined according to reported criteria [127];  
myocardial infarction, documented by history, ECG or cardiac enzymes [128]; 
angina pectoris [129, 130]; heart failure [131]; atrial fibrillation [132]; lower limb 
arteriopathy and peripheral vascular disease [133]; history of stroke and/or TIA 
[134]; cigarette smoking, defined as packs of cigarettes per day multiplied by years 
smoked; alcohol consumption, expressed as consumed grams per day; c) other 
age-related co-morbidities, such as: thyroid diseases, head injuries, falls in the last 
year, hip fractures, visual impairment, hearing loss, recurrent vertigo, any hospital 
admission over the last 3 years and currently used drugs were registered in a 
structured way. Participants were specifically asked if they had gait or bladder 
disturbances, and/or memory complaints. All possible medical information and 
family history vascular disease or risk factures were also collected (See Appendix 
2 with the definition criteria for vascular risk factors and related diseases). 
 
Functional and clinical assessment encompassed: 1) a standard 
cardiovascular and neurological examination, that included blood pressure supine 
measurements; 2) the evaluation of functional status and disability, measured by 
means of the IADL [108] and the Disability Assessment for Dementia scale [109] 
respectively; 3) the evaluation of health-related quality of life, measured by means 
of  the Euro-QoL 5D [110]; 4) the evaluation of depressive symptoms and 
depression (presence and severity), using the Geriatric Depression Scale [112] 
and the Cornell Scale for Depression in Dementia [113], as well as the Diagnostic 
and Statistical Manual Disorders IV (DSM IV) criteria [111]; 5) the evaluation of 
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motor performance using the Short Physical Performance Battery [114] and 
measures of single leg stance and gait velocity [115]; 6) the evaluation of cognitive 
performance using a neuropsychological battery that included the Mini-Mental 
State Examination [37], the Vascular Dementia Assessment Scale [116], the 
Stroop test [56] and the Trail-making test [57]. 
 
For patients who could not attend the follow-up clinical visits, a phone interview 
collecting clinical data and functional status was performed with the patient and 
the carer. The phone protocol also included the Telephone Interview for Cognitive 
Status (TICS) [117] performed with the patient, whenever possible. Based on 
these telephone interviews, and in order to collect information beyond the initial 
follow-up period, a delayed contact took part in 2008–2009. In this contact, 
participants performed the TICS and were asked to answer a clinical questionnaire 
that was also corroborated by the carer. 
 
The MRI evaluation was performed at baseline and at the end of the 3-year 
period, following a standard protocol. MRI studies included T1, T2, proton-density-
weighted and fluid-attenuated inversion recovery pulse sequences. The exact 
sequence parameters were determined at the specific sites to give optimal 
contrast between the normal brain and WMC. For confirmation, representative 
images were checked centrally before the study. Diffusion tensor and 
magnetization transfer techniques were employed by selected centres to further 
characterize tissue changes [106]. 
 
The degree of WMC severity on MRI was rated using the visual scale of Fazekas 
et al. [107] taking into account only deep and subcortical white matter lesions. 
Presence of WMC is classified as mild, moderate and severe stages (Figure 1). To 
improve the homogeneity of ratings, centres were provided with an online atlas 
containing rules and examples for assessing WMC severity. Lesions were 
classified into 3 categories: mild WMC (single lesions below 10 mm; areas of 
‘grouped’ lesions smaller than 20 mm in any diameter); moderate WMC (single 
lesions between 10 and 20 mm; areas of ‘grouped’ lesions more than 20 mm in 
any diameter; no more than ‘connecting bridges’ between individual lesions); 
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severe WMC (single lesions or confluent areas of hyperintensity 20 mm or more in 
any diameter). The local rating in each centre was used to balance the enrolment 
across the 3 severity WMC groups. In parallel, WMC severity was determined 
centrally at the Department of Neurology, Vrije Universiteit Medical Center, 
Amsterdam, the Netherlands, by raters blinded to the clinical details. This rating is 
used for all analyses in the context of WMC. The exact rating procedures and the 
correlation between local and central readings were analysed and the results were 
good. 
 
Figure 1: Grades of WMC severity according to the Fazekas’ Scale 
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During the study period, several analyses were developed and performed using 
MRI data. Volumetric analysis of WMC was performed by a single rater on the 
same axial FLAIR images, including the infratentorial region [120]. Medial temporal 
lobe atrophy was assessed on coronal T1 weighted sequences using the MTA 
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scale [121]. Brain atrophy was evaluated by a single rater at baseline on FLAIR 
images with a template-based rating scale ranging from 1=no atrophy to 8=severe 
atrophy separately for cortical (sulcal) and subcortical (ventricular) regions. In case 
of asymmetry, the side with a more severe atrophy was used for rating. The sum 
of cortical and sulcal atrophy score was taken as a measure of global atrophy. 
 
Based on the comparison of baseline and follow-up MRI scans, progression of 
WMC and presence of new lacunes were visually rated in a side-by-side fashion. 
WMC progression was rated on FLAIR images according to the modified 
Rotterdam Progression Scale (range 0 to 9) [124], in which  “no progression” or 
“progression” (0 and 1, respectively) was rated in 3 periventricular regions (frontal 
caps, occipital caps, bands), 4 subcortical white matter regions (frontal, parietal, 
occipital, temporal), basal ganglia, and infratentorial region. Progression was also 
classified as “no progression”, “mild” (progression in 1 to 3 regions) or “severe” 
(progression in more than 3 regions) [122]. New lacunes were also visually 
assessed, according to the number and location in 5 brain regions (frontal, parieto-
occipital, temporal, basal ganglia, and infratentorial). New cortical / lobar infarcts 
were also identified according to the number and location [122]. 
 
All investigators participated in a general meeting to get familiarized with the 
protocol before they were provided with a specifically developed handbook with 
guidelines for applying criteria and tools. 
 
Neuropsychological evaluation 
The construction of a neuropsychological battery, harmonization of cognitive 
assessment and data analysis procedures, as well as the definition of cognitive 
criteria, were the main tasks attributed to the Portuguese centre in the LADIS 
study. Being such a complex process, with several steps and inherent difficulties, 
the whole procedure was itself object of study and it is presented in Chapter IV. 
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Cognitive Status criteria 
As previously reported, neuropsychological evaluation was performed at baseline 
and yearly during a period of 3 years. 
 
In the follow-up visits participant’s cognitive status was evaluated clinically and 
classified into three groups: 1) no cognitive impairment; 2) cognitive impairment no 
dementia; and 3) dementia, accordingly to established sets of criteria. 
Two types of cognitive impairment no dementia were considered: amnestic mild 
cognitive impairment (MCI), defined as memory complaint, preferably corroborated 
by an informant; impaired memory function for age and education, preserved 
general cognitive function, intact activities of daily living and no dementia [135]; 
and  vascular cognitive impairment without dementia (VCIND), defined as 
evidence of cognitive impairment and clinical consensus to identify significantly 
related vascular features; exclusion of dementia when impairments were not 
sufficiently severe to interfere with social or occupational functioning or when 
impairments were more focal than the global requirement for a diagnosis of 
dementia [136]. 
 
For dementia, the following subtypes and criteria were considered: probable 
Alzheimer disease, according to the NINCDS-ADRDA Work Group [137]; probable 
vascular dementia, according to NINDS-AIREN criteria [138]; subtype of 
subcortical vascular dementia according to Erkinjuntti et al. [139]; frontotemporal 
dementia according to McKhann et al. [140] and dementia with Lewy bodies 
according to McKeith et al. [141]. The criteria of Alzheimer’s disease with vascular 
component was made when the investigator judgement considered that the clinical 
picture presented both aspects of Alzheimer’s disease and vascular dementia. 
 
Instruments and criteria were chosen based on the most frequently used and 
established at the beginning of the LADIS study. 
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Long-Term Follow-Up of the Portuguese Group of 
Participants in the LADIS study 
The second part of the present Chapter offers an extension of former research, 
introducing a long-term follow-up of the Portuguese group of participants in the 
LADIS study. The neuropsychological performance of this cohort in the 10-year 
follow-up period is evaluated, abiding the former standard protocol. Additionally, 
data on the impact of the progression of the disease on caregivers and family are 
reported. 
 
The follow-up of the Portuguese participants of the LADIS study at the end of the 
10-years intermission focused: a) survivors of the Portuguese group of participants 
in the LADIS study; b) attendants or caregivers of those participants. Attendants or 
caregivers included for assessment were those who had been present for at least 
three of the five visits made for evaluation of participants, or those who had 
permanently replaced original caregivers (for example, institution caregivers). 
Caregivers were interviewed for the purpose of assessment on occasion of the 
final visit. 
 
Procedures and instruments 
The research included the clinical, functional, neuro-radiological and 
neuropsychological assessments as formerly detailed and described elsewhere 
[142]. All clinical and neuropsychological assessments were performed by the 
same neurologist and neuropsychologist, who completed them in the course of the 
LADIS study. Follow-up MRI was also carried out with the same equipment and 
following the former protocol so as to ascertain the comparability of results. 
 
For the present purpose, all the Lisbon surviving participants were contacted and 
invited to come to an extra evaluation at the 10th year of follow-up. This visit 
consisted of: 1) a clinical and functional evaluation performed by the neurologist, 
according to the LADIS protocol [106]; (2) a neuropsychological assessment, as 
included the LADIS battery  (the MMSE as a measure of global cognitive status; 
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the ADAS-Cog, to assess memory, orientation, language, ideational and 
constructional praxis, with the extension for vascular impairment, or VADAS-cog, 
that adds the delayed recall of the ADAS’s 10 word lists, and a symbol digit test, a 
digit span backwards, a maze task, a digit cancellation task and an animal naming 
verbal task; the Trail-Making and Stroop tests to assess executive functions; and 
the 9-word version of the California Verbal Learning Test, or CVLT-9 to assess 
memory and learning - see [142], for detailed description of the battery); 3) an MRI 
scan was performed according to the LADIS protocol, at the same Centre and with 
the same equipment previously used in the LADIS study. 
 
Severity of WMC was visually rated by the neurologist, who was blind to 
neuropsychological data, using the Fazekas’ scale. CD copies of the MRI scans 
were sent by mail to the same researcher who rated the follow-up MRI evaluation 
in the LADIS study and who was blind to clinical details and neuropsychological 
data. Progression of the WMC and presence of new lacunes were visually rated in 
a side-by-side fashion, on FLAIR images according to the modified Rotterdam 
Progression Scale. Procedures and criteria are detailed in Chapter VI 
 
For participants who were unable to come to the hospital for assessment, home 
visits were conducted for clinical and neuropsychological evaluation. Information 
concerning non-surviving participants was collected in a face-to-face or telephone 
interview with the caregivers/informants. This interview included a drop out/death 
questionnaire used in the LADIS study, which collects clinical and functional data. 
 
Impact of the Progression of the Disease on Caregivers and 
Family 
Caregivers were invited to participate in this research at the same moment that 
their relatives or patients were contacted. They were informed that the study was 
conducted by the neuropsychologist and that they had to be interviewed in one-
only visit with the aim to identify caregiver’s needs. The same information was 
written and explained when requested, in the consent form (Appendix 3). 
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Participants in this research were assessed using the following instruments: 
MMSE [37] to evaluate any cognitive deficit; an open nondirective interview 
modelled on that used in the Canadian Study of Health and Aging [143], which 
collects information on the caregiver’s sociodemographic and professional identity, 
on the type of care offered, on the support obtained (institutional, or others), its 
bearing on professional and social activities and its effect on health and quality of 
life; The Caregiver Strain Index [144]to assess subjective burden; the MOS SF-36 
Index, to assess quality of life [145]; the Brief COPE [146] to identify what coping 
strategies caregiver uses. In addition to quantitative analysis of data produced with 
scales applied, content analysis of open interviews, aiming to pinpoint the more 
frequent complaints / needs reported, were performed. 
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IV - Development of a neuropsychological battery 
for a multinational study: the LADIS (Leukoaraiosis 
And DISability) experience and baseline data 
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Introduction 
The relationship between age-related white matter changes (ARWMC) and 
cognitive impairment has been described in several studies in different population 
samples [147, 148]. 
 
In community-dwelling and independent elderly subjects, some studies reported 
an association between the presence of ARWMC and deficits in global mental 
functioning, speed of mental processing and memory [22, 24, 26, 30, 149-151]. 
However, others failed to find a relationship between the presence of ARWMC and 
cognitive performance [15, 152, 153]. 
 
There are a number of factors that can explain the inconsistency of these results. 
They may be related to the design of the studies, the type of analysis performed 
on imaging and the neuropsychological evaluation. Further, regarding cognitive 
performance, the variability of results can be due to the use of different 
instruments and measures to assess cognition, the use of different criteria to 
define cognitively impaired performance, and the use of non-sensitive instruments, 
such as global measures of cognition, or tests sensitive to memory decline but not 
to executive functioning. 
 
Despite the recent interest and effort to analyse the impact of ARWMC on 
cognition, there are still several issues that need to be explored. How is cognitive 
functioning influenced by ARWMC? Is there a threshold of ARWMC needed to 
affect cognition? Which cognitive domains are mainly affected by the presence of 
ARWMC and which domains are more sensitive to decline in parallel to the 
progression of ARWMC? Is there a neuropsychological profile related to the 
location of ARWMC? 
 
The LADIS (Leukoaraiosis and Disability) Study aims to assess the role of 
ARWMC as an independent predictor of disability in the elderly [154], contributing 
with answers to the above-mentioned issues. The LADIS study involves 11 
centres of 10 European countries (Appendix 1). 
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The assessment of cognitive functions is a difficult task, starting with the selection 
of the appropriate tests to evaluate specific domains. The difficulty increases in 
multinational studies since the performance in majority of the tests is dependent 
on educational, language, cultural and demographic variables. 
 
The aims of the present work are to describe the development of the LADIS 
neuropsychological battery, to present LADIS neuropsychological baseline data, 
and to discuss the methodological problems and limitations of the cognitive 
assessment within the LADIS study. 
 
Methods 
LADIS organisation and methodology have already been reported elsewhere [154]. 
 
Construction of the neuropsychological battery 
The construction of the LADIS neuropsychological battery took in consideration 
that: 1) selected tests had to be available and familiar in the majority of the 
centres; 2) the tests had to be sensitive to cognitive decline; 3) the battery had to 
be innovative, comprehensive, easy to administer, but not too long; 4) all centres 
had to use the same version of each test; 5) the original English version of tests 
had to be translated in each local language. 
 
In order to construct the neuropsychological battery for the LADIS study, we 
performed a review of the studies investigating elderly samples with ARWMC 
using comprehensive cognitive assessments, published until 2001, and selected 
the most frequently used instruments. In this review, we also retrieved the criteria 
for the definition of abnormal performance on the neuropsychological tests used 
on each study. A list of tests was made according to the frequency they appeared 
in the studies. All participating centres received a questionnaire in which, for each 
test of the list, several questions were asked: a) if the test was available at their 
centre; b) if it was routinely used for cognitive assessment; c) if it had 
local/national validation norms; d) if the original or other versions were used. 
 
 40 
Of the eight tests initially selected, the Mini-Mental State Examination [37] and the 
Stroop test [56, 155] were the only tests available and in use for assessment in all 
centres. However, the versions used were slightly different from centre to centre 
and normative values existed in only 62% (MMSE) and 69% (Stroop) of the 
countries. Verbal fluency tests were also available in all centres, with normative 
values for 92% of the countries. Nevertheless, the variability of versions was wide: 
some centres used semantic fluency (animals, colours, fruits, cities, or 
supermarket goods), others used only controlled oral word association tests (using 
different letters such as FAS, PFL or LPS). The Wisconsin Card Sorting Test [156] 
was available in almost all the centres, but with different versions (original and 
modified). Further, in half of the centres it was not used on a regular basis. 
 
The following tests were initially selected for inclusion in the LADIS 
neuropsychological battery: the MMSE to assess global mental status; the Stroop 
Test and Trail-Making [57] to assess executive functions. In the absence of any 
frequently used battery, we added the VADAS-Cog [46] which is a recently 
developed instrument used to assess the cognitive performance of patients with 
vascular dementia. It is composed by the well-known ADAS-Cog [44], which 
assesses memory, orientation, language, ideational and constructional praxis, in 
addition to other specific tests that evaluate memory with interference, attention 
and executive functions (delayed recall, symbol digit, digit span, maze, digit 
cancellation, verbal fluency). The psychometric properties of these tests have 
been previously described with elderly populations [157, 158]. Table 2 tabulates 
the neuropsychological tests composing the initially LADIS battery and the 
cognitive domains they assess. 
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Table 2: LADIS Neuropsychologicalbattery 
 
 
In order to reduce the time needed to administer the VADAS-Cog, only one trial 
was used on subtest 1 (word recall) and subtest 8 (word recognition), instead of 
the original three. On the VADAS-Cog, the translation of the words on subtests 1 
and 8 was made according to the frequency of the words in each language [159]. 
On subtest 5 (naming objects), we used drawings instead of real objects, as it was 
the best way to reduce the heterogeneity of administration. The subtest “delayed 
recall” of the words of subtest 1 was also included on the ADAS-Cog. This subtest 
is scored as the other items of the ADAS-Cog (higher score representing worse 
performance). Because of these modifications, we will use the designation ADAS-
Mod instead of ADAS-Cog. Finally, part B of trail-making (original version) was 
locally adapted to the alphabet of each country. 
 
The original English version of all tests was collected by the centre responsible for 
the neuropsychological assessment workpackage and mailed to each centre to be 
locally translated. A handbook with the instructions of all the tests was also 
distributed to the centres in order to guarantee that each instrument would be used 
in the same way. 
 
For the second year of follow-up, two additional tests were included: the 9-Word 
California Verbal Learning Test [160] and the constructional praxis delayed recall 
(based on the CERAD battery [161]), in order to improve the assessment of 
memory decline. Both these tests and the instrument used to assess participants 
who were unable to come to the visits (the Telephone Interview for Cognitive 
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Status [162]) will be described and analysed elsewhere, along with the results of 
the last follow-up.  
 
Analysis of neuropsychological data 
Neuropsychological data were analysed as follows: 1) analysis of the test scores 
distribution; 2) analysis of the differences on the neuropsychological performance 
related to the demographic variables and centre; 3) analysis of the influence of 
demographic variables on cognitive performance; 4) analysis of the influence of 
other potential confounding variables such as visual deficit, previous stroke, or 
centre of inclusion on the neuropsychological performance. 
 
MMSE was used only as a global measure of cognitive functioning and analysed 
either as a continuous variable or categorised using the cut-off of ≤ 23 (for 
dementia), or < 25 (for cognitive deficit) [163]. The Stroop test was considered a 
measure of executive function, and the analysed measure was time used to 
perform Stroop 3 minus the time to perform Stroop 2. The Trail-making test was 
considered a measure of executive functions using the score “time needed to 
perform part B minus the time to perform part A”. Trail-making/A score was also 
used as a measure of speed and motor control. Higher scores on both the Stroop 
and the Trail-making represented worse performance. VADAS-Cog was analysed 
in two ways: a) as a global measure, consisting of the scores of ADAS-Mod items 
word recall, commands, constructional praxis, delayed recall, naming, ideational 
praxis, orientation, word recognition, remembering instructions, spoken language 
ability, word finding difficulty, comprehension, and concentration / distractibility. 
Higher scores represented worse performance; b) the 5 additional subtests digit 
span backwards, maze task, digit cancellation, symbol-digit and verbal fluency 
were evaluated independently. In all the tests except for maze (where the score is 
the time to complete the task), higher scores represent better performance. 
 
Depending on the aim of the study performed on the LADIS sample, cognitive 
variables were analysed as continuous or categorical using specific cut-offs (in the 
case of MMSE) or the quartiles of the distribution of the LADIS sample (Table 3). 
For the present paper, all the test scores were analysed as continuous variables. 
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Table 3: Quartiles of the distribution of the neuropsychological tests scores 
 
 
 
The distribution of the test scores was analysed for each variable. Non-normal 
distributions with marked skewness (> 2) were transformed into normal or less 
skewed distributions using a logarithmic transformation of the scores. Data 
analysis was conducted using both the raw and the transformed scores. As the 
results of raw and transformed scores where similar, the results based on raw 
scores were presented.  
 
To compare performances across tests and by cognitive domain, we used Z-
standard scores, using the distribution of the LADIS sample. To analyse 
performances by domain, compound measures were calculated using standard 
scores. Three main domains were analysed: 1) memory = z-scores of (Immediate 
word recall + delayed recall + word recognition + digit span) / 4; 2) executive 
functions = z-scores of ((Stroop3-2) + (Trail-making/B-Trail-making/A) + Symbol 
digit + verbal fluency) / 4; 3) speed and motor control = z-scores of (Trail-making/A 
+ Mazes + Digit cancellation) / 3. Z-scores of the tests that had higher scores 
representing worse performance were inverted (- Z) in order to calculate the 
compound measure score. A preliminary exploratory factor analysis was 
performed to evaluate the validity of the neuropsychological battery and the 
aforementioned compound measures, using Principal Component Analysis as 
extraction method and Varimax Rotation. The obtained solution was compared 
with the theoretically derived dimensions. 
 
The degree of ARWMC severity on MRI was rated into mild, moderate and severe 
using the visual scale of Fazekas et al. [164], taking only deep and subcortical 
white matter lesions into account. 
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The demographic variables considered for the present analysis were age, 
education, gender, living conditions (alone or with others), and employment status 
(retired, working). Age and education were analysed as continuous variables, 
except for when comparing demographic variables and neuropsychological 
performance where they were dichotomized using the median of the LADIS 
sample (74 years and 9 years, respectively). 
 
There were several reasons for referral for the LADIS study, including minor 
cognitive or neurological complaints, stroke or other neurological disturbances 
[154]. Therefore, sources of referral were analysed as variables that could 
influence the performance on neuropsychological testing. Other possible 
confounders for the analysis of cognitive performance, such as visual or hearing 
deficits, were also considered in data analysis. 
 
Statistical analysis 
Descriptive statistics was performed to analyse the quality and distribution of the 
neuropsychological data. The distribution of demographic characteristics and test 
scores among centres was performed using box and whiskers plots. Differences 
among centres were calculated using one-way ANOVAs with Bonferroni or 
Tamhane’s (equal variance not assumed) post-hoc analyses for multiple 
comparisons. 
 
The neuropsychological performance in each test and domain was compared 
across demographic characteristics (age, sex, education, living conditions, 
employment status) using t-tests. Performance across cognitive tests was also 
compared according to the sources of referral using one-way ANOVA with 
Bonferoni post-hoc analysis. In order to study the influence of demographic 
variables on cognitive performance, linear regression models (including all the 
significant variables in the previous comparisons, p<0.05) were performed for each 
neuropsychological test and domain. Possible confound variables that could 
influence the results on neuropsychological performance, such as presence of 
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visual or hearing deficits, previous stroke or centre of origin, were also included in 
an additional linear regression model. 
 
Results 
Baseline neuropsychological data 
Six hundred thirty-nine patients were enrolled in the LADIS study. Baseline 
demographic and WMC characteristics, as well as the reasons for referral of the 
patients are shown on Table 4. Neuropsychological examination was performed 
on 638 (99.8%) patients. 
 
Table 4: Baseline demographic and WMC characteristics and reasons for 
referral of the patients 
 
 
Quality of data and distribution of the test scores: 
The highest number of missing values (33 patients, 5%) was observed on trail-
making / part B (mental flexibility) and Stroop test / part 3 (3%). Five-hundred 
seventy-eight patients (91%) had no missing values on the neuropsychological 
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evaluation. Skewed distributions with a ceiling effect were observed in the subtests 
command, naming, ideational praxis, orientation, mazes, remembering 
instructions, spoken language, word finding difficulties, comprehension and 
concentration, which were transformed using the logarithmic of the scores. There 
were no differences in the results either using transformed or raw scores (data 
available when requested). 
 
Preliminary exploratory factor analysis: 
Factor analysis of principal components with varimax rotation extracted three 
factors: The eigenvalues for the 3 factors were 5.90, 1.44 and 1.41, explaining 
48.6% of the total variance. For Factor I, the most salient tests were trail A, trail B, 
trail B-A, symbol digit, digit cancellation, maze task and verbal fluency. We 
denominated this factor as Executive Functions. Factor II was designated as 
Selective Attention because only Stroop 3 and Stroop 3-2 were loaded saliently. 
Factor III, was designated as memory as the loadings of the tests of memory as 
word immediate and delayed recall, word recognition and orientation were the 
most salient. For the compound measures scores, we excluded the simplest time 
performed tests as trail A, maze task and digit cancellation from the Executive 
Functions and added the Stroop test, for theoretical and interpretability reasons. 
The timed-performed tests were grouped into a Speed / Motor control measure. 
 
Distribution of the test scores according to centre: 
Significant differences among centres were observed for all tests (One-way 
ANOVAs). Post-hoc analysis (Bonferroni’s was employed for all tests, except for 
symbol digit and verbal fluency which were analysed with Tamanhe’s test) showed 
that differences were randomly distributed, and no consistent pattern was found 
(there was no centre always better or worse than the others) (Figure 2). 
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Figure 2: Distribution of the test scores of the whole sample and by center 
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Box and whiskers represent the upper quartile (top of the box) and the lower quartile (bottom); bar represents 
the median; the largest value is on the superior whisker; the smallest value is on the inferior whisker. Open 
circles and asterisks signify outliers and extreme scores, respectively 
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The distribution of age and education by centre was analysed, as they are 
important variables for neuropsychological performance. No significant differences 
were found among centres with respect to age (F(10,628)= 1.27; p= 0.24). Education 
had a normal distribution with significant differences among centres 
(F(10,627)=11.76; p<0.001). Using Bonferroni post-hoc test, we found that Lisbon 
and Florence centres differed systematically from the other centres as they had 
the lowest mean educational levels (for both, p<0.01). 
 
Mean differences regarding demographic variables: 
Table 5 shows the differences on neuropsychological performance according to 
the demographic variables 
 
Age 
Older subjects (> 74 years) performed significantly worse than younger subjects 
on the ADAS-Mod Total based on the differences found on ADAS-Mod subtests 
constructional praxis (t(513)= -3.09; p< 0.01) and delayed recall (t(607)= -3.12; 
p<0.01). Older subjects also showed worse performances on Stroop part 3 (t(617)= 
-2.63; p<0.01), trail making A (t(537)= -3,16; p<0.01) and B (t(456)= -3,40; p<0.01), 
symbol digit (t(625)= 3,72; p<0.01), digit cancellation (t(631)= 4.94; p<0.001) and 
verbal fluency (t(629)=-2.83; p<0.01). Comparing the performance by cognitive 
domain, older subjects performed worse than younger subjects on executive 
functions (t(581)= 4.68; p<0. 01), memory (t(631)= 3.25; p<0. 01) and speed/motor 
control (t(587)= 4.01; p<0.01). 
 
Gender 
Women performed significantly worse on the ADAS-Mod subtest constructional 
praxis (t(635)= 3.18; p<0. 01) and maze (t(630)= 2.54; p<0.01). There were no gender 
differences considering the three cognitive domains: executive functions (t(581)= -
0.99; p=0.31), memory (t(628)= -0.18;; p=0.85) and speed/motor control (t(621)= -
1.46; p=0.14). 
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Education 
Significant differences between subjects with higher (> 8 years of school) and 
lower educational level (< 9 years) were observed on all tests, except on ADAS-
Mod orientation (t(555)=1.93; p=0.05, immediate word recall (t(635)=1.59; p=0.11), 
word recognition (t(633)=1.93; p=0.05), and commands (t(577)=1.94; p=0.05). 
Considering the compound measures of cognitive domains, subjects with lower 
educational level had worse performances on executive functions (t(581)=-10.74; 
p<0.01), memory (t(631)=-4.99; p<0.01), and speed/motor control (t(381)=-8.36; 
p<0.01). 
 
Living conditions 
Participants who lived alone tended to performed better on trail-making A (t(568)= 
2.19; p<0.05). However, there were no differences on the other tests, nor on the 
cognitive domains executive functions (t(581)=0.52; p=0.60), memory (t(631)=0.46; 
p=0.64) and speed/motor control (t(530)=-1.20; p=0.22). As it was not a significant 
variable, it was not included in the regression models. 
 
Employment status 
Participants who were still working performed worse on the ADAS-Mod commands 
(t(29)=-3.28; p<0.01). No differences were found on other tests, nor on cognitive 
domains of executive functions (t(576)=1.48; p=0.14), memory (t(626)=1.05; p=0.29) 
and speed/motor control (t(616)=1.02; p=0.31). As participants still working 
represented only 4% of the LADIS population, this variable was also not included 
in the regression models. 
 
Sources of referral 
Using a one–way ANOVA, we found significant differences in all the cognitive tests, 
except for the MMSE (F(6,631)= 0.72; p= 0.63), ADAS-Mod subtests word recall 
(F(6,630)= 1.93 p= 0.07), commands (F(6,630)= 1.33; p= 0.24) and constructional 
praxis (F(6,630)= 1.67; p= 0.12). Post-hoc analysis showed that healthy volunteers 
performed better in all the cognitive tests compared with patients with previous 
stroke or other complaints. 
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Multiple regression analysis 
Multiple linear regression models were used to analyse the influence of the 
demographic variables on the neuropsychological performance. Table 5 shows the 
analyses performed with model 1, that included the variables age, education and 
gender; model 2, with added possible confounders, such as previous stroke, and 
any complaint or visual deficit; and model 3, in which centre origin was added as a 
covariable. Age remained an important variable influencing the performance of 
ADAS-Mod Total (R2= 0.10; F2,630 = 35.41; β=0.17; p<0.001) and cognitive 
domains executive functions (R2= 0.22; F2,580 = 79.99; β=-0.22, p<0.001), and 
speed/motor control (R2= 0.16; F2,619 = 59.68; β=-0.17, p<0.001). 
 
There was no other significant influence of gender on neuropsychological 
performance except on ADAS-Mod constructional praxis (R2change= 0.004; F6,629 = 
10.62; ; β= -0.10, p<0.01). 
 
Education remained an important variable influencing the performance on all the 
tests and domains of executive functions, memory, and speed/motor control 
(Table 6). 
 
Variables that might work as confounders of cognitive performance, such as 
“referral for any complaint“ (vs healthy volunteers), and previous stroke and visual 
problems, were included on the second linear regression model. To have any 
complaint remained an important variable influencing the performance on trail-
making A (R2change= 0.02; F6,625 = 19.48; β= 0.12, p<0.01), trail-making B-A 
(R2change= 0.10; F16,587 = 11.81; β= 0.10, p<0.01), symbol digit (R2change= 0.03; F6,619 
= 44.90; β= -0.13, p<0.001), digit cancellation (R2change= 0.06; F6,618 = 31.90; β= -
0.21, p<0.001), digit span (R2change= 0.01; F6,627 = 18.62; β= -0.10, p<0.01) and 
compound measures speed / motor control (R2change= 0.03; F6,615 = 24.03; β= -
0.12, p<0.001) as well as executive (R2change= 0.02; F6,576 = 30.32; β= -0.10, 
p<0.01).  When visual impairment was included on the linear regression models its 
influence was observed on the performance of trail-making B-A (R2change= 0.10; 
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F16,587 = 11.81; β= 0.10, p<0.01), maze task (R2change= 0.03; F6,624 = 14.57; β= 
0.15, p<0.001) and delayed recall (R2change= 0.03; F6,628 = 10.34; β= -0.12, p<0.01). 
 
On the third step of the models, centre of origin was included as covariable. We 
found that centres influenced the performance of all the tests, but again the 
findings were randomly distributed and there was no centre influencing 
systematically all the dependent variables in the same way (Table 6). 
In all the models, age and education remained important factors for 
neuropsychological performance. 
 
Discussion 
The LADIS neuropsychological battery was constructed with the purpose to 
evaluate the cognitive performance of a cohort of independent subjects with 
ARWMC, during a period of three years of follow-up. It is a comprehensive but not 
too long instrument able to be administered on a single visit, making it less 
unpleasant and intrusive for older patients.  This battery was chosen based on the 
familiarity of the tests and the validity of the instruments to assess the decline of 
cognitive functions of patients with vascular disease. The LADIS battery explores a 
whole range of cognitive functions. Along with widely known and validated 
instruments (MMSE, Stroop and trail-making tests), it included the recently 
developed VADAS-Cog, which provides detailed information on cognitive global 
and selective functioning. Although based on the Alzheimer’s Disease Assessment 
Scale (ADAS), the inclusion of time dependent tasks on VADAS (symbol-digit 
substitution, mazes tracing, digit cancellation and verbal fluency) complemented 
the evaluation of attention, speed of mental processing and motor control. These 
cognitive functions, along with executive functioning, are possibly more likely to be 
affected by white matter changes [165]. 
 
The inclusion of memory specific measures, particularly the 9-word CVLT, during 
the second and third year of follow-up, was adopted as a way to improve the 
evaluation of memory decline minimizing the learning effect that might occur if the 
memory test or the VADAS word recall subtest were administered four times 
instead of two. 
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The use of the same version and guidelines for administration of the tests in all the 
centres reduced the heterogeneity of the cognitive evaluation and allowed the 
appropriate evaluation of the whole sample of the LADIS cohort. 
 
Nevertheless the neuropsychological battery adopted on the LADIS Study has 
some limitations: 1) when trying to reduce the time to administer the cognitive 
battery by using one trial instead of three as described in the original version of 
VADAS word recall subtest, we did not include any measure of learning memory 
on the baseline assessment and compromised the possibility of comparing the 
results of the LADIS sample with other studies that use the same instrument. 
However, this limitation was minimized by the inclusion of the 9-word CVLT during 
the second and third follow-up visits; 2) the test versions adopted were not 
validated in each centre/country and there is no control group to compare the 
results of the LADIS sample. The absence of a control group is due to fact that it 
would be necessary to perform MRI on normal volunteers and that would increase 
enormously the costs of the study; 3) using a handbook with all the administration 
norms for each test, we tried to reduce the differences concerning the training of 
the examiners that could lead to differences on the results. 
 
Analysis of data obtained using the LADIS neuropsychological battery shows that 
differences among centres were observed for almost all the tests except naming 
and ideational praxis. However, the differences were randomly distributed and no 
consistent pattern was found. Cultural and educational variables might explain 
some of the differences between centres. Despite that, when Florence and Lisbon 
(which had the lowest mean education level) were excluded from the analysis, 
differences among centres remained. We found that, when compared with 
younger subjects, older subjects performed significantly worse on trail-making, 
symbol digit, digit cancellation tests and on executive functions and memory 
compound measures. Age remained an independent variable influencing the 
performance on memory and executive functions domains even when controlling 
for ARWMC severity. The effect of age on neuropsychological performance of 
healthy subjects with ARWMC was also reported by Ylikoski [30] ,who found that 
cognitive performance decreased on memory tests, constructional abilities, 
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language, timed performed tests and speed of mental processing. Our results are 
similar to those found on this work. 
 
Education was the most consistent factor influencing the performance in all the 
neuropsychological tests and domains. The association between education and 
cognitive performance remained significant in the presence of ARWMC. Memory 
performance seems to be independent of the effect of education. This could be 
explained by the fact that in the baseline assessment of our study, memory was 
mainly evaluated verbally (word recall, delayed recall, word recognition, digit span), 
reducing the influence of education on pencil/paper tests. On the other hand, 
education seems to play a more important role on complex tasks such as 
executive functions. One study evaluating mainly speed and executive functions 
[166] reported the influence of education on the cognitive performance of a sample 
of elderly subjects with ARWMC. Dufouil et al. [167] found no relationship between 
WMC severity and cognitive performance on participants with a high level of 
education, and thus reinforced the hypothesis of the cognitive reserve [167]. 
Independently of the way education influences cognition, it should be considered 
as a covariate variable on analysing the effect of ARWMC on neuropsychological 
performance. 
 
On the LADIS sample women performed worse on MMSE, constructional praxis 
and mazes. Female gender has been associated with difficulties performing 
visuoconstructional tasks and spatial orientation, which could explain the 
difficulties performing both constructional praxis and maze task. Although some 
studies [22, 168] reported a prevalence of earlier and more severe ARWMC on 
women, in our sample the prevalence and severity of ARWMC was similar for both 
sexes. In our study, women tended to have less years of education, which might 
explain the difference on the MMSE. Ott et al., on a large populational study [169], 
reported a stronger association between low education and dementia in women 
than in men. However, in a recent study, Ruitenberg et al. [170] found that this 
association was mainly significant among people over 90 years old and that the 
incidence of dementia was similar for both sexes before this high age. 
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Conclusion 
In our study, the analysis of the baseline neuropsychological data showed a 
significant influence of demographic variables on cognitive performance.  
Neuropsychological performance in patients with ARWMC was influenced by age 
and education. Higher educational level was consistently associated with better 
performances on cognitive tasks, while older age was associated with difficulties 
on memory and executive functions. The analysis performed on 
neuropsychological data on the LADIS study, thus, had to use age and education 
as modifiers and therefore as covariables. 
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Table 5: Influence of demographic variables on neuropsychological performance (t-test results) analysis 
 
Values are t-test; *p<0.01; **p<0.05; TM = Trail making; EXEC = executive functions compound measure; DC = digit cancellation; Sy Dig = Symbol-digit; Dig Sp = Digit Span; Im Word 
Recall=Immediate Word Recall; Word Del Recall= Word Delayed Recall; Word Recog = Word Recognition; MEM = Memory compound measure; Com = commands; Name = Naming; VC 
Praxis = Visuo-Constructional Praxis; Id Praxis = Ideational Praxis.  
 
 MMSE 
Executivefunctions Attention 
Speedand motor 
control 
Memory Language Praxis ADAS 
Stroop 
3 
Stroop 
3-2 
Verbal  
fluency 
TM 
B-A 
TM-B EXEC DC Sy 
Dig 
TM-A Maze Speed Dig 
Sp 
ImWord 
Recall 
Del 
Word 
Recall 
Word 
Recog 
MEM Com Name VC 
Praxis 
Id 
Praxis 
ADAS 
Total 
Age NS. -2.63* -2.55* -2.83* -2.86** -3.40* 4.68* 4.94* 3.72* -3.16* -2.21** 4.01* NS NS -3.12* -2.14** 3.25* NS NS -3.09* NS -3.84* 
Gender -2.31** NS NS NS NS NS NS NS NS NS 2.54** NS NS NS NS NS NS NS NS 3.18* NS NS 
Education -6.66* 6.01* 5.14* -7.37* 6.93* 8.33* -10.74* -9.80* -13.48* 7.84* 5.87* -8.36* -9.41* NS 5.83* NS -4.99* NS 6.7* 5.39* 2.97* 5.69* 
LivingConditi
ons 
NS NS NS NS NS NS NS NS NS 2.19** NS NS NS NS NS NS NS NS NS NS NS NS 
Employment 
Status 
NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS -3.28* NS NS NS NS 
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Table 6: Influence of demographic variables on neuropsychological performance (linear regression analysis) 
 
Values are standardized Beta; *p<0.001; ** p< 0.01; NS = p>0.05; TM = Trail making; EXEC = executive functions compound measure; DC = digit cancellation; Sy Dig = Symbol-digit; Dig Sp = Digit Span; Im Word Recall=Immediate Word Recall; Word 
Del Recall= Word Delayed Recall; Word Recog = Word Recognition; MEM = Memory compound measure; Com = commands; Name = Naming; VC Praxis = Visuo-Constructional Praxis; Id Praxis = Ideational Praxis.  
Centres: AM = Amesterdam; CO = Copenhagen; FL = Florence; GO = Goteborg; GR = Graz; HE = Helsinki; HU = Huddinge; LS = Lisbon; MA = Manheim; NC = Newcastle; PA = Paris, 
 
 
MMSE 
Executivefunctions 
EXEC 
Attention 
Speedand motor 
control 
Memory 
MEM 
Language Praxis ADAS 
Stroop 
3 
Stroop 
3-2 
Verbal 
fluency 
TM 
B-A 
TM 
B 
DC 
Sy 
Dig 
TM-A Maze 
SPEE
D 
Dig 
Sp 
Im Word 
Recall 
Del Word 
Recall 
Word 
Reco 
Com Name VC Praxis Id Praxis ADAS Total 
MODEL 1 
 
(R2) 
.12* .07* .05* .12* .12* .18* .22* .18* .27* .14* .10* .16* .14* .02* .06* .04* .08* ns .09** .10* .02** .10* 
Age ns ns ns -.14* .15* .18* -.23* -.23* -.18* .13** ns -.17* ns  .15* .11** -.15*  ns .10** ns .15* 
Education 0.33* -.24* -.20* .31* -.31* -.38* .40* .34* .49* -.34* -.27* .36* .38* -.12** -.18* -.15* .24*  -.30* -.25* -.13** -.27* 
Gender ns ns ns ns ns ns ns ns ns ns ns ns ns ns ns  ns   -.10** ns ns 
MODEL 2 
 
(R2change) 
ns .02** ns ns .02** .03* .02* .06* .03* .02** .03*. .03* ns ns .03* ns ns ns ns ns ns ns 
Age  ns   .15* .17* -.22* -.22* -.17* .12** ns -.15*   .16*        
Education  -.22*   -.29* -.36* .38* .32* .46* -.33* -.26* .34*   -.17*        
Gender  ns   ns ns ns ns ns ns ns ns   ns        
Anycomplaint  ns   ns ns -.10** -.21* -.13* .12** ns -.12**   ns        
Stroke  ns   ns ns ns ns ns ns ns ns   ns        
Visual deficit  ns   ns .10** ns ns ns ns .15* ns   -.12**        
MODEL 3 
 
(R2change) 
.07*. .05*. .05**. .09* .10* .13* .10*. .07*. .08* .10* .11* .10* .06* .10*. .29* .09* .14** ns .12* .07* .06* .15* 
Age ns ns ns -.16* .16* .18* -.22* -.22* -.18* .12* .12** -.17* ns .11** .17* .11** -.17*   ns ns .16* 
Education .37* -.20* -.17* .29* -.30* -.33* .37* .26* .43* -.25* -.21* .27* .36* -.17* -.21* -.15* .27*   -.26* -.11** -.29* 
Gender ns ns ns ns ns ns ns ns ns ns ns ns ns ns ns ns ns   -.12** ns ns 
Anycomplaint ns ns ns ns .15**. .14**. -.12** -.12** ns ns ns ns ns ns ns ns ns   ns ns ns 
Stroke ns ns ns ns ns ns ns ns ns ns ns ns ns ns ns ns ns   ns ns ns 
Visual deficit ns ns ns ns .10** .11** ns ns ns ns ns ns ns ns ns ns ns    ns ns 
Centre1 HU -.18* CO -.20*;  
GO -.17** 
CO -.14**; 
GO -.15** 
CO .20*;  
HE .13** 
CO -.18*; 
HU -.13** 
CO -.22*;  
FL .13**;  
GO -.16**;  
HU -.20* 
AM -.14**;  
CO .14**;  
FL -.18** 
CO .13**; 
FL -.12**;  
GO .13**;  
NC .21* 
CO .19*; 
HU .16*; 
NC .15** 
CO -.21*; 
GO -.14**; 
GR -.14**; 
HE -.13**; 
HU -.22*; 
MA -.15**; 
NC -.21* 
All centres 
All 
except 
PA 
and FL 
CO .13**; 
NC .19**; 
PA .12** 
AM .13**; 
GO -.15**; 
GR .27* 
AM .14**; 
GO -.19*; 
GR .29*; 
HE .14**; 
HU -.23*; 
NC -.22* 
AM .17**; 
FL .15**; 
PA -.15** 
AM -.20*; 
GR -.25* 
 
CO -.20*; 
FL .15**; 
GO -.16**; 
HU -.18*; 
MA -.21*; 
NC -.19** 
AM .19*; 
FL .23*; 
GO .17**; 
HU .21*; 
MA .19*; 
NC .18**; 
PA .21 * 
GO -.14**; 
HU -.14**; 
NC -.17** 
AM .30*; 
FL .21*; 
GR  .19* 
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V - Neuropsychological predictors of dementia in a 
3-year follow-up period: data from the LADIS study 
 
 
  
 62 
Introduction 
Age-related white matter changes (ARWMC) have been associated with cognitive 
impairment and dementia, and represents a form of cerebrovascular disease. 
However, the relation between severity of ARWMC and progression to dementia 
or other forms of vascular cognitive impairment, which include vascular dementia 
and other cognitive impairment without dementia, is still not completely understood. 
 
The LADIS study is a large multinational three-year longitudinal study [106, 171] 
that aims to identify the importance of the presence of ARWMC on the transition to 
disability in a non-disabled elderly population. For this pan-European study, a 
specific neuropsychological battery was constructed in order to include 
instruments sensitive to changes related with the presence of ARWMC, mainly 
executive and speed of mental processing functions [172, 173]. 
 
The importance of the use of sensitive measures for the cognitive evaluation of 
this specific population was described by Ylikoski et al. [173]. Their results showed 
that the inclusion of tests reflecting mental speed and executive functions, the 
VADAS-cog extension of the ADAS-Cog [46], was an important tool differentiating 
patients with mild to moderate and severe ARWMC. Although several instruments 
have been used in the assessment of cognitive dysfunction (including VADAS-Cog 
in clinical trials), it is important to validate sensitive tools for specific populations as 
it is the case of vascular patients, since different patterns of neuropsychological 
functioning are expected. 
 
In addition, in a previously reported cross-sectional analysis of the 
neuropsychological baseline LADIS data, we identified the importance of other 
demographic (older age, lower educational level) and clinical (presence of 
diabetes, hypertension, previous stroke) factors on cognitive performance [172, 
174] along with the presence of ARWMC. 
 
Several studies performed with patients and healthy elderly have also associated 
specific cognitive deficits with ARWMC, such as speed of mental processing and 
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executive functions [30, 175, 176]. However, there is less information regarding 
the way these deficits progress over time. 
 
Recent studies [177, 178] tried to identify neuropsychological predictors of 
vascular cognitive impairment (VCI), differentiating them from those frequently 
associated with Alzheimer’s disease (AD). Ingles et al. [177] reported that low 
baseline scores on tests of free recall, similarities, comprehension, block design, 
and verbal fluency were associated with incident VCI 5 years after the inclusion. 
Also a trend toward an association between low baseline scores on the similarities 
subtest and incident VCI was found, in comparison with incident AD. 
 
The aim of this paper is to determine the extent to which in the LADIS population, 
baseline performance in specific neuropsychological tests was able to predict the 
clinical diagnosis of dementia three years later. 
 
Methods 
Participants and methods 
The rationale and methodology of the LADIS study have been extensively reported 
elsewhere [171, 172]. Briefly, the LADIS is a longitudinal multinational study 
involving 11 centres from 10 European countries (see Appendix 1) which aims to 
evaluate the impact of white matter changes on the transition to disability. 
Inclusion criteria were: a) age 65 to 84 years, b) white matter changes of any 
degree according to the modified Fazekas’ visual rating scale [179], c) no or mild  
impairment (none or one item affected) on the instrumental activities of daily living 
(IADL) scale [108], and d) presence of a contactable informant and agreement to 
sign an informed consent. We excluded participants with: a) severe illness likely 
leading to drop out, b) severe unrelated neurological disease, c) 
leukoencephalopathy of non-vascular origin, d) severe psychiatric disorders, and 
e) inability or refusal to undergo brain MRI. Patients were enrolled due to minor 
neurological, cognitive or motor complaints or incidental finding on cranial imaging 
due to non-specific reasons (incidental finding in brain imaging) [171]. 
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Participants were submitted to a comprehensive clinical, functional, motor and 
neuropsychological examination that was repeated yearly during a three year 
follow-up period. Clinical and functional assessment included: 1) standard 
cardiovascular and neurological examination; 2) functional status measured by 
means of the IADL scale and the Disability Assessment for Dementia scale [109]; 
and 3) health-related quality of life measured using the Euro-QoL 5D [180]. 
MRI was performed at baseline and at the 3rd year follow-up visit using a standard 
protocol [171]. White matter rating and volumetric analysis was performed by a 
single centre (Amsterdam) [181]. 
 
Six-hundred and thirty nine participants were included at baseline and 638 
performed the complete baseline assessment.  At the 3rd year of the study, 475 
(75%) came to the last follow-up visit. 
 
Neuropsychological evaluation 
Participants were submitted to a standardized cognitive evaluation every year. The 
construction of the neuropsychological battery was described in detail in a 
previous paper [172]. The battery included: the Mini-Mental State Examination 
(MMSE)[37, 182] as a measure of global cognitive status; the Alzheimer’s Disease 
Dementia Scale (ADAS-Cog) to assess memory, orientation, language, ideational 
and constructional praxis [44, 183] used in the original version (except on the 
words list recall item where we used one trial instead of 3); the Vascular Dementia 
Assessment Scale-cognition (VADAS-cog) extension, which includes delayed 
recall of the ADAS’s 10 words list, a symbol digit  test, a digit span backwards, a 
maze task, a digit cancellation task and a verbal fluency task (animal naming); the 
Trail-Making [57] and Stroop test [56] used to assess executive functions. The 
VADAS-cog total score was calculated accordingly to Ylikoski et al. [173]. The 
scores used as measures of executive functions were “time used to perform 
Stroop part 3 minus the time to perform Stroop part 2” and “time needed to 
perform Trail-making part B minus the time to perform trail-making part A”. As 
described in detail in a previous paper [172], compound measures were calculated 
in order to analyse performances by domain. Three main domains were analysed: 
1) memory, using the z-scores of Immediate word recall, delayed recall, word 
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recognition and digit span; 2) executive functions, using z-scores of Stroop3-2, 
Trail-making/B-Trail-making/A, Symbol digit and verbal fluency; 3) speed and 
motor control, using z-scores of Trail-making/A, Maze and Digit cancellation. 
 
Criteria of dementia and cognitive impairment no dementia 
At each follow-up visit, a questionnaire for the clinical diagnosis of dementia and 
dementia subtypes included in the LADIS protocol was filled by the clinician. 
Criteria used to define dementia, dementia subtypes and cognitive impairment no 
dementia (CIND) are described in detail in a previous paper [171]. For the current 
study, we used the clinical diagnosis of dementia defined according to the DSM-IV 
criteria [111] and CIND according to Wentzel et al. [184]. 
When analysing the participants according to the clinical diagnosis, we used the 
Last Observation Carried Forward (LOCF) method to classify the participants who 
did not come to the 3rd year follow-up visit. The diagnosis observed on the last visit 
of the participant was then considered as the final diagnosis and analysed 
accordingly. The LOCF method was used to reduce the number of missing values. 
 
Statistical analysis 
Reasons of referral, demographic (age, gender, years of education), clinical (WMC 
severity) and cognitive (scores on neuropsychological tests) baseline 
characteristics were compared between participants who came to the 3rd year 
follow-up visit with those who did not, using bivariate analysis (T- test and Qui-
square). The same procedure was used to compare participants with and without 
the diagnosis of dementia at the last follow-up. 
When comparing baseline characteristics of participants with dementia, CIND, and 
no cognitive impairment, we used ANOVA with multiple comparisons analyses. 
In order to ascertain the sensitivity and specificity of each neuropsychological test 
to predict diagnosis of dementia and CIND at the 3-years period, we used 
Receiver Operating Characteristic (ROC) analyses. 
Multinomial logistic regression models adjusted for the confound variables were 
then used to identify the neuropsychological baseline predictors of dementia at the 
last follow-up visit. 
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In order to reduce the chance of Type I error, Bonferroni post-hoc analyses were 
used for ANOVA comparisons. A more conservative p-level of 0.01 was used for 
single tests. 
 
Results 
Descriptive and comparative analysis 
Baseline demographic and clinical characteristics of the LADIS population have 
been described elsewhere [172]. 
 
From the 639 participants enrolled in the LADIS study, 480 (75%) could be 
evaluated in the last follow-up visit 3 years later. Patients who came to the last 
evaluation were younger (t = 3.68; p < 0.001), had a higher level of education (t = -
2.94; p = 0.004) and presented better performance in the baseline MMSE (t = -
4.30; p < 0.001), ADAS-Cog (t = 4.24; p < 0.001) and VADAS-Cog (t = 5.80; p < 
0.001), Stroop test (t = 4.53; p < 0.001) and Trail-making (t = 6.17; p < 0.001) tests, 
when compared to those who were not able to come to the last follow-up. No 
differences were found considering WMC severity (X2 = 5.39; p= 0.07) and 
reasons of referral (X2 = 7.44; p= 0.28). 
 
Four-hundred and eighty participants had the clinical diagnosis at the third-year 
visit of follow-up. Using the LOCF method we obtained a total of 588 participants 
with clinical diagnosis. A total of 90 (14%) out of these 588 participants had a 
clinical diagnosis of dementia:  12 participants with diagnosis at the 1st year follow-
up visit; 7 with diagnosis at the 2nd year visit and 71 with the diagnosis on the 3rd 
year visit. 
 
When comparing demographic and clinical characteristics of participants 
diagnosed with dementia and those without dementia on the last follow-up 
(Table7), we found that patients with dementia were older (t = 3.71; p < 0.001), 
had lower educational level (t = -2.38; p <0.02), more severe WMC (X2 = 39.07; p 
< 0.001) and higher volume of WMC (t = 4.73; p < 0.001). 
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Table 7:  Comparisons between participants with dementia and those with 
no dementia concerning demographic and clinical data 
 
 
Concerning baseline cognitive performance (Table 8), participants with dementia 
had had lower scores in all the neuropsychological tests, except for the ADAS-Cog 
following command subtest (t = 2.56; p < 0.02). Participants with dementia had 
also had significantly lower scores at executive functioning (t = - 8.21; p < 0.001), 
memory (t = -9.68; p < 0.001), speed and motor control (t = -9.55; p < 0.001) than 
participants without dementia at the end of follow-up (Table 8). 
 
Table 8: Comparisons between participants with dementia and those with no 
dementia concerning neuropsychological baseline performance 
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Demographic and Neuropsychological predictors of Dementia 
We performed ROC analyses to ascertain the sensitivity and specificity of each 
neuropsychological test and battery to identify participants with dementia following 
a 3-year period. On the single tests analyses, we identified (Table 9) symbol digit 
and verbal fluency as having the higher scores of sensitivity and specificity (AUC 
78% and 75% respectively) although fair. 
 
Table 9: ROC analyses, sensitivity and specificity of neuropsychological 
batteries and single tests 
 
 
Concerning the neuropsychological batteries, MMSE and ADAS-Cog obtained the 
same rate (79%) but VADAS-Cog had a good rate (82%) of sensitivity and 
specificity on identifying dementia at 3 years (Figure 3). VADAS-extension alone 
obtained 79% of sensitivity and specificity for dementia at 3 years. 
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Figure 3: ROC Curves of the three batteries 
 
 
 
 
 
 
 
 
 
 
a MMSE total (AUC = 79%). b ADAS-Cog total (AUC = 79%). c VADAS Cog (AUC = 82%). 
 
Using logistic regression analyses to identify neuropsychological predictors of 
dementia while controlling for age, education and WMC severity (as they are 
known predictors; see Table 10), we found that worse performance on MMSE (B 
=.33; OR = 1.39, 95%CI 1.19 -1.62; p<.001) and VADAS-cog (B = -.07; OR =.93, 
95%CI 0.88 -1.0; p = 0.02) were independent predictors of dementia. In order to 
know which component of the VADAS (ADAS or the VADAS extension) was the 
stronger predictor of dementia, we repeated the logistic regression model 
separating the ADAS score from the VADAS-extension total score (data not 
shown). In this model, VADAS extension was an independent predictor of 
dementia (B =-.08; OR = 1.09, 95%CI 1.02-1.15; p<.01). 
 
Table 10: Baseline neuropsychological predictors of dementia at a 3 years 
period (logistic regression analysis) 
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Concerning the neuropsychological baseline compound scores, both memory (B = 
1.2; OR =3.33, 95%CI 1.9-5.9; p < 0.001) and executive functions (B =.69; OR = 
2.0, 95%CI 1.15-3.46; p<.01) were independent predictors of dementia at the third 
year (Table 11). 
 
Table 11:  Baseline compound measures predictors of dementia at a 3 years 
period (logistic regression analysis) 
 
 
 
 
 
 
 
 
 
Demographic and neuropsychological predictors of cognitive 
impairment (dementia and cognitive impairment no dementia) 
We compared participants who were diagnosed with dementia (DEM) (N= 90) with 
those diagnosed with CIND (N= 147) and those with no cognitive impairment (NCI)  
(N= 351) as clinically classified. Using ANOVA’s with Bonferroni’s multiple 
comparisons analyses (data not shown), we found that age was significantly 
different when comparing NCI participants with those with DEM (mean age NCI 
=73.4 ± 5, DEM = 75.8 ± 5; p<.001) but not when comparing NCI with CIND 
patients (mean age NCI = 73.4 ± 5, CIND = 74.2 ± 5; p = 0.41) not CIND with 
participants with DEM (p=0.05). Differences in educational level were significant 
when comparing NCI with CIND (mean educational level NCI = 10.3 ± 4, CIND = 
8.8 ± 4; p< .001) and DEM (mean 8.8 ± 4¸p=.003), but not when comparing CIND 
with DEM (p> .05).  Volume of WMC was significantly different in the 3 groups 
(mean WMC volume NCI = 16.5, CIND = 23.9; DEM = 33.8; p< .001). 
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Concerning baseline scores of the neuropsychological tests, there were significant 
differences between the three groups in the global measures (Figure 4), 
compound scores (Figure 5) and in all the single tests, except for ADAS-Cog’s 
subtest following command. Multiple comparisons analyses (data not shown) 
allowed us to conclude that for ADAS-Cog subtests’ word recall, delayed recall, 
word recognition, orientation, construction, naming, ideational praxis, remembering 
instructions, spoken, word finding, comprehension and concentration, the 
differences were significant only when participants with DEM were compared with 
those with NCI. In these tests, in the MMSE and in the Stroop “time to perform part 
3 minus time to perform part 2”, participants with NCI did not differ significantly 
from the group with CIND. When comparing the group of CIND with DEM we 
found significant differences in all the tests except ADAS-Cog’s subtest 
construction, naming and ideational praxis. 
 
 
 
 
 
 
 
 
* Higher scores represent worse performance; **All differences were significant (t test with p < 0.001) 
 
When using ROC analyses to assess sensitivity and specificity of the 
neuropsychological tests and batteries in identifying participants with CIND at the 
third year (excluding participants with DEM), we found that none of the tests, 
batteries or compound measures had good rates (data available when requested). 
In the multinomial logistic analysis model (R2 = .28), we included baseline global 
measures of MMSE, ADAS-Cog, VADAS-Cog, the Stroop and Trail-making test, 
Figure 4: Comparisons between 
participants with no impairment, CIND 
and dementia concerning baseline 
neuropsychological batteries (mean 
scores) 
Figure 5: Comparisons between 
participants with no impairment,CIND 
anddementia concerning baseline 
neuropsychological compound scores 
(mean Z-scores) 
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and used age, education and WMC (categorized) as covariates (Table 12). MMSE 
(B -.311; OR 1.36 (1.16- 1.60); p =.001) and VADAS-Cog (B -.093; OR .911 (.858-
.968); p =.003) were independent predictors of dementia at a 3 year period of 
follow-up. 
 
Table 12: Baseline NP tests predictors of no impairment, cognitive 
impairment no dementia (CIND) and dementia (multinomial logistic 
regression) 
 
 
 
 
Discussion 
Participants included in the LADIS study were followed during a 3 year period and 
assessed with a complete clinical and neuropsychological evaluation each year. At 
each visit, a clinical diagnosis of the mental status was made, which was defined 
as “dementia”, “cognitive impairment no dementia” and “no cognitive impairment”, 
for the purpose of this study. When we analysed the baseline results of these 3 
groups, and despite the fact that participants were all functionally independent at 
the time of inclusion, we found that those clinically diagnosed with dementia at the 
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end of the 3-year follow-up period had had lower scores in almost all the baseline 
neuropsychological tests, when compared with participants without dementia. This 
is consistent with the understanding of dementia as a progressive disease that 
starts insidiously, usually without evident signs besides subtle differences of 
cognitive tests scores. In the LADIS study, the differences were observed in all the 
baseline tests and not only in those previously reported as sensitive enough to 
predict cognitive decline in normal individuals, such as episodic memory, 
executive functions or abstract reasoning and verbal fluency [177, 185]. 
Differences were also observed on the total scores of MMSE, ADAS-Cog and 
VADAS-Cog batteries between participants who developed dementia during a 
three-year period and those who did not, showing that general cognitive capacities 
are also affected by ARWMC. 
 
Participants with dementia were also older, had lower educational levels and more 
severe ARWMC than participants without the diagnosis of dementia. These results 
are in line with previous reported data on the LADIS study. Increasing age and low 
educational levels have been identified as risk factors for lower cognitive 
performance even in the presence of ARWMC [172]. 
 
Besides older age and lower educational levels, baseline scores in the MMSE 
were important predictors of the diagnosis of dementia at the end of follow up. 
These were also reported in previous studies that tried to identify preclinical 
markers of VD and AD [177, 178]. Backman and Small [178] described a research 
program to identify preclinical markers of VD and AD. When reviewing the data 
from a community-based, longitudinal study, they reported the presence of 
preclinical deficits 3 years before the diagnosis of VD in the total score, delayed 
recall and orientation of the Mini Mental State Examination (MMSE), being used as 
an outcome measure. MMSE is a common instrument assessing global functions 
and detecting cognitive impairment. However, its sensitivity and specificity 
decrease when used to assess mild cognitive impairment, at least when using the 
original cut-off values. Nevertheless, in the LADIS study, the median baseline 
score for MMSE of participant who developed dementia during the 3 year period 
(median = 26) was higher than the original MMSE proposed cut off for dementia (< 
25). This is also consistent with the reports of the importance of using different cut 
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off scores for the MMSE according to age and level of education. In a recent paper 
[186], it is proposed that a higher cut-off score should be used for detecting 
dementia among patients with higher educational levels. This change might also 
increase the rates of sensitivity and specificity of the MMSE for mild cognitive 
impairment. 
 
Concerning sensitivity and specificity rates, we found MMSE to have lower scores 
compared with the VADAS-Cog battery. VADAS-Cog was previously reported that 
it was a more sensitive instrument to evaluate patients with WMC when compared 
with ADAS-Cog[173]. The authors identified that 5 (out of the 6) tests that 
compound the VADAS-Cog extension (namely, delayed recall, symbol-digit, maze, 
digit cancellation and verbal fluency), were able to differentiate among mild, 
moderate and severe WMC. Most of these 5 tests are used to assess speed of 
mental processing and executive functions, cognitive capacities shown to be 
impaired in patients with vascular disease or WMC [175]. However, in the LADIS 
population, none of the specific tests used to assess executive functions (Stroop 
and Trail-making tests) were baseline predictors of dementia at the end of follow-
up. Some studies have found no relationship between ARWMC and specific tests 
for the assessment of executive functions [187, 188]. Nevertheless, in our study, 
the compound score of executive functions that, besides the Stroop and trail-
making, includes scores on symbol-digit and verbal fluency tests, was an 
independent predictor of dementia at the end of follow up. Similarly, both symbol-
digit and verbal fluency were the single tests with higher rates of sensitivity for 
dementia at 3 years. Semantic category fluency was seen to be an independent 
predictor of VCI [177]. 
 
Memory and executive baseline compound scores were independent predictors of 
dementia. An association between WMC and memory impairment has been 
previously reported [175]. Jokinen et al. found that memory impairment was 
mediated by executive functions and mental speed. They suggest that executive 
dysfunction causes secondary deficits such as memory impairment. In the LADIS 
population, dementia at the end of follow-up might be related with other causes 
rather than a direct effect of ARWMC. The heterogeneity of the type of dementia 
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(VD, AD with vascular component, others) might explain this multidomaine pattern 
of cognitive impairment. 
 
In this paper we also compared participants with no impairment (NI) with those 
with CIND and Dementia at the end of follow-up. We found that performance on 
the baseline neuropsychological tests was distinctively different for the 3 groups 
clinically diagnosed at the end of the follow-up period, showing a consistent 
relation between clinical criteria and neuropsychological assessment. 
 
We found that patients with CIND were older than patients with NI and younger 
than those with dementia. This group of patients had also a lower educational level 
when compared with participants with NI, but did not differ from those with 
dementia. Concerning cognitive performance at baseline, patients with CIND 
differed from patients with dementia in almost all the tests and global measures. 
When compared with those with NI, patients with CIND had no significant 
differences on the baseline performance of MMSE, Stroop and ADAS-Cog. These 
findings show the heterogeneity of this particular group, which seems to be in the 
continuous line between the “no impairment” and “dementia”. In the CIND group, 
we found participants with similar performances to those with no impairment but 
also with those with dementia, along with more risk factors for dementia such as 
older age. These results illustrate the difficulty of identify predictors in the CIND 
group, since it is very heterogeneous. 
 
A possible limitation of this study is related to the use of dichotomized or 
categorized variables such as dementia/no dementia or NCI/CIND, including 
patients with different types of dementia in the same group. However, splitting 
these groups would reduce the statistical power and compromised the results. 
Also the absence of sensitive measures of memory, such as verbal learning and 
cued recall, limits our interpretation of the baseline results. However, the 
introduction of these tests during the follow up of the LADIS study will permit us to 
analyse the evolution of memory performance over time in further studies. 
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Conclusion 
The present study contributes to the identification of sensitive measures to assess 
participants with ARWMC and to evaluate the risk of progression for dementia in a 
population with no functional or major cognitive impairment in initial evaluations. It 
also enhances the importance of the neuropsychological assessment to the study 
of subtle changes on progression to dementia. 
 
In the LADIS study, baseline scores of MMSE and memory and executive 
compound scores were predictors of dementia at the end of the 3 year follow-up 
period. 
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VI - White matter changes and cognitive decline in 
a 10 year follow-up period: a pilot study from a 
single centre cohort from the LADIS study 
 
 
  
 78 
Introduction 
Longitudinal studies in the general population of cognitively intact participants, 
have demonstrated that increasing volume and increased progression of white 
matter lesions (WML) are related to lower global cognitive performance and 
conversion to mild cognitive impairment and dementia [38, 39]. In the 3 year 
follow-up of the Leukaoaraiosis and Disability (LADIS) study, WML and lacunes 
were found to progress over time appearing mostly in the subcortical white matter. 
Progression was related to more severe WML and higher number of lacunes at 
baseline, and to several vascular risk factors [122]. The impact of diabetes and 
severity of WML on decline of cognitive performance was also reported by 
Verdelho et al. in the LADIS study [174]In the same sample, neuropsychological 
predictors of dementia and cognitive impairment no dementia (CIND) were both 
identified, above and beyond clinical and demographic factors [189]. Patients who 
developed CIND or dementia 3 years after the inclusion, already presented lower 
scores on cognitive baseline performance in global measures such as Mini-Mental 
State Examination (MMSE) and Vascular Dementia Assessment Scale (VADAS), 
compared with those who had no cognitive impairment or CIND at three year 
follow-up, despite the fact that they were all functionally independent at baseline. 
Very long-term follow-up studies on the impact of WML for the transition to 
dementia are still rare [190-192] and none of them had followed a group of initially 
non-dependent participants with WML. Furthermore, prediction of no impairment is 
particularly less common in the literature and, hence, it is one of our foci using 
both global batteries and subtests scores. 
 
In the present study we aimed to evaluate a subcohort of the LADIS study who 
had been functionally independent at baseline, after 10-year of follow up, in order 
to: 1) locate the cognitive evolution of different groups of cognitive clinical 
diagnosis; and 2) identify neuropsychological predictors of non impairment, 
cognitive impairment and dementia.   
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Methods 
Participants and Methods 
For the purpose of this study, we included all the 66 participants of the Portuguese 
Lisbon Centre who were previously enrolled in the longitudinal European 
multinational LADIS study. The rationale and methodology of the LADIS project 
had been extensively reported in other papers [106, 142]. Briefly, the LADIS study 
started in 2001 and aimed to evaluate the impact of WML in the transition to 
disability, during a follow-up of 3 years. Each of the 11 European centers involved, 
had to include participants with:  (a) age 65–84 years, (b) WML of any degree 
according to the modified Fazekas’ visual rating scale [107], (c) no or mild 
impairment (none or 1 item affected) on the instrumental activities of daily living 
scale [108], and (d) presence of a contactable informant and agreement to sign an 
informed consent. Patients were enrolled due to minor neurological, cognitive or 
motor complaints or incidental finding in brain imaging due to nonspecific grounds 
(controls on other studies and volunteers) [106]. The participants were submitted 
to a comprehensive clinical, functional, motor and neuropsychological examination 
that was repeated yearly, and an MRI was performed at baseline and at the end of 
the 3-year period. 
 
For the current study, all the Lisbon surviving participants were contacted by a 
neuropsychologist (SM) and invited to come to an extra evaluation at the 10th year 
of follow-up. This visit consisted of: 1) a clinical and functional evaluation 
performed by a neurologist (AV), according to the LADIS protocol [106]; 2) a 
neuropsychological assessment, which included the LADIS battery consisting of 
the Mini-Mental State Examination (MMSE) [37] a measure of global cognitive 
status; the Alzheimer’s Disease Assessment Scale-Cognition (ADAS-Cog) to 
assess memory, orientation, language, ideational and constructional praxis [44, 
193] with the extension for vascular impairment (VADAS-cog) [116], that adds the 
delayed recall of the ADAS’s 10 word lists, a symbol digit test, a digit span 
backwards, a maze task, a digit cancellation task and an animal naming verbal 
task; the Trail-Making [57] and Stroop tests [56] to assess executive functions; and 
the 9-word version of the California Verbal Learning Test (CVLT-9) [160] to assess 
memory and learning (for a more detailed description of the battery, see [142]; 3) 
 80 
an MRI scan was performed according to the LADIS protocol [106], at the same 
Centre and with the same equipment which were previously used in the LADIS 
study. Severity of WML was visually rated by a neurologist (AV), who was blind to 
neuropsychological data, using the Fazekas’ scale [107]. CD copies of the MRI 
scans were sent by mail to the same researcher who rated the follow-up MRI 
evaluation in the LADIS study (AG) and who was blind to clinical details and 
neuropsychological data. Progression of the WML and presence of new lacunes 
were visually rated in a side-by-side fashion and the entire procedure is described 
elsewhere [122]. Briefly, WML progression was rated on FLAIR images according 
to the modified Rotterdam Progression Scale (range 0 to 9) [124], in which  “no 
progression” or “progression”(0 and 1, respectively) was rated in 3 periventricular 
regions (frontal caps, occipital caps, bands), 4 subcortical white matter regions 
(frontal, parietal, occipital, temporal), basal ganglia, and infratentorial region. 
Progression was also classified as “no progression”, “mild” (progression in 1 to 3 
regions) or “severe” (progression in more than 3 regions) [122]. New lacunes were 
also visually assessed, according to the number and location in 5 brain regions 
(frontal, parieto-occipital, temporal, basal ganglia, and infratentorial). New cortical / 
lobar infarcts were also identified according to the number and location [122]. 
 
For participants who were unable to come to the hospital for assessment, home 
visits were conducted for clinical and neuropsychological evaluation. Information 
concerning non-surviving participants was collected in a face-to-face or telephone 
interview with the caregivers/informants. This interview included a drop out/death 
questionnaire used in the LADIS study, which collects clinical and functional data. 
The study was submitted and approved by the Ethical Committee of the university 
hospital (Faculdade de Medicina, Hospital de Santa Maria). 
 
Neuropsychological data and cognitive status 
For the purpose of this study, neuropsychological battery scores were analyzed as 
previously described in detail [142]. Briefly, we used both subtests scores and total 
raw scores of ADAS and VADAS-Cog, the last one calculated according to 
Ylikoski et al.[194]. We considered ‘time used to perform Stroop part 3 minus the 
time to perform Stroop part 2’ and ‘time needed to perform Trail-Making part B 
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minus the time to perform Trail-Making part A (raw scores), as measures of 
executive functions. CVLT-9 scores used for the purpose of this study were the 
total raw score of the 5 learning trials and the raw score of both short and long 
delayed free recall tasks, as measures of verbal learning and retrieval. 
Cognitive status of participants was evaluated clinically and classified into three 
groups by a Neurologist (AV), who had access to MRI results but was blinded to 
neuropsychological data, 1) no cognitive impairment (NI); 2) cognitive impairment 
not demented (CIND); and 3) demented (DEM), accordingly to previously 
established sets of criteria[195]. Briefly, for CIND two types were considered: 1. 
amnestic mild cognitive impairment (MCI) [135]; and 2. vascular cognitive 
impairment without dementia (VCIND)[136]. For dementia were considered the 
following subtypes: probable Alzheimer disease (AD) [137],probable vascular 
dementia (VD) [138], frontotemporal dementia [140] and dementia with Lewy 
bodies (DLB) [141]. 
 
Statistical analyses 
To test associations between clinical diagnosis or progression of WML with 
different variables, and differences among participant groups, bivariate analyses 
were used: a) comparing survivors and non-survivors and, b) those who came to 
the follow-up evaluation at 10 years with those who did not, to assess potential 
selection bias, using non-parametric tests (Mann-Whitney test, Chi-Square test); c) 
comparing groups of diagnosis (NI, CIND, DEM) concerning neuropsychological 
performance using non-parametric statistics such as Mann-Whitney test and 
Kruskall-Wallis test for multiple groups. ANOVAs with repeated measures were 
performed in order to study how test scores changed across the 3 time points 
(baseline, 3rd and 10th years of follow-up), exploring the effect of time, clinical 
diagnosis group and the interaction between them. In these series, time and 
clinical diagnosis at 10th year (NI vs CIND vs DEM) were used as independent 
variables. We also performed regression analyses (linear and logistic) to identify 
predictors of clinical decline using the most significant demographic, clinical and 
neuropsychological data as independent variables. For each analysis age and 
education were included in step 1 as independent variables, since they are known 
to influence cognitive performance. Baseline WMC severity (mild, moderate or 
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severe) was added in step 2 and cognitive baseline performance was included in 
step 3. No more than 4 variables were included in each model to avoid Type I 
errors. Specifically we tested the effects of known clinical predictors (diabetes and 
stroke) and global neuropsychological measures. A 0.05 level of significance was 
used except when comparing multiple tests with multiple variables, where a more 
conservative level of 0.01 or 0.001 (Bonferroni’s correction) was adopted. Data 
analyses were performed using the SPSS 21.0 software. 
 
Results 
From the initial group of 66 Portuguese elderly participants who had been enrolled 
in the LADIS study in 2001-2002, 41 (62%) were still alive at the 10 year-follow up 
visit (Figure 6). Twenty-three participants died during the 10-year period (1 during 
the first year of the study, 1 in 2004 and 21 between 2005 and 2012). The most 
frequent cause of death was stroke (4 patients) and heart failure (4 patients). Two 
participants were lost for this follow-up and we were unable to obtain any further 
information. One of them was lost during the first year of the study. 
 
Figure 6: Schematic representation of participants assessed at year 10th 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 83 
There were no significant differences between survivors (n=41) and non-survivors 
(n= 23) concerning sex (X2(1)=0.03, p=0.88), educational level (U=368, p=0.11) 
and WML severity (X2(2)=2.56, p=0.28) or WML volume (U=590, p=0.10) at 
baseline. Non-survivors (mean age at baseline = 74.7±4.8) tended to be older than 
survivors (mean age at baseline = 72.1±5.1; U = 691, p=0.04). Concerning the 
cognitive clinical diagnosis at the third year of evaluation, survivors and non-
survivors had no significant differences (X2(2)=4.66, p=0.10). 
 
Of the 41 participants who were alive 10 years after the enrollment in the LADIS 
study, 4 refused to participate and 1 was living in a nursing home far from Lisbon 
and it was not possible to evaluate him in the new residence. Thus 37 (90%) could 
be evaluated at the 10th year of follow-up. Participants who came to this evaluation 
(n=37), when compared with all those who did not come (n= 29), had a higher 
level of education (U=377; p=0.02), but were not different concerning sex, age, 
baseline WMC severity, or clinical diagnosis at the 3rd year. There were also no 
differences concerning MMSE scores at baseline (U=434, p=0.18) and at the 3rd 
year of follow-up (U=275, p = 0.08), as illustrated in Table 13. Of the 37 
participants who came to the 10th year of follow up, 5 refused (n=3) or had 
contraindications (n=2) to repeat the MRI scan. Thus, a final group of 32 (78%) 
participants conducted complete neuropsychological and also had MRI evaluation 
at 10 years of follow-up. 
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Table 13: Comparisons between participants who conducted the 10thyear 
follow-up and those who did not 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WMC = white matter changes; MMSE = Mini-Mental State Examination; CIND = Cognitive Impairment No Dementia; 
 
In the sample at the 10th year follow-up there were 37 participants (21 women; 
57%), with a mean age of 81 years old (ranging from 74 to 92 years old) and a 
mean educational level of 8.2 years (ranging from 4 to 26 years of education). Of 
those who underwent a MRI, severe WML at follow-up were observed in 16 (43%) 
patients, moderate in 7 (19%) and mild in 9 (24%) of the participants. 
 
Fifteen patients (41%) were clinically diagnosed with dementia (Vascular 
Dementia =10; Alzheimer’s Disease =4; Dementia with Lewy Bodies (DLB) =1), 12 
(32%) with CIND, and 10 (27%) showed no cognitive impairment (NI). 
Compared to the clinical diagnosis of the 3rd year of follow-up, 14 participants had 
cognitively declined:  6 participants (16%) changed from NI into CIND (MCI= 2; 
VCIND=1) and DEM (VD = 1; AD= 1; DLB=1), and 8 participants (22%) changed 
from CIND to DEM (VD=6; AD=2). 
At the 10th year follow-up, cognitive performance for the total sample as well as for 
the groups of participants with NI and participants with any impairment (CIND or 
dementia) is presented in Table 14. Overall, data showed that, as expected, 
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neuropsychological performance after 10 years was statistically better for 
participants without any cognitive impairment than for those who had CIND or 
Dementia. 
 
Table14: Neuropsychological performance at the 10thyearfollowup (raw test 
scores) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Changes in cognitive performance across the 10-year period 
Regarding general scores of neuropsychological measures, we used ANOVA 
repeated measures to evaluate the main effect of time and group in each battery 
or test. For MMSE scores (Figure 7), the main effect of time was significant 
[F(2,66)=21.52, p=0.000], with performance decreasing after the 3rd year; the main 
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effect of participant group (NI, CIND, DEM) was also significant, [F(2,66)=17.65, 
p=0.001], with the group of patients with dementia demonstrating the lowest 
results; and the interaction effect of time x group was significant [F(4,66)=14.24, 
p=0.000]. The steeper decline was found among participants with dementia even 
though the three groups decreased performance over time. 
 
Figure 7: MMSE, ADAS-Cog and VADAS-Cog scores over 10 years for 
participants with no cognitive impairment (NI), with cognitive impairment no 
dementia CIND and with Dementia (DEM) 
 
A similar analysis was performed for ADAS-Cog in which we also found a 
significant main effect of time [F(2,62)=37.88, p=0.000], of group [F(2,62)=15.85, 
p=0.000], and of the interaction between time x group [F(4,62)=8.97, p=0.000]. 
Given that high scores represent worse performance, the Graph (Figure 7) reveals 
that performance also decreased with time, especially after year 3 and that the 
group whose results worsened the most was the group with dementia. 
 
The VADAS-Cog was also explored in terms of the change across the 10-year 
period. The main effect of time [F(2,48)=41.35, p=0.000], the main effect of group 
[F(2,48)=5.87, p=0.008], and the interaction effect [F(4,48)=3.430, p=0.018] were 
significant as well (Figure 7). 
 
When changes across time were explored for the executive measures of both trail-
making and Stroop, only a significant effect of time [F(2,46)=6.95, p=0.002] and  
group [F(2,46)=5.98, p=0.008] were found for TM B-A, but the interaction time x 
group was not significant. 
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WML progression, cognitive performance and clinical diagnosis 
Four (13%) out of the 32 participants who performed the MRI, showed no WML 
progression from the baseline assessment. Mild WML progression was observed 
in 11 (34%) participants, and 17 (53%) had severe WML progression (Figure 8 
illustrates an example of WML progression from baseline to the 10th year of follow 
up). Presence of, at least, one new lacune was identified in 9 (28%) participants. 
Participants with severe WML progression had a tendency to have lower 
education comparing with those who did not progress or had a mild progression 
(U=178.5, p=0.05). No other differences were found concerning age (U=170, 
p=0.11) or WML volume at baseline (U=142, p=0.58).  There were no significant 
differences between participants with NI and those with any impairment 
concerning WML progression (U=102.5, p=0.96) or presence of new lacunae 
(U=90, p=0.47).  Concerning WML severity at 10th year, participants with NI had 
less severe WML than participants with any impairment (X2(2)=9.21, p=0.01). 
 
Figure 8: MRI axial FLAIR images of one patient at baseline (a) and 10 years 
after (b), show a clear progression of WMC in the frontal caps and bands of 
the periventricular region (b) 
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Predictors of Clinical Diagnosis at 10-years follow-up 
Participants with NI at 10 years had also no significant differences concerning 
volume of WML at baseline, when compared with participants with CIND or DEM 
(U=72; p=0.031), presence of medial temporal lobe atrophy (MTA) (U=86, p=0.08), 
or WML progression rated at year 3 (U=104, p=0.60).Regarding the presence of 
new stroke (N=4) or lacunes (N=9) during the long-term follow up, its effect also 
failed to reach statistical significance comparing participants with NI or any 
cognitive impairment. 
 
A logistic regression was performed in order to determine the ability to predict non 
impaired participants (NI) after 10 years, based on the cognitive measures that 
appeared to distinguish participants with NI from those with any cognitive 
impairment. For each analysis, step 1 included the demographic variables of age 
and education, given their known association with cognitive performance, in order 
to control for their effect. Step 2 entered the baseline WML and in step 3 were 
included cognitive scores as dependent variables. Only MMSE (β = 1.14; p=0.03; 
OR=3.13 (95% CI 1.09 - 8.97) and ADAS (β = 0.61; p=0.02; OR=.54 (95% CI .32 -
 .91) scores at baseline were found to be significant predictors of NI after 10 years 
of follow-up, with both models (MMSE X2=14.66, R2 = 0.48; ADAS X2 = 21.20, R2 
= 0.63) able to correctly predict 87% of the participants. No effects were found for 
age and education. 
 
Discussion 
In this study, the Lisbon group of functionally independent elderly people with age-
related WML, who had been included in the multinational pan-european LADIS 
study, was followed during a period of 10 years. The long-term follow-up allowed 
the identification of different profiles of evolution of the three groups of clinical 
diagnosis. As expected, the group of participants with dementia showed more 
prominent decline all over the time, while the group with a clinical diagnosis of 
CIND revealed a profile closer to non impaired participants, even after such a long 
period of time. Differences between groups of diagnosis were observed in the 
main batteries MMSE, ADAS-Cog and VADAS, but not in executive measures 
when composed scores (Stroop 3-2 and Trail-making B-A) were used: in both 
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Stroop and Trail-Making tests, only the effect of time was significant. The absence 
of differences in composed executive measures could be explained 1) by the fact 
that age-related decline in processing speed might contribute for an increase of 
time to perform the task in less complex parts (reading words, naming colors and 
connecting ordered numbers), reducing the magnitude of the difference between 
both tasks [196]; b) by the increasing number of persons who performed the first 
part of the tests but are not able to perform the more complex parts. Considering 
these findings, the best discriminative measures in long-term follow-up evaluations 
seemed to be the individual scores of each task and not the differences between 
them. 
 
When baseline clinical and neuropsychological variables were analysed, we found 
that the only predictor of NI at the end of the decade was baseline MMSE score. 
MMSE baseline scores were already identified as predictors of dementia in a 
sample of independent elderly participants with WML after a 3-year follow up 
period [189]. Moreover, MMSE mean scores were relatively high and suggestive of 
the importance of establishing high cut off scores for early identification of CIND. 
Another study has also reported the importance to use higher cut off scores on 
MMSE to detect people at risk of dementia in highly educated elderly [197]. 
 
More than half of the participants showed progression of WML in more than 3 
regions which is consistent with what was previously described in a similar group 
of patients [122]. However, in our cohort, we did not find an association between 
severe progression of WML and any demographic, vascular risk factors or 
baseline severity of WML. It has already been described that some factors related 
with progression of WML on a medium follow up period might disappear in longer 
periods[198], which might explain the absence of these associations in our study. 
On the other hand, in the visual rating of some MRI scans obtained in the 10th year 
of follow-up, white matter atrophy with prominent ventricular enlargement could be 
seen in absence of an expressive WML increase. This could lead us to the 
hypothesis that the disease might have a different expression of progression after 
such a long-term process. 
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The interpretation of these results might be limited by some aspects of the present 
research. Such long-term periods of follow-up in elderly populations are 
associated with high rates of attrition, either due to death or the presence of other 
diseases that might interfere with the WML natural progression. Moreover, the 
small number of patients did not allow more specific analysis, for instance of what 
type of dementia could be better predicted. Nevertheless, we were able to 
evaluate a group of older adults with severe vascular risks or/and vascular disease 
for a period of 10 years. The small sample, an intrinsic risk in long-term follow-up 
studies performed in elderly populations, contributes to a loss of statistical power 
in some analyses. The use of a conservative level of significance in order to 
reduce type I error can also explain the absence of associations regarding some 
variables that are consistently reported as related with cognitive decline in this 
population (eg. age or educational level). Still, this procedure allowed us to identify 
some significant findings such as the identification of a global battery, the MMSE, 
as a potential predictor of non-impairment on this very long period of follow up. 
However, these findings as well as the absence of a clear association between 
WML progression on cognitive performance, reflect the importance of the present 
data and replication of the study with a larger population. 
 
Conclusion 
In this study we presented different longitudinal profiles of cognitive performance 
in a cohort of independent elderly participants with WML, and identified higher 
scores on baseline MMSE cognitive performance as the strongest predictor of 
long-term clinical diagnosis of no cognitive impairment. Higher cut-off points on 
global batteries such as MMSE should be used to identify participants at risk of 
cognitive decline on long-term periods. 
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VII - Informal caregivers’ burden and needs on a 
long-term follow-up study of independent elderly 
patients with WMC: an exploratory study 
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Introduction 
Loosing autonomy during the aging process is inevitably related with the need of a 
caregiver. Frequently, this process occurs in the context of the family, becoming 
an element of this system the first care-provider, assuming the informal care. The 
impact of being an informal caregiver, especially if dealing with chronic and 
progressive diseases (eg. dementia), on mental and physical health has been 
consistently reported [199-202]. Factors such as caregiver’s age and co-
morbidities, type of relationship with the patient, time spent on providing care, 
degree of dependency [203], seem to play a role on the perceived burden. Also 
factors related with personality traces and coping styles of the caregivers are 
being explored as mediators on the relationship between caregiving experience 
and physical and psychological health [204, 205]. 
 
Some studies have also explored differences between caregivers of patients with 
Alzheimer’s Disease or Vascular Dementia and identified length of time care, 
severity of symptoms and stage of the disease as factors associated with 
caregivers burden [206, 207]. The onset and course of the disease that 
differentiate these two types of dementia, seems to play an important role on 
caregiver’s perceived burden and adaptation during the different stages of both 
diseases. 
 
White matter changes (WMC), frequently present in elderly subjects, are a 
recognized marker of small vessel disease[208], and have been associated with a 
higher risk of transition from a state of autonomy to disability and dementia [209]. 
In this population, disability can be due to multiple factors such as motor difficulties, 
urinary incontinence, depression or cognitive impairment [210]. Elderly people with 
severe WMC are at risk to decline on global functional performance even counting 
from just one year [210, 211]. An important issue which has not yet been 
sufficiently explored is the impact of this transition on caregivers. 
 
During the follow up of the LADIS study[106, 212], it was possible to study the 
cognitive decline and consequent loss of autonomy of a group of initially 
independent elderly people. We intend to explore and characterize informal 
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caregiver’s burden and needs as they followed the elderly subjects with WMC’s 
process of transition to a condition of disability. We aim to i) describe the 
subjective burden and physical and psychological health status of caregivers of 
those patients who became dependent; ii) evaluate to what extent the degree of 
dependency predicted subjective burden; and iii) explore the possible mediating 
role of coping strategies on this relationship. 
 
Methods 
Participants and Methods 
For the purpose of this study, we included the attendants of the 66 Portuguese 
participants of the European multinational LADIS study. The rationale and 
methodology of the LADIS had been extensively reported elsewhere [106, 142]. 
Briefly, the LADIS was a longitudinal study that aimed to evaluate the impact of 
WMC in the transition to disability during a follow-up of 3 years. Criteria for 
inclusion of participants had been: (a) age 65–84 years, (b) WML of any degree 
according to the modified Fazekas’ visual rating scale [107], (c) no or mild 
impairment on the instrumental activities of daily living scale [108], and (d) 
presence of a contactable informant and agreement to sign an informed consent. 
Participants were submitted to a comprehensive clinical, functional, motor and 
neuropsychological examination that was repeated yearly. In each visit were 
accompanied by an informant who was interviewed in order to complete the 
information and to evaluate the functional status of the participant. 
 
An extra evaluation at the 10th year of follow-up of the LADIS participants was 
made for the Lisbon group of participants [212] intending to explore and 
characterize informal caregivers’ burden and needs as they followed the elderly 
subjects’ process of transition from an independent state to a condition of 
disability. Caregivers were defined as subjects delivering or being directly involved 
in providing care. In the course of this extra evaluation, each elderly subject’s 
attendant, often a relative was directly contacted by a neuropsychologist (SM), on 
occasion being invited to contribute to the research, in the position of informant 
and caregiver. They were all told that this study was to be conducted by the 
neuropsychologist and that they had to be interviewed in one-only visit, with the 
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aim of identifying caregiver’s needs during the evolution of the disease. The same 
information was written in the consent form, and explained when requested. 
Informants, or caregivers, considered for assessment were those who had been 
present for at least three of the five visits made for evaluation of LADIS 
participants, or those who had permanently replaced original caregivers (for 
example, institutional caregivers). 
 
Caregivers who accepted to participate in the study were submitted to an open 
nondirective interview modelled on that used in the Canadian Study of Health and 
Aging (CSHA) [143], which collected information on the caregiver’s 
sociodemographic and professional identity, on the type of care offered, on the 
support / resources obtained (institutional, or others), and on how informed they 
were about the diagnosis of the care recipient. They were also assessed with the 
Caregiver Strain Index (CSI) [144] to identify subjective burden; the Medical 
Outcomes Study Short Form-36 Index (MOS SF-36), to assess quality of life [145]; 
and the Brief COPE inventory [146] to identify what coping strategies caregiver 
uses. Participants older than 65 years old, were also screened with the Mini 
Mental State Examination (MMSE) [37] to exclude any cognitive deficit. For 
informants, or caregivers, of non-surviving LADIS patients, scales were adopted 
and they were asked to refer to the last year they accompanied or provided care. 
For participants who were unable to come to the hospital for assessment, home 
visits were conducted. All self-administrated scales were reviewed with the 
participant and questions/items clarified whenever needed. 
 
Our study included attendants of LADIS participants who were dependent or 
presenting any functional limitations when compared to baseline. 
The study was submitted and approved by the Ethical Committee of the university 
hospital (Faculdade de Medicina, Hospital de Santa Maria). 
 
Caregiver Burden, Quality of Life and Coping strategies 
After collecting socio demographic data, informants were asked if they were 
involved (in the present or past) in providing care to their relatives and, if not, if this 
was because they did not need assistance, or if there were other formal care 
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providers. Type of external assistance and classification (on a 5 points Likert 
scale) were also identified. Only informants who were, or had been, directly 
involved in providing care were considered for this study and included as 
caregivers. 
 
Quantitative measures of burden were obtained using the CSI[213], a brief, easily 
to administrate scale. In its original form is consisted of 13 negative statements on 
which participants are asked to agree or disagree (yes/no). Following what was 
used in previous studies [214], we determined substantial subjective burden a total 
score higher than 6 points (7 to 13). 
 
Caregiver’s health related quality of life was assessed with the Portuguese version 
of the MOS-SF-36 [145]. Briefly, it is a self-administrated scale, consisted of 36 
items covering 8 health concepts, grouped in two main components (mental and 
physical). Items are designed to evaluate the presence of limitations in these 
different concepts: physical functioning (intend to evaluate limitations in performing 
usual physical activities from the lighter to the heaviest), physical role functioning 
(type and quantity of work that might be limited); bodily pain, general health (global 
perception of health status), mental health (anxiety, depression, emotional and 
behavioral control, and well being), emotional role functioning, social functioning 
and vitality. An extra scale is obtained by asking the respondent to identify the 
quantity of change in her/his health during a one-year period. These scales can be 
grouped in two main components: physical and mental [215]. Raw scores were 
transformed and calculated according to the Portuguese norms and presented in 
terms of percentage [145]. 
 
Caregiver’s coping strategies were identified using the Brief COPE inventory [146].  
It is a self-administrated instrument that consists of 28 items organized in 14 
dimensions (2 items for each dimension): Active Coping, Planning, Positive 
Reframing, Acceptance, Humor, Religion, Emotional Support, Instrumental 
Support, Self-Distraction, Denial, Venting, Substance use, Behavioral 
Disengagement, Self-Blame. Participants were asked to choose from a 4-points 
Likert scale (1 =”I haven’t been doing this at all”, to 4 = “I have been doing this a 
lot”) in what extent those activities were performed by them. Again, for those 
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caregivers that were no longer providing care, an adaptation of the questionnaire 
was made, asking them to report how they have dealt with the situation. The items 
were grouped into 3 main types of coping styles, based on what was found in 
previous studies [216, 217]: problem-focused, emotion-focused and dysfunctional 
coping. 
 
Functional status and clinical diagnosis 
Care recipient’s degree of dependency was assessed using a questionnaire based 
on the caregiver’s questionnaire of the Canadian Study of Health and Aging 
[143](www.csha.ca). 
 
Caregivers were asked to describe how their relative managed her/his daily life. 
Fourteen common activities were listed and participants were asked to tell if the 
relative was able to manage it “without help” (0 points); “with some help” (1 
point)or “could not do it at all” (2 points). We classified as “not applicable” activities 
that were never performed by the relative. For example, patients who had never 
prepared their own meals were classified as “item not applicable”. Scores range 
from 0 (functional autonomy status) to 28 (complete functional dependency). 
 
Data from the LADIS study 
Functional status of the care recipient, measured by the IADL scale [108] as a part 
of the LADIS protocol, was also analyzed. For the purpose of this study, IADL was 
rated in number of items with any impairment (raging from 0 to 8). 
 
Care recipient’s cognitive status was evaluated clinically at the 10th year follow-up 
evaluation and classified into three groups accordingly to previously established 
and described in the LADIS study [195]. For those who did not survive, cognitive 
diagnosis was obtained by the information collected with the informant using a 
death form questionnaire. Whenever possible, information was also collected with 
the patient’s general practitioner. All the information obtained in this way was also 
compared with the previous data from the LADIS study. Presence of behavioral 
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symptoms, mood disorders, gait disturbances and loss of sphincter control were 
registry according to the LADIS protocol [106]. 
 
Statistical Analyses 
Descriptive analyses were performed using raw scores, means and percentages. 
In exploring significant differences, non parametric statistics were used due to 
sample size. Bivariate linear regression analyses were performed to identify 
predictors of subjective perception of burden. We used the most significant 
demographic variables (age, educational level and sex), functional status and 
coping strategies as independent variables. Categorical variables were dummy 
coded. Due to the small size of the sample, initial data analyses were conducted to 
ensure relevant assumptions to perform regression analyses. 
 
A p-value of <0.05 was used to determine statistical significance. Analyses were 
performed using SPSS, version 20.0 for Windows. 
 
Results 
The initial sample was composed by the group of 66 informants who consented to 
accompany their relatives or friends during the whole period of the LADIS study. 
From this initial group, 58 informants (87%) were contacted and invited to 
participate in this study. Ten refused to come to a visit or to be interviewed by 
phone. Forty-nine informants (74%) of the initial group were included in this study. 
From these, 17 informants were not caregivers: participants who were 
accompanied by them were completely autonomous (16 persons); or were not 
directly involved in care giving (1 person). One participant did not allow her 
informant to participate, and one participant lived in a religious community where 
all the activities were shared. 
 
As in our study we included caregivers of LADIS participants who became 
dependent along the follow-up period of the study, this inclusion/exclusion criteria 
resulted in a sample of 31 caregivers (23 women; 74%), with a mean age of 65 
years old (ranging from 43 to 86) and a mean educational level of 9,7 years of 
schooling (ranging from 4 to 21). Concerning the relationship with the patient, 
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almost all the caregivers had a family connection: 14 were daughters or sons 
(46%); 14 were spouses (43%); 2 (6%) were a nephew and niece; and only 1 (3%) 
was a friend. Eighteen participants (58%) lived in the same residence (Table 15). 
Eighteen care recipients (58%) had a clinical diagnosis of dementia and this was 
the main reason for care need. Reasons for care need not related with the clinical 
diagnosis of dementia were gait impairment and incontinence (n= 6; 21%). 
 
Table 15: Socio-demographic characteristic of caregivers (N=31) 
   
Age  (mean, minimum, maximum) 64.89 (42-86)  
Education (years of schooling) 9.7 (4-21)  
Female sex (number/%) 23 (74%)  
Kinship ties (number/%)   
 Wife/Husband 
 Daughter/Son 
 Friend 
13 (42%)/1(3%) 
8 (26%)/6 (19%) 
1 (3%) 
 
Common residence (number/%) 18 (58%)  
Care recipient clinical diagnosis 
(N=24)* 
 No cognitive impairment 
 
 
11 
 
 CIND (MCI/VCIND) 52(2/3)  
 Dementia (AD/VD/FTD/LBD)
  
18 (4/10/1)  
*based on the LADIS evaluation using the LOCF; 1patient with post-stroke severe motor deficit; 2 patients with gait 
impairment and/or incontinence; CIND=Cognitive impairment no dementia, MCI=Mild  
Cognitive Impairment, VCIND=Vascular Cognitive Impairment Alzheimer’s Disease, VC=Vascular Dementia, FTD=Fronto 
Temporal Dementia, LBD= Lewy Body Dementia; 
 
Subjective burden and coping strategies 
Substantial subjective burden (CSI >6) was identified in 14 participants (45%). 
Caregivers with substantial burden did not differ significantly from those with no 
substantial burden, in terms of socio-demographic characteristics such as age, 
gender, educational level, place of residence and kinship ties. 
 
Concerning the coping strategies used by caregivers, acceptance, planning, active, 
emotional and instrumental support were the most reported dimensions by the 
whole group, with emotional-focused coping type the most frequent. None of the 
caregivers reported the use of substances. When comparing participants with 
substantial burden with those with no to mild burden, caregivers with substantial 
burden used a higher number of active (U = 59, p=0.03, r=0.40), and denial (U = 
71, p= 0.03, r=0.39) strategies. Concerning the type of strategies used (problem-
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focused, emotional-focused or dysfunctional), no differences were found between 
both groups of caregivers (see Table 16).  
Caregivers with substantial burden had care recipients with more severe functional 
impairment, (U= 26, p=0.05, r=0.34) when compared with the group of no 
substantial burden (Table 16). Caregivers of 21 patients had also evaluated their 
relatives with the IADL scale, as part of the 10th year follow-up visit, and the 
difference between groups was the same, with care recipients of caregivers with 
substantial burden, being more dependent than the others (U=26, p=0.05, r=.42). 
 
Table 16: Coping strategies, health related quality of life, and care recipient 
functional status 
Variables 
All group (N=31) 
(mean±SD) 
No substantial 
burden (n=17) 
(mean±SD) 
Substantial 
burden (n=14) 
(mean±SD) 
Test 
Mann-Whitney  
COPING STRATEGIES 
(Brief COPE) 
    
Problem-focused 7.8±2.7 7.2±2.7 8.9±2.4 n.s. 
 Active  2.8±1.0 2.5±1.0 3.2±0.9 U = 59, p=0.03, r=0.40 
 Planning 2.9±1.1 2.7±1.2 3.2±1.1 n.s. 
 Instrumental support 2.2±0.9 2.1±1.0 2.5±0.7 n.s. 
Emotion-focused 11.3±2.3 11.6±2.4 11.0±2.2 n.s. 
 Positive reframing 2.4±0.9 2.7±0.9 2.1±0.8 n.s. 
 Acceptance 3.4±0.8 3.4±0.9 3.4±0.5 n.s. 
 Emotional support 2.3±0.9 2.2±0.9 2.5±1.1 n.s. 
 Humor 1.1±0.2 1.1±0.3 1.0±0.1 n.s. 
 Religion 2.13±1.2 2.2±1.2 2±1.1 n.s. 
Dysfunctional coping 8.2±2.0 7.9±1.7 8.7±2.5 n.s 
 Venting 1.4±0.5 1.4±0.4 1.3±0.6 n.s 
 Denial 1.3±0.6 1.1±0.3 1.5±0.8 U = 71, p= 0.03, r=0.39 
 Self-Blame 1.6±0.6 1.7±0.7 1.6±0.6 n.s. 
 Behavioral 
disengagement 
1.3±0.7 1.1±0.5 1.6±0.9 n.s. 
 Self-distraction 1.6±0.8 1.5±0.9 1.6±0.8 n.s. 
 Substance use 1.0±0 1.0±0 1.0±0 n.s. 
     
CARE RECEIVER FUNCTIONAL 
STATUS 
 CSHA (total) 
 
 
13.5±9.8 
 
 
9.12±8.9 
 
 
18.7±8.5 
 
 
U=49.5, p=0.006, r=0.50 
 IADL (N=21)* 4.4±2.3 3.7±2.3 5.5±2 U=26, p=0.05, r=.42 
*IADL only available for participants who were reevaluated at 10th year 
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When health related quality of life of both groups was compared (Figure 9), 
caregivers with substantial burden reported relatively more limitations on physical 
role functioning (physical role functioning 75±41 vs 65±30), although had less 
physical functioning complaints (physical functioning = 68±33 vs 73±27).  
 
Figure 9: Health related quality of life (MOS SF-36) 
 
PF-physical functioning; PRP-physical role functioning; BP-bodily pain; GH-general health; MH-mental health; 
ERF-emotional role functioning; SF-social functioning; VT-vitality 
 
 
Needs and Resources used 
Nineteen caregivers (61%) reported the use of an external aid for care providing. 
The most frequent type of aid referred was the assistance of an housemaid (42%), 
either on full or part-time. Home care assistance (palliative care or non 
differentiated teams) was also frequent (26%). Nursing home was referred as a 
choice for severe or terminal states (26%). 
 
 
Predictors of burden 
Bivariate regression analyses were performed in order to examine the predictive 
value of dependency on experienced substantial burden of caregivers. 
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Initial data analyses were conducted to ensure relevant assumptions to perform 
regression analyses. No significant outliers were detected and independence of 
observations was ensured (Durbin-Watson statistic= 2.21). Score distributions did 
not significantly differ from a normal curve – skewness and kurtosis values, and P-
P plots and Q-Q plots appeared to approximate normal distribution. Similarly, 
standardized residuals approached normality (histogram with superimposed 
normal curve and Normal P-P plot). When also taking into account coping styles, 
data did not show multicollinearity (VIF’s close to 1) (data not shown). 
 
Bivariate linear regression analyses showed that the degree of dependency, 
measured by the CSHA, was a predictor of the intensity of the burden (R2=34.5%; 
F (1,29) = 14.75, p<0.01; β=0.59, p<0.01). This effect maintained statistical 
significance even after controlling the effect of demographic variables (F (7,29) = 
2.97, p<0.05; β=0.65, p < 0.01), with age as the only additional marginal effect 
(β=-0.63, p = 0.05) with younger caregivers reporting less burden. 
 
When clinical diagnoses were added to the model, as dummy coded variables, 
having dementia was a predictor of the intensity of burden (R2=19.6%, F(1,22)=5.12, 
p=0.03; β=0.44, p = 0.03). Gait disturbances, incontinence or memory and 
behavior complaints did not predict intensity of burden. 
 
Finally, in order to test the possible role of the mechanisms of coping as mediators 
of the relationship between dependence and perceived burden, a set of multiple 
regressions was performed. “Active coping” was the only mechanism of coping 
that was found to be a predictor of level of burden (R2=22.4%, F(1,29)=8.10, p=0.01; 
β=1.64; p=0.008). However, when the extent of dependency of the 
patient (measured on the CSHA scale) was added to the model, the latter variable 
fully absorbed all related variance in respect to the burden of caring (R2=45.0%, 
F(1,30)=5.33, p=0.003; β=0.38; p=0.05). Thus, coping did not seem to contribute as 
an independent variable to the degree of experienced burden. 
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Discussion 
To our knowledge this is the first study that aimed to evaluate the characteristics of 
burden in caregivers of this elderly population with WML who evolved from a 
complete independent functional status to a loss of autonomy. Caregivers were, 
with one exception, family members of participants of the LADIS study, who 
became the main care providers during the follow-up period. It is well recognized 
that relatives, usually spouses or adult children, are the most frequent type of care 
providers of home living elderly people and the most long lasting support for 
patients with dementia [218, 219]. In our study, for more than half of care 
recipients, the need for caring was due to a dementia diagnosis, being the high 
degree of dependency associated to the substantial burden, reported by nearly 
half of the caregivers. 
 
Caregiver burden is a concept that is being explored for some decades and 
related with the physical and psychological well-being of informal care providers 
[220]. It is a complex response to the act of care that involves a multiplicity of 
factors that goes from those directly related with patients characteristics (such as 
presence of behavioral and psychiatric symptoms or lack of self-care/need of 
support), to those determined by caregivers (such as personality traits, coping 
style or social functioning) [204]. 
 
Caregivers burden, as an expression of stress response, can be explained based 
on the model of Lazarus and Folkman [221] , that assumes that the stress reaction 
is not immediately related with the life event, but rather with the individual’s 
appraisal of the situation as harmful. This immediate perception (defined by 
“primary appraisal”) could be aggravated by the self-evaluation of own capacities 
as unable to cope with the potential threat (“secondary appraisal”). Therefore, and 
adopting this model to the caregiver’s process [222], burden response, as a result 
of this dual appraisal process,  can be mediated by a set of variables including 
personal, illness-related, social and material factors. 
Based on this assumption, we expected that in this sample, substantial burden 
would be mediated by both caregivers’ determinants (coping mechanisms, health 
related quality of life), and illness/care recipient related characteristics (clinical 
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diagnosis, degree of functional impairment). In our sample, the perception of 
substantial burden was associated with the degree of functional impairment - 
measured both as number of compromised instrumental activities (IADL) and 
degree of impaired basic activities (caregivers’ questionnaire) -, presence of active 
and denial coping strategies, and lower health status perception in almost all the 
dimensions except in physical role functioning (type and quantity of work that 
might be limited), with higher percentages revealing less complaints. Considering 
health related quality of life, main results are consistent with what is being reported 
in the literature, where complaints of depressive symptoms and poor perceived 
health among caregivers associated to higher care needs have been previously 
reported [223-226]. In our sample, however, there were lower rates of physical role 
functioning complaints among caregivers with more substantial burden. This could 
be explained by the fact that caregivers with substantial burden tend to consider 
their physical performance as good, based on what they consider to be possible in 
terms of their job as care providers. 
 
An association of substantial burden with some caregiver’s approaches, namely 
active and denial coping strategies, was found in our study. Although the use of 
such different type of strategies (problem-focused and dysfunctional coping, 
respectively) could be seem as a paradox, it can be also be revealing of the 
psychological effort and conflict associated to caregiver’s role. It can also explain 
the fact that no predominant main type of coping style (problem-focused, emotion-
focused or dysfunctional), was found in association with substantial burden. 
 
Previous studies, that included patients with different types of dementia, have 
reported a clear relation between loss of functional ability in daily living activities 
and high rates of caregivers perceived burden, being factors related with functional 
decline, predictors of caregivers burden [227-230]. As previously reported [229], 
care recipient loss of capacities in daily living management of basic or instrumental 
activities, requires a higher level of involvement of care providers with direct 
impact in the time need to care. In our sample, dementia was the main reason of 
care need but its role as predictor of burden was fully absorbed by impairment in 
functional activities, which became the only independent variable able to predict 
perceived burden. Therefore, loss of capacities in performing instrumental and 
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basic activities in daily living became the only predictor of burden on this 
caregiver-patient dyad. 
 
Our study has some limitations that might constrain the generalization of results. 
The first is related with the small size of the sample of caregivers-patient dyads. 
Although obeying a cross-sectional design, this study emerged from a longitudinal 
approach of 10 years of length. Hence, attrition during this period is 
understandably high, especially it being a case of research with elderly 
populations. A second limitation stems from the high number of variables involved, 
as a result of the complex response that we aimed to understand, combined with a 
heterogeneous sample of participants, this leads to a great number of possible 
confounders. In addition, comparisons between groups (e.g. dementia type) were 
compromised due to sample size. 
 
However, the fact that we were able to evaluate caregivers of such a specific 
group of patients is a clear strength of this study. Besides, the long-term follow-up 
of this group of care recipients enables us to have a more comprehensive 
characterization of this population. Last, despite the low statistical power, we were 
able to establish a strong effect of functional impairment on perceived burden. 
 
Conclusion 
The importance of this result in this particular population - initially independent 
elderly people with WMC who became functionally disabled through time -, relies 
on the fact that small vessel disease have specific clinical symptoms that might 
contribute to a loss of functional capacities, even in very mild stages of the disease 
[231]. Gait and balance disturbances, as well as incontinence, are disabling 
conditions directly associated to white matter changes [210, 232, 233], that 
contribute to a more functional dependent state, and higher care need. Therefore, 
more attention should be payed to the evaluation of these conditions and caregiver 
support throughout the disease process. 
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Discussion of the hypotheses under study 
The present thesis constitutes an effort to characterize the long-term 
neuropsychological performance of elderly subjects with WMC, who were 
functionally independent at the baseline. We aimed to evaluate the extent to which 
age-related WMC influence cognitive performance and determine the transition 
from a healthy status to disability as well as to explore the impact of this change in 
caregivers. 
 
Cognitive Functioning and WMC 
Our first aim was to identify how cognitive functioning was related with WMC, 
which cognitive domains were mainly affected and which were more sensitive to 
decline. This goal was operationalized in the following hypotheses. 
 
A properly designed neuropsychological battery is able to differentiate the 
cognitive performance of independent elderly subjects with different 
degrees of WMC, in association with specific demographic variables (age 
and education) 
 
It was clearly demonstrated that the present neuropsychological battery, chosen 
based on the familiarity of the tests and the validity of the instruments to assess 
the decline of cognitive functions of patients with vascular disease, but also 
incorporating innovative assessment proposals (the VADAS-Cog), constitutes a 
sensitive instrument to differentiate levels of cognitive performance [142]. 
Preliminary exploratory factor analyses were performed in this study and 
confirmed later by longitudinal data, as described in Moleiro et al. [234]. Results 
showed that executive functioning, memory and speed of motor abilities were valid 
latent variables of neuropsychological performance among older adults, and that 
this structure was relatively consistent longitudinally. 
 
This aforementioned hypothesis was confirmed in a cross-sectional study which 
demonstrated that the use of both global measures of mental status and specific 
measures for individual domains assessment, was able to determine different 
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levels of cognitive performance [142]. Furthermore, the analysis of the baseline 
neuropsychological data showed a significant influence of demographic variables 
on cognitive performance. Complementary data presented in a different study 
[235] have also confirmed that neuropsychological performance is influenced by 
demographic factors (age, education) and also by severity of WMC and vascular 
risk factors. 
 
Higher educational level was consistently associated with better performances on 
cognitive tasks. Education was the most consistent factor influencing the 
neuropsychological performance in this sample of elderly subjects with WMC, with 
higher impact in complex tasks involving executive functioning. At the time of our 
cross-sectional study, only one study reported the relationship between education 
and cognitive performance associated with WMC [236]. Nevertheless, the idea of 
a cognitive reserve, that encompasses the ability to resist brain disease without 
developing signs or symptoms of the same, and acting as a mediator of cognitive 
decline in dementia, was being explored as an explanation for the inter-individual 
differences on the course of the diseases [167, 237, 238]. The importance of 
education, while a measure of cognitive reserve as a mediator between the 
severity of brain small vessel disease and the clinical expression of the pathology, 
has been recently reported [239-241]. This factor has been pointed as a possible 
explanation for the high rates of variability in the outcome of this population and 
may constitute a buffer against the negative effects of having WMC. 
 
Long-term influence of WMC on Cognitive Functioning 
 
Subtle deficits on global cognitive performance and specific cognitive 
domains observed at baseline, are predictors of dementia on a 3 year 
period, in a functionally independent elderly population with WMC 
This hypothesis was explored and confirmed in the first longitudinal study 
performed in the LADIS sample [189]. In this study, participants were followed 
during 3 years and a clinical diagnosis was made in each follow-up visit, every 
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year. Participants were diagnosed as having “dementia”, “cognitive impairment no 
dementia” (CIND) and “no cognitive impairment”. 
 
In this sample of functionally independent elderly population with WMC, subtle 
deficits on cognitive performance were predictors of dementia on a 3 year period, 
even after controlling for age and educational level. Participants clinically 
diagnosed with dementia at the end of the 3-year follow-up period had had lower 
scores in almost all the baseline neuropsychological tests, when compared with 
participants without dementia. This is consistent with the understanding of 
dementia as a progressive disease that starts insidiously, usually without evident 
signs besides subtle differences of cognitive tests scores. 
 
In our sample, memory and executive functioning baseline compound measures 
were predictors of dementia at 3 years. Executive functioning measured by trail-
making or Stroop tests individually, were not predictors of dementia. The absence 
of relationship between specific tests for the assessment of executive functions 
and WMC, was also reported in other studies [188, 242]. What we found was that, 
using a combination of more complex tests, such as verbal fluency and symbol-
digit, in a compound measure of executive functioning, could increase the 
sensitivity to detect preclinical changes of the disease. 
 
These cognitive performance differences could be considered a marker of 
preclinical stage and are observed either in tests that are proven to be more 
sensitive to cognitive change in cerebrovascular patients [243, 244], either in 
global measures that are usually considered to be less sensitive, such as the 
MMSE. This is in accordance to previous studies that also identify lower global 
cognitive scores, as preclinical markers of dementia [178]. In the LADIS sample, 
scores on MMSE were higher than those reported as cut-off scores for dementia, 
which enhances the importance of using different cut off scores among patients 
with higher educational level. 
 
In this second study, we were also able to identify that patients with CIND were 
older and had lower educational levels when compared with participants with no 
cognitive impairment, independently of the severity of WMC. Again, these results 
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reflect the influence of demographic variables on cognitive decline that act beyond 
the pathology. However, except for demographic factors, we did not find 
neuropsychological variables that could predict the transition from no impairment 
to CIND, since baseline cognitive performance did no differ between these two 
groups. This also reflects the heterogeneity of this group of patients and the 
importance of develop more sensitive cognitive measures to detect subtle 
differences of performance. 
 
The neuropsychological battery was able to identify different profiles of 
cognitive performance on a long-term evolution of a sample of initially 
independent elderly people with WMC. Higher performance in global 
measures and specific cognitive domains are predictors of no cognitive 
impairment at 10 years. 
 
In the third study of the present thesis, a long-term 10-year follow-up research 
effort, the Lisbon group of participants in the LADIS study was evaluated in order 
to identify long-term neuropsychological predictors of non-impaired cognitive 
functioning. In this study we presented different longitudinal profiles of cognitive 
performance in a cohort of initially independent elderly participants with WMC. The 
average cognitive scores of the participants, in the three groups of clinical 
diagnosis (no cognitive impairment, CIND and dementia), declined during the 
follow-up period, the steeper decline being found in the group of participants with 
dementia. Differences between groups of diagnosis were observed in the main 
batteries MMSE, ADAS-Cog and VADAS, but not in the individual tests used to 
evaluate executive functioning (trail-making and Stroop). Combined scores in 
outcomes on trail-making and Stroop tests (resulting from the difference between 
time to perform both tasks) did not differentiate participants with no cognitive 
impairment from those with any impairment. These results could be related with a) 
the fact that age-related decline in processing speed might contribute for an 
increase of time to perform the task in less complex parts (reading words, naming 
colors and connecting ordered numbers), reducing the magnitude of the difference 
between both tasks [196], or b) by the increasing number of persons who 
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performed the first part of the tests but are not able to perform the more complex 
parts. Considering these findings, we identified that the best discriminative 
measures in long-term follow-up evaluations should to be the individual scores of 
each task and not the differences between them. 
 
When baseline clinical and neuropsychological variables were analysed, we found 
higher scores on baseline MMSE were the strongest predictor of long-term clinical 
diagnosis of no cognitive impairment. These results are consistent with what was 
previously found at the third year of follow-up of the same population [189]. 
 
It became clear that, for participants with WMC, higher cut-off points on global 
batteries such as the MMSE, should be used in future to identify participants at 
risk of cognitive decline. The importance of using high cut off scores on MMSE to 
determine highly educated subjects at risk of decline was also discussed in a 
previous study[197]. There is some criticism to the use of MMSE to detect mild 
cognitive impairment and the newly adapted Montreael Cognitive Assessment 
Battery (MoCA) [47], has been pointed out as a better screening instrument for 
subtle cognitive changes of vascular origin [47, 245, 246]. However, results are 
still not consistent, with some studies presenting MMSE with equal discriminant 
[247] and predictive characteristics [248] than MoCA. Only two relevant studies 
have compared both instruments strictly in a sample of participants with SVD [54, 
249] and report MoCA as a more suitable instrument for detecting mild cognitive 
impairment. However, more studies are needed to provide extensive support for its 
future use in this population. 
 
Progression of WMC was an independent predictor of dementia among 
elderly people on a long-term follow up  
The third hypothesis of this study was not confirmed. In our 10 years follow-up 
study, severe progression of WMC was observed in more than half of the 
participants, which is consistent with what was previously reported [122]. Previous 
long-term studies [45, 250, 251] have described the same or higher rates of 
progression of white matter lesions, correlating them with loss of brain volume [45] 
and establishing an association between progression of WMC and deterioration of 
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cognitive functioning [45, 251, 252]. In the LADIS sample [251], deterioration of 
cognitive functioning was only moderately associated with progression of WMC 
and attenuated in subjects with severe WMC grade at baseline. In the referred 
study, only subjects with severe grade at baseline and progression of WMC 
showed marked cognitive decline [251]. 
 
However, in the present study, we found no relationship between WMC 
progression and dementia. We also did not find differences between participants 
with no impairment or any cognitive impairment concerning progression of WMC. 
WMC progression was also not found to be associated to any demographic, 
vascular risk factors or baseline severity WMC. 
 
Some factors associated with long-term progression of WMC, such as brain 
parenchymal volume loss, have been associated to cognitive decline, rather than 
WMC progression [45]. In our study brain volume loss associated to WMC 
progression loads was not evaluated, which might explain the absence of these 
associations in our study. On the other hand, in such a long-term evaluation, the 
expression of the disease could change, being the contribution of other variables. 
In our study we add an unique opportunity to compare MRI data in a very length 
period of time, by using the same MRI protocol, as well as the same equipment (or 
similar) and even, the same person, who rated all the scan images of the LADIS 
study. However, the use of the same protocol and techniques, limited the 
exploration of other measures and identification of other variables, such as mesial 
lobe atrophy, normal appearing white matter anisotropy or cerebral microbleeds 
that could play, in this long-term period, a more prominent role than white matter 
lesions itself [198]. As suggested in a recent study [219], periventricular white 
matter changes might be an indirect consequence of the Alzheimer-related brain 
atrophy, subsequent ventricular dilatation and ruptures of the ependymal lining 
with increased leakage of CSF into the surrounding periventricular white matter, or 
alternatively, might result directly from hippocampal and neocortical 
neurodegeneration and subsequent loss of axons in fibre tracts, which run near 
the lateral ventricles. Amyloid burden has also been associated with white matter 
microstructure changes [220]. Finally, it has also been demonstrated that WMC 
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differ according to the technique used, and that macrostructural and 
microstructural studies are complementary [218]. 
 
Impact of transition to disability in informal caregivers 
The final part of this thesis was committed to the effort to offer a more efficient 
treatment to the elderly with WMC, by exploring the impact of transition to a 
dependent status on family and caregivers. It was designed to evaluate how this 
transition was perceived by caregivers and what possible factors would mediate 
this relationship. 
 
To explore and characterize informal caregivers and needs as they follow the 
elderly subjects’ process of transition from an independent to a condition of 
disability, we established two hypotheses: 
 
Progressive change from an independent and autonomous status to a 
disabled functioning has an impact on the quality of life of caregivers 
 
This hypothesis was explored and confirmed in the last study of this thesis. In our 
sample of caregivers of the LADIS participants who became dependent during the 
10 year follow-up period, almost half reported substantial burden. In more than half 
of care recipients, the need for care was due to a diagnosis of dementia, with high 
degree of dependency, measured by a functional questionnaire, associated to the 
substantial burden. 
 
The perception of substantial burden was associated with 1) the degree of 
functional impairment; 2) presence of active and denial coping strategies; and 3) 
lower health status perception in almost all the dimensions except in physical role 
functioning (type and quantity of work that might be limited). 
 
Functional impairment, measured both as degree of impaired basic activities 
(caregivers’ questionnaire) or number of compromised instrumental activities 
(using the IADL), was the most prominent factor associated with subjective burden. 
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Loss of functional ability in daily living activities associated with high rates of 
caregivers perceived burden have been previously reported [227-230]. 
 
An association of substantial burden with some caregiver’s approaches, namely 
active and denial coping strategies, was found in our study. The way caregivers’ 
coping styles affect the perception of burden and / or health related quality of life, 
is still not clear. Based on the Transactional Stress Theory model [221] several  
theories have been used to explain caregivers’ stress response. Several factors 
have been identified in the stress response of caregivers, such as background and 
context of caregiving, objective stressors (care demands and care provided), 
subjective primary stressors (role overload and relational deprivation), secondary 
stressors (role strains and intrapsychic strains) and mediators such as social 
support and coping [253]. A recent systematic review [205],  found some evidence 
for a positive association between avoidance coping and subjective burden in 
home caregivers of older relatives with cognitive impairment. Avoidance coping 
strategies, in which denial can be included, are strategies oriented to avoid 
problems and engage in indirect attempts to reduce distress [254]. However, the 
direction of this relationship was not identified. Is still not clear if coping mediates 
or moderates subjective burden or if it is the cause of it [205]. 
 
In our study, both avoidance strategies, such as denial, and approach strategies 
(coping strategies oriented for the resolution of the problems) such as active 
strategies, were found to be related with subjective burden.  Although the use of 
such different type of strategies could be seen as a paradox, it can be also be 
revealing of the psychological effort and conflict associated to caregiver’s role. It 
can also explain the fact that no predominant main type of coping style (problem-
focused, emotion-focused or dysfunctional), was found in association with 
substantial burden. 
 
Considering health related quality of life, main results are consistent with what has 
been reported in the literature, where complaints of depressive symptoms and 
poor perceived health among caregivers are associated to higher care needs [223-
226]. 
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Results lead to the conclusion that the degree of dependency was the only 
predictor of the intensity of the burden. Despite the fact that ‘active coping’ 
appeared as a predictor of level of burden, the extent of dependency of the patient 
(measured on the CSHA scale) fully absorbed all related variance in respect to the 
burden of caring. 
 
The way in which caregivers are affected by the progression of the disease 
is related with their own coping mechanisms 
This hypothesis was not confirmed in our study. As above stated, based on the 
model of stress response of Lazarus and Folkmann [221] and adapting it to 
caregiver’s process [222, 253], we assumed that burden response would be 
mediated by both caregivers’ determinants (coping mechanisms, health related 
quality of life), and illness/care recipient related characteristics (clinical diagnosis, 
degree of functional impairment). 
 
An association of substantial burden with some caregiver’s approaches, namely 
active and denial coping strategies, was found in our study. However, as 
mentioned, when other objective stressors, such as care recipient degree of 
dependency, were included, the only independent predictor of substantial burden 
was the degree of functional impairment. 
 
Previous studies have reported a clear relation between loss of functional ability in 
daily living activities and high rates of caregivers perceived burden, being factors 
related with functional decline, predictors of caregivers burden [227-230]. Care 
recipient loss of capacities in daily living management of basic or instrumental 
activities, requires a higher level of involvement of care providers with direct 
impact in the time needed to care [229]. In our sample, dementia was the main 
reason of care need but its role as predictor of burden was fully absorbed by 
impairment in functional activities, which became the only independent variable 
able to predict perceived burden. Therefore, loss of capacities in performing 
instrumental and basic activities in daily living became the only predictor of burden 
on this caregiver-patient dyad. 
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Main results 
In the attempt to characterize the long-term neuropsychological performance of 
elderly subjects with WMC, who were functionally independent at the baseline, 
and were followed during a period of 10 years, we found that: 
 
1. There is a significant influence of demographic variables on cognitive 
performance.  Neuropsychological performance in patients with ARWMC 
was influenced by age and education. Higher educational level was 
consistently associated with better performances on cognitive tasks, while 
older age was associated with difficulties on memory and executive 
functions. 
2. In an elderly population with WMC and no functional or major cognitive 
impairment in initial evaluations, comprehensive neuropsychological 
assessment detected subtle changes in cognitive performance associated 
with progression for dementia. 
3. Concerning cognitive performance at baseline, there is a clear distinction 
between the three groups of clinical diagnosis (no cognitive impairment, 
CIND and dementia). Patients with CIND differed from patients with 
dementia in almost all the tests and global measures. The 
neuropsychological distinction between participants with no cognitive 
impairment and with CIND is less prominent, reflecting the heterogeneity of 
this particular group, which seems to be in the continuous line between the 
“no impairment” and “dementia”. 
4. Baseline scores of MMSE and memory and executive compound scores 
were predictors of dementia at the end of the 3 year follow-up period. 
5. It was possible to identify different longitudinal profiles of cognitive 
performance in a cohort of independent elderly participants with WMC. As 
expected, the group of participants with dementia showed more prominent 
decline all over the time, while the group with a clinical diagnosis of CIND 
revealed a profile closer to non-impaired participants, even after such a long 
period of time. We identified higher scores on baseline MMSE cognitive 
performance as the strongest predictor of long-term (10 years) clinical 
diagnosis of no cognitive impairment. 
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6. More than half of caregivers of participants who became dependent during 
the follow-up study, showed substantial burden.  Although an association 
between coping strategies and perception of burden could be noted, the 
high degree of dependency was the only predictor associated to the 
substantial burden. 
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Strengths and limitations of the study 
Strengths of the study 
The study here presented was carried out in the context of the LADIS project that 
consisted in a rare opportunity to study a specific pathology, i.e. age-related white 
matter changes in an elderly population, based on data taken from a large 
heterogeneous multinational sample. Exhaustive and rigorous information was to 
be collected allowing a better understanding of the impact of the disease on 
cognitive functioning. The cultural and socio-economic characteristics which 
differentiate the various participating countries, had to be accepted as a challenge 
in constructing a battery of neuropsychological assessment. 
 
The balanced combination of neuropsychological measures, using both long 
validated tests (e.g. MMSE, Trail-making), as well as recently developed proposals 
(VADS-Cog), and the multicentre harmonization work based on the use of the 
same version of chosen tests for all the countries (adapted only for national 
language specificities), accompanied by strict guidelines of application, made it 
possible to improve the cognitive assessment of this population. 
 
Cultural and social differences across countries contributed to a great 
heterogeneity of the sample. The impact of these differences on cognitive 
performance was explored and identified cross-national variables were controlled 
in several analyses and did not interfere with the results [142]. 
 
The longitudinal design of this study also made possible to evaluate the evolution 
of the disease and its impact in the transition from a healthy to a disabled 
functional state. The medium (3 years) and long (10 years) follow-up of this 
sample, enabled us to identify demographic, clinical and neuropsychological 
predictors of impairment which would not be possible in a cross-sectional design. 
Using data from the Lisbon Center, we were able to register and rate the 
progression of white matter changes in a 10 year follow-up period, in a smaller 
sample of initially independent elderly participants, which constitutes a unique 
study. 
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Furthermore, the 10th year follow up of this small sample of Lisbon centre 
participants made it possible to evaluate the impact of progressive disability on 
caregivers. Although this last study was constrained in the interpretation of the 
results, it enabled the characterization of the burden on this group of caregivers 
and the exploration of some possible predictors. 
 
Finally, it is rare to have such long periods of follow-up with this amount of data, 
which included demographic, clinical, and vascular risk factors, as well as MRI 
studies. Although it was not possible to extend the extra 10th year follow up to 
other LADIS centers - mainly due to organizational difficulties (changes in the 
researcher’s staff, for instance) and to the fact that there was no funding for this 
study -, we were able to registry and rated the progression of white matter 
changes in a 10 year follow-up period in a small sample of initially independent 
elderly participants. We used exactly the same criteria and imaging techniques, 
and scans were rated by the same person who classified the entire sample during 
the LADIS follow-up. This constitutes a rare or, to our knowledge, maybe a unique 
achievement.  
 
 
Limitations of the study 
Longitudinal studies, especially very-long term ones, have always some limitations 
in the interpretation of data. One important limitation has to do with the high 
attrition rates that are due to a diverse number of factors, but especially important 
in the case of older adults in a long-term follow-up. Higher attrition, death and co-
morbity rates are inherent to this type of study design and population, and may 
limit some conclusions. Whenever possible, we tried to decrease this impact by 
obtaining all the information we could concerning clinical and mental status, by 
using structured phone interviews (e.g., TICS), contacting relatives or friends, and 
getting clinical information from general practitioners. 
 
Another limitation results from the continuous technological and methodological 
changes occurring during the period of the study. In a decade, it is natural and 
desired to witness some improvement in measures, parameters, instruments, etc. 
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These adaptations may constrain comparability of results. For instance, during the 
10 year follow-up period, imaging techniques changed considerable. Time 
susceptibility-weighted imaging (SWI) and T2 * and perfusion/diffusion MRI 
sequences became more frequently used but were not included at the beginning 
of our study. Again, due to some technical constraints, diffusion tensor imaging 
(DTI) and magnetisation transfer ratio (MRT) techniques were not available in all 
the centres and were left optional [106]. As DTI has been reported as able to 
detect changes in normal-appearing white matter [238], the impact of white matter 
changes was probably underestimated. Concerning imaging analyses, the LADIS 
study did include hippocampal volumetry evaluation and cerebral atrophy was 
conducted in a sub-sample of subjects. These measures would be important 
contributors to understand and differentiate neuropsychological profiles and 
clinical outcomes. In order to compare results between baseline and the 10th year 
follow-up period, we had to use exactly the same equipment and protocol, even 
knowing that more sensitive measures had been developed since the beginning of 
the study. 
 
The same reasoning is also applicable to the construction of the LADIS 
neuropsychological battery. At the beginning of the study, we tried to use the most 
familiar and easy to administer instruments (such as MMSE, trail-making, Stroop) 
in order to decrease possible differences between centres. Recent proposals of 
screening tests for vascular impairment, such as the MoCA battery, did not exist at 
the moment. The inclusion of specific measures to improve the assessment of 
vascular impairment (such as delayed recall, symbol-digit, digit span, maze, digit 
cancellation and verbal fluency that make up the VADAS-Cog) increased the time 
needed to administer and would increase the risk of patient’s withdrawal. For this 
reason, we reduced the number of memory trials (only one trial was used on word 
recall and word recognition tests), which limited the assessment of verbal learning 
and thus might have limited the interpretation of baseline results. 
 
Another possible drawback of our study is related to the use of dichotomized or 
categorized variables such as dementia/no dementia or NCI/CIND, including 
patients with different types of dementia in the same group. However, splitting 
these groups into subsamples would have reduced statistical power and 
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compromised the analysis of the results, given that certain types of dementia had 
very low frequencies. 
 
Finally, there are a number of contributors for cognitive functioning, directly or 
indirectly related with small vessel disease, that were not controlled in this study, 
limiting the interpretation of some results. For instance, global atrophy was not 
controlled in this study. However, in other study [77], medial temporal and 
subcortical atrophy were identified as predictors of global cognitive decline, and 
decline in psychomotor speed, executive functions, and memory, potentiating the 
effect of WMC. Moreover, the presence of microbleeds, that have been related 
with cognitive decline, mainly non-memory functioning [103, 255, 256], was not 
analysed in our study, since at the time of beginning of the LADIS study, there was 
no evidence of the impact of cerebral microbleeds in cognitive functioning. 
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Implications for clinical practice 
After a decade of work in evaluating the impact of WMC on cognitive performance, 
we hope to have contributed with some evidence on this field. It became clear that 
WMC, as one of the most detectable expressions of small vessel disease, can 
interfere in cognitive performance of elderly subjects, even before they have 
functional complaints. Still, even before the onset of these complaints, subtle 
changes in cognitive performance are detectable through sensitive 
neuropsychological evaluation. 
 
These results enhance the importance of neuropsychological assessment in 
clinical practice as a form of detecting subtle changes in very initial phases of brain 
diseases. The use of adequate cut-off scores and sensitive measures in the 
neuropsychological evaluation can lead to the detection of people at risk of 
cognitive decline and dementia. Earlier neuropsychological diagnosis of elderly 
people with WMC leads to more efficacious implementation of non-
pharmacological approaches that aim to compensate cognitive deficits, and 
therefore, to the maintenance of their maximum autonomy. In the same way, 
knowing the impact of the progression of the disease in the patients and their 
families, early interventions with caregivers should also be used. 
 
Implications for future research 
Although the knowledge acquired during the last years considering the 
neuropsychological assessment of WMC, there is still work to be done on the 
development of more sensitive cognitive measures. Instruments more able to 
distinguish neuropsychological profiles among patients with CIND and to identify 
predictors of long-term decline and dementia, are needed.  Similarly, it is still 
needed to identify early neuropsychological profiles able to predict the progression 
for different types of dementia. 
 
In the same line, it is also needed to identify other SVD manifestation markers, 
such as mibrobleeds, lacunes and regional or global atrophy, on the impact of 
cognitive performance. In order to do that, future research must include imaging 
sensitive tools for the measure of cerebral WMC. Recent MRI diffusion, perfusion 
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and spectroscopy sequences, that allow the visualization of tissue changes in 
areas of white matter that appear normal using conventional MRI, should be used.  
It is also important to address the impact of pharmacological and non-
pharmacological therapies on neuropsychological performance. Programs of 
cognitive stimulation in early stages of the disease, comparing patients with and 
without structured interventions, should be evaluated. Three types of non-
pharmacological programs could be evaluated in this population: 1) cognitive 
stimulation and rehabilitation programs in early stages of the disease; 2) 
implementation of physical activity programs for patients; 3) programs directed to 
caregivers of patients in moderate to severe stages of the disease. To perform 
these types of studies, we need to increase the number of included subjects, to 
allow the control of multiple concomitant factors that can confound the 
interpretation of results and interfere with statistical power. Multi-national clinical 
trials may provide the frame and resources for such studies. 
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Conclusion 
The thesis here presented aims to have a say in further identifying clear profiles of 
cognitive functioning in patients with WMC, and to underline the existence of 
subtle deficits independent of the degree of severity of the WMC which are to be 
found in autonomous and independent subjects (1st study). 
 
As detailed, when comparing different evolutionary profiles, the battery 
constructed proved to be effective in detecting deficits appearing in early stages 
(2nd study). While identifying predictors of good cognitive functioning (MMSE > 28) 
in lengthy follow-up research efforts, the battery gives support in establishing 
intervention programs for a population identified as at risk. 
 
Though WMC are almost exclusively detected by imaging markers, the clinical 
expression of those changes, particularly as related to cognitive function, should 
become possible to assess through sensitive batteries adapted to this population. 
 
Neuropsychological assessment allows the definition of the impairment, as well as 
the determination of its impact on daily life and adaptation of intervention 
programmes either in early or later stages of progression of the disease. This 
approach allows the introduction of non-pharmacologic complementary therapies 
in view of promoting functional autonomy for the longest period of time possible. 
 
Similarly, the identification of changes in cognitive functioning and the 
corresponding impact on patients and their environment, mostly in the family, 
allows the adoption of broader intervention strategies, potentiating the maximum 
autonomy, involving future informal caregivers in terms of decreasing their load. 
 
Regarding caregivers, and considering the evolutionary character of this disease, 
a fact which becomes more prominent each day, it is important to develop 
research projects focusing on larger groups of patients and their relatives, using 
sensitive measures of assessment and resource strategies over time. 
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This would lead to identify determinants of subjective overload and, more 
importantly, it would produce wellness indicators associated with the function of 
care which, in turn, would be enhanced as mediators of psychological and 
emotional well-being. 
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Appendix 1: List of participating centers and personnel 
 
Helsinki, Finland (Department of Neurology, Helsinki University Central Hospital and 
Department of Neurological Sciences, University of Helsinki, Finland): Timo Erkinjuntti, 
MD, PhD, Tarja Pohjasvaara, MD, PhD, Pia Pihanen, MD, Raija Ylikoski, PhD, Hanna 
Jokinen, PhD, Meija-Marjut Somerkoski, MPsych, Riitta Mäntylä, MD, PhD, Oili Salonen, 
MD, PhD;  
Graz, Austria (Department of Neurology and Department of Radiology, Division of 
Neuroradiology, Medical University Graz): Franz Fazekas, MD, Reinhold Schmidt, MD, 
Stefan Ropele, PhD, Brigitte Rous, MD, Katja Petrovic, MagPsychol, Ulrike Garmehi, 
Alexandra Seewann, MD;  
Lisboa, Portugal (Serviço de Neurologia, Centro de Estudos Egas Moniz, Hospital de 
Santa Maria): José M. Ferro, MD, PhD, Ana Verdelho, MD, Sofia Madureira, Psy, Carla 
Moleiro, PhD;  
Amsterdam, The Netherlands (Department of Radiology and Neurology, VU Medical 
Center): Philip Scheltens, MD, PhD, Ilse van Straaten, MD, Frederik Barkhof, MD, PhD, 
Alida Gouw, MD, Wiesje van der Flier, PhD;  
Goteborg, Sweden (Institute of Clinical Neuroscience, Goteborg University): Anders 
Wallin, MD, PhD, Michael Jonsson, MD, Karin Lind, MD, Arto Nordlund, PsyD, Sindre 
Rolstad, PsyD, Ingela Isblad, RN;  
Huddinge, Sweden (Karolinska Institutet, Department of Neurbiology, Care Sciences and 
Society; Karolinska University Hospital Huddinge): Lars-Olof Wahlund, MD, PhD, Milita 
Crisby, MD, PhD, Anna Pettersson, RPT, PhD, Kaarina Amberla, PsyD;  
Paris, France (Department of Neurology, Hopital Lariboisiere): Hugues Chabriat, MD, 
PhD, Karen Hernandez, psychologist, Annie Kurtz, psychologist, Dominique Hervé, MD, 
Sarah Benisty, MD, Jean Pierre Guichard, MD; 
Mannheim, Germany (Department of Neurology, University of Heidelberg, Klinikum 
Mannheim): Michael Hennerici, MD, Christian Blahak, MD, Hansjorg Baezner, MD, Martin 
Wiarda, PsyD, Susanne Seip, RN;  
Copenhagen, Denmark (Memory Disorders Research Group, Department of Neurology, 
Rigshospitalet, and the Danish Research Center for Magnetic Resonance, Hvidovre 
Hospital, Copenhagen University Hospitals): Gunhild Waldemar, MD, DMSc, Egill Rostrup, 
MD, MSc; Charlotte Ryberg, MSc, Tim Dyrby MSc, Olaf B. Paulson, MD, DMSc; Ellen 
Garde, MD, PhD; Kristian Steen Frederiksen, MD;  
Newcastle-upon-Tyne, UK (Institute for Ageing and Health, Newcastle University): John 
O'Brien, DM, Sanjeet Pakrasi, MRCPsych, Mani Krishnan MRCPsych, Andrew 
Teodorczuk, MRCPsych, Michael Firbank, PhD, Philip English, DCR, Thais Minett, MD, 
PhD. 
The Coordinating centre is in Florence, Italy (Department of Neurological and Psychiatric 
Sciences, University of Florence): Domenico Inzitari, MD (Study Coordinator); Luciano 
Bartolini, PhD, Anna Maria Basile, MD, PhD, Eliana Magnani, MD, Monica Martini, MD, 
Mario Mascalchi, MD, PhD, Marco Moretti, MD, Leonardo Pantoni, MD, PhD, Anna 
Poggesi, MD, PhD, Giovanni Pracucci, MD, Emilia Salvadori, PhD, Michela Simoni, MD. 
The LADIS Steering Committee is formed by Domenico Inzitari, MD (study coordinator), 
Timo Erkinjuntti, MD, PhD, Philip Scheltens, MD, PhD, Marieke Visser, MD, PhD, and 
Peter Langhorne, MD, BSC, PhD, FRCP who replaced in this role Kjell Asplund, MD, PhD 
beginning with 2005. 
Appendix 2: Definition Criteria for Risk Factors and 
Diseases under Study 
Myocardial Infarction 
Myocardial infarction, documented by history, ECG or cardiac enzymes, was 
defined according to the Consensus Document of the Joint European Society of 
Cardiology/American College of Cardiology Committee for the redefinition of 
myocardial infarction [28]. Criteria were the following: 
 
Criteria for Acute, Evolving or Recent Myocardial Infarction 
Typical rise and gradual fall (troponin) or more rapid rise and fall (CK-MB) of 
biochemical markers of myocardial necrosis with at least one of the following: (a) 
ischemic symptoms; (b) development of pathological Q waves on the ECG; (c) 
ECG changes indicative of ischemia (S–T segment elevation or depression), or (d) 
coronary artery intervention (e.g. coronary angioplasty). Pathological findings of an 
acute myocardial infarction. 
 
Criteria for Established Myocardial Infarction 
Any of the following criteria satisfies the diagnosis of established myocardial 
infarction: 
Development of new pathological Q waves on serial ECGs. The patient may or 
may not remember previous symptoms. Biochemical markers of myocardial 
necrosis may have normalized, depending on the length of time that has passed 
since the infarct developed. Pathological findings of a healed or healing 
myocardial infarction. 
 
Angina pectoris 
Angina pectoris was defined according to the American College of 
Cardiology/American Heart Association Task Force on Practice Guidelines [29, 30] 
as follows. 
A clinical syndrome typically characterized by a deep, poorly localized chest or 
arm discomfort that is reproducibly associated with physical exertion or emotional 
stress and relieved promptly (i.e. 15 min) with rest or sublingual nitroglycerine. The 
discomfort of angina is often hard for patients to describe, and many patients do 
not consider it to be ‘pain’. Patients with unstable angina may have discomfort with 
all the qualities of typical angina except that episodes are severer and prolonged 
and may occur at rest with an unknown relationship to exertion or stress. 
 
Cardiac Valvulopathy 
Cardiac valvulopathies were classified according to the American College of 
Cardiology/American Heart Association Task Force on Practice Guidelines [31]. 
Information was available from history and/or clinical records and the best clinical 
judgment was used to determine whether the valvulopathy was relevant in terms 
of cardiac function. (Leukoaraiosis and Disability Neuroepidemiology 2005; 24:51–
62 59) 
Heart Failure 
Heart failure was defined according to the Task Force on Heart Failure of the 
European Society of Cardiology [32]. The definition was the following: symptoms 
of heart failure, objective evidence of cardiac dysfunction and response to 
treatment directed toward heart failure. 
 
Cardiac Arrhythmias 
Diagnosis of cardiac arrhythmias was based on history and/or available clinical 
records. Atrial fibrillation was defined according to Falk [33], as characterized 
electrocardiographically by the presence of rapid, irregular, fibrillatory waves that 
vary in size, shape and timing, usually associated with an irregular ventricular 
response. 
 
Cerebrovascular Diseases 
Stroke and TIA were defined according to the World Health Organization [34]. The 
Rankin scale [35] was used as a functional measure of stroke severity. Ischemic 
stroke subtypes were classified according to the TOAST classification [36]. 
 
Stroke 
Rapidly developing clinical symptoms and/or signs of focal, and at times global, 
loss of cerebral function, with symptoms lasting for more than 24h or leading to 
death, with no apparent cause other than that of vascular origin. 
 
Transient Ischemic Attack 
Sudden onset of clinical symptoms and/or signs related to focal cerebral or vision 
deficit attributable to vascular origin, with symptoms and/or signs lasting less than 
24 h. 
 
Arterial Hypertension 
Hypertension was defined according to the World Health Organization Guidelines 
for the management of hypertension [37] as asystolic blood pressure of 140 mm 
Hg or greater and/or a diastolic blood pressure of 90 mm Hg or greater in subjects 
who are not taking antihypertensive medication. The diagnosis of hypertension 
had to be based on multiple blood pressure measurements, take non several 
separate occasions. 
 
Lower Limb Arteriopathy/Peripheral Vascular Disease 
Lower limb arteriopathy and peripheral vascular disease were defined according to 
the American College of Cardiology/American Heart Association Guidelines [38]. 
Symptomatic disease presenting as intermittent claudication and/or critical leg 
ischemia were considered according to the criteria reported below. Furthermore, a 
documented aortic aneurysm, if clinical records were available, was considered. 
 
 
 
 
 
 
 
 
Definition of Lower Limb Arteriopathy 
Depending on its severity, lower extremity arterial disease can present in different 
ways, including (1) asymptomatic arterial insufficiency, (2) symptomatic disease 
presenting as intermittent claudication with positive non invasive tests and (3) 
critical leg ischemia, which defines the subgroup of patients with symptomatic 
lower extremity arterial disease, in which the ischemic process endangers part or 
all of the lower extremity, and which includes patients undergoing surgical 
revascularization procedures or limb amputation. 
 
Diabetes mellitus 
Diabetes mellitus was defined and classified according to the American Diabetes 
Association Criteria [39]. 
Previous diagnosis and/or current treatment with insulin or oral hypoglycemic 
medications, or at least 8-hour fasting plasma glucose≥7.0 mmol/l (126 mg/dl) as 
in the reported criteria were considered. 
 
Criteria for the Diagnosis of Diabetes mellitus 
Symptoms of diabetes plus casual plasma glucose concentration≥200 mg/dl (11.1 
mmol/l). Casual is defined as any time of day without regard to time since last 
meal. The classic symptoms of diabetes include polyuria, polydipsia and 
unexplained weight loss 
or 
fasting plasma glucose ≥126 mg/dl (7.0 mmol/l; fasting is defined as no caloric 
intake for at least 8 h) 
or 
2-hour plasma glucose ≥200 mg/dl during an oral glucose tolerance test. The test 
should be performed as described by the WHO, using a glucose load containing 
the equivalent of 75 g anhydrous glucose dissolved in water. 
 
Hyperlipidemias 
Hyperlipidemia was defined according to the National Cholesterol Education 
Program Adult-Treatment Panel II [40]. Hypercholesterolemia included total 
cholesterol >200, low-density lipoprotein>130, high-density lipoprotein <35 mg/dl 
(each value found elevated in at least 2 measurements). Hypertriglyceridemia 
included serum triglyceride >200 mg/dl (in at least 2 measurements). 
 
Migraine 
Migraine was defined according to the Headache Classification Committee of the 
International Headache Society [41]. Criteria were the following. 
 
Migraine without Aura 
(A) At least 5 attacks fulfilling B–D. 
(B) Headache attacks lasting 4–72 h (untreated or unsuccessfully treated). 
(C) Headache has at least 2 of the following 4 characteristics: 
(1) Unilateral location; (2) pulsating quality; (3) moderate or severe intensity 
(inhibits or prohibits daily activities); (4) aggravated by walking stairs or similar 
routine physical activity. 
(D) During headache at least 1 of the following symptoms occur: (1) nausea and/or 
vomiting; (2) photophobia and phonophobia. 
 
Migraine with Aura 
(A) At least 2 attacks fulfilling B. 
(B) Headache has at least 3 of the following 4 characteristics:(1) one or more fully 
reversible aura symptoms indicating focal cerebral cortical and/or brainstem 
dysfunction; (2) at least 1 aura symptom develops gradually over more than 4 min, 
or 2 or more symptoms occur in succession; (3) no aura symptoms last more than 
60 min; if more than 1 aura symptom is present, accepted duration is 
proportionally increased; (4) headache follows aura with a free interval of <60 min 
(it may also begin before or simultaneously with the aura). (Pantoni et al. 60 
Neuroepidemiology 2005; 24:51–62) 
 
Losses of Consciousness 
Seizures were defined according to the Commission on Classification and 
Terminology of the International League against Epilepsy [42–44] and syncopal 
episodes were registered on the basis of best clinical judgment. 
 
Chronic Obstructive Pulmonary Disease 
Chronic obstructive pulmonary disease was defined according to the British 
Thoracic Society guidelines for the management of chronic obstructive airways 
disease [45], as a chronic, slowly progressive disorder characterized by airways 
obstruction (FEV 1 <80% predicted and FEV 1 /VC ratio <70%) which does not 
change markedly over several months. The impairment of lung function is largely 
fixed but is partially reversible by bronchodilator (or other) therapy. Thus, a 
diagnosis in clinical practice requires: history of chronic progressive symptoms 
(cough and/or wheeze and/or breathlessness), objective evidence of airways 
obstruction, ideally by spirometric testing, that does not return to normal with 
treatment. 
 
Depression 
History of depression was based on the presence of previous depressive episodes 
requiring treatment or hospital admission, corroborated by specific tests assessing 
mood alterations (15-item Geriatric Depression Scale, Cornell Scale for 
Depression, DSM-IV criteria checklist) [46–48]. 
 
Osteoarthritis and Chronic Pain 
Ostheoarthritis (OA) was defined according to the Workshop on Etiopathogenesis 
of Osteoarthritis [49]. OA of the knee, characterized by knee pain for most days of 
the prior month, OA of the hand, characterized by hand pain, aching or stiffness 
for most days of the prior month, and OA of the hip with hip pain for most days of 
the prior month were considered. 
Chronic pain was defined according to the National Institute of Neurological 
Disorders and Stroke [50]. 
Appendix 3: Consent form 
Instituto de Medicina Molecular, Unidade Neurológica de Investigação Clínica 
Serviço de Neurologia, Hospital de Santa Maria 
 
 
INFORMAÇÃO PARA OS FAMILIARES / CUIDADORES DOS 
PARTICIPANTES NO ESTUDO 
 ALTERAÇÕES DA SUBSTÂNCIA BRANCA, EVOLUÇÃO NEUROPSICOLÓGICA E IMPACTO 
NOS CUIDADORES: 10 ANOS DE SEGUIMENTO  
 
Como é do seu conhecimento, estamos a dar continuidade ao estudo LADIS 
(Estudo do Impacto das Alterações da Substância Branca Relacionadas com a Idade), no 
qual o seu familiar participou entre 2000 e 2004 (ver folha em anexo). Com o 
objectivo de compreendermos melhor o impacto que estas alterações tiveram 
na vida dos doentes e na dos seus familiares / cuidadores, gostaríamos de o 
convidar a participar no estudo “Alterações da Substância Branca: perspectiva 
do cuidador”. 
 
O estudo consiste numa única entrevista, de cerca de 40 minutos, que será 
realizada no Piso 6 (por baixo do Serviço de Neurologia, local habitual das 
visitas do estudo LADIS) do Hospital de Santa Maria, aquando da consulta de 
reavaliação do doente, ou num dia a combinar conforme a sua disponibilidade.  
A entrevista será feita pela Psicóloga (Dra. Sofia Madureira) e tudo o que disser 
será tratado com confidencialidade. O tratamento dos dados será feito sob 
anonimato e a confidencialidade dos mesmos assegurada mediante 
codificação dos dados, não sendo nunca guardados nomes com os dados 
recolhidos e não podendo ser identificados indivíduos a partir de informação 
em qualquer registo do estudo.  
 
Para qualquer esclarecimento solicitamos que nos contacte (Dra. Sofia 
Madureira) para o telefone, nº 21 795 7474 (Ext.: 44197) 
 
Agradecemos, desde já, a atenção que prestou ao nosso convite e esperamos 
contar com a sua colaboração. 
 
Instituto de Medicina Molecular, Unidade Neurológica de Investigação Clínica 
Serviço de Neurologia, Hospital de Santa Maria 
 
 
ESTUDO : ALTERAÇÕES DA SUBSTÂNCIA BRANCA: PERSPECTIVA DO 
CUIDADOR 
 
CONSENTIMENTO INFORMADO 
 
 
Certifico que li a informação relativa à continuidade do Estudo do Impacto das 
Alterações da Substância Branca Relacionadas com a Idade, perspectiva 
do cuidador . 
. Concordo em realizar esta entrevista no âmbito do estudo acima 
referido 
 
Nome do Participante:_____________________________________________ 
 
 
Assinatura: ____________________________Data:________________ 
 
 
Nome da Psicóloga: Dra. Sofia Madureira 
 
Assinatura:__________________________ Data: _______________ 
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INFORMAÇÃO PARA OS PARTICIPANTES NO ESTUDO 
 ALTERAÇÕES DA SUBSTÂNCIA BRANCA, EVOLUÇÃO NEUROPSICOLÓGICA E IMPACTO 
NOS CUIDADORES: 10 ANOS DE SEGUIMENTO 
 
Como é do seu conhecimento, estamos a dar continuidade ao estudo LADIS (Estudo 
do Impacto das Alterações da Substância Branca Relacionadas com a Idade), no qual 
participou entre 2000 e 2004 (ver folha em anexo). Nesse sentido gostaríamos de o 
convidar a fazer uma nova consulta de avaliação geral da sua saúde bem como da 
sua capacidade cognitiva e desempenho motor, com o objectivo de comparar a 
evolução ao longo do tempo.  
 
Consulta: 
Tal como nas consultas anteriores, a avaliação clínica incluirá a compilação de dados 
demográficos, a identificação de factores de risco vasculares (hipertensão, diabetes, 
tabagismo etc), exame físico, e exame neurológico. A avaliação neuropsicológica 
engloba um conjunto de testes (tipo pergunta e resposta), dirigidos à avaliação das 
capacidades cognitivas. A capacidade motora será avaliada mediante provas simples 
de marcha e de equilíbrio. Ambas as consultas serão realizadas pelas Neurologista 
(Dra. Ana Verdelho) e Psicóloga (Dra. Sofia Madureira) que o / a acompanharam no 
estudo anterior.  
 
Exames a realizar: 
Tal como no estudo anterior, será realizada uma Ressonância Magnética para que se 
possa avaliar as alterações da substância branca. Este é um exame não invasivo (não 
traz incómodo ao doente em resultado da sua execução) do qual não se conhecem 
efeitos secundários. Apenas os doentes com algumas próteses metálicas cirúrgicas ou 
pace-maker artificial não poderão repetir o exame. A administração de contraste não 
será em princípio realizada. Nesta última eventualidade será solicitado o seu 
consentimento escrito, visto existirem numa pequena percentagem de doentes casos 
de reacções alérgicas. 
 
Local: 
A consulta será feita no Hospital de Santa Maria, através da Consulta Externa de 
Neurologia, com excepção feita à ressonância magnética que será efectuada no 
Hospital da Cruz Vermelha.  
 
Confidencialidade: Tudo o que disser em consulta será tratado com 
confidencialidade. O tratamento dos dados será feito sob anonimato e a 
confidencialidade dos mesmos assegurada mediante codificação dos dados, não 
sendo nunca guardados nomes com os dados recolhidos e não podendo ser 
identificados indivíduos a partir de informação em qualquer registo do estudo. Se 
desejar ou concordar, poderemos informar o seu Médico de Família que realizou este 
exame e fornecer os dados que achar necessários (relatório da Ressonância 
Magnética, por exemplo) 
 
É livre de recusar ou interromper a participação sem que isso afecte o seu tratamento 
ou o seu seguimento em Consulta Externa de Neurologia. 
 
 
CONSENTIMENTO INFORMADO 
 
 
ESTUDO: ALTERAÇÕES DA SUBSTÂNCIA BRANCA, EVOLUÇÃO NEUROPSICOLÓGICA E 
IMPACTO NOS CUIDADORES: 10 ANOS DE SEGUIMENTO 
 
 
Certifico que li a informação relativa à continuidade do Estudo do Impacto das 
Alterações da Substância Branca Relacionadas com a Idade, na Transição 
para a Dependência no Envelhecimento 
.Concordo em realizar esta avaliação no âmbito dos 10 anos de 
seguimento estudo acima referido 
 
Nome do Participante:_____________________________________________ 
 
 
Assinatura: ____________________________Data:________________ 
 
 
Nome do Médico: Dra. Ana Verdelho 
 
Assinatura: ______________________Data:______________________ 
 
 
 
Nome da Psicóloga: Dra. Sofia Madureira 
 
Assinatura:__________________________ Data: _______________ 
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Assessment Scale plus tests of Delayed recall, Symbol digit, 
Digit span, Maze, Digit cancellation and Verbal fluency), Trail 
making and Stroop test. Six hundred thirty-eight patients 
(mean age 74  8 5 years; mean educational level 10  8 4, F/M: 
351/287) were included in this study. Neuropsychological 
data were analyzed test by test and also grouped in three 
compound measures (executive, memory and speed/motor 
control domains). Older subjects ( 1 74 years) performed sig-
nificantly worse than younger subjects on the ADAS-Mod 
and on the tests of memory (t 631  = 3.25; p = 0.001), executive 
functions (t 581  = 4.68; p = 0.001) and speed/motor control 
(t 587  = 4.01; p = 0.001). Participants with higher educational 
level ( 1 8 years of school) showed better performances on 
the compound measures for memory (t 631  = 3.25; p = 0.001), 
executive functions (t 581  = 4.68; p = 0.001) and speed/motor 
control (t 587  = 4.01; p = 0.001). Using multiple regression anal-
ysis models to study the influence of demographic variables 
on cognitive performance, age and education remained im-
 Key Words 
 White matter changes   Aging   Cognitive performance   
Neuropsychological tests 
 Abstract 
 The relationship between age-related white matter changes 
and cognitive performance in independent elderly people is 
still not clear. The Leukoaraiosis and Disability in the Elderly 
study (LADIS) involves 11 European centers. It aims to assess 
the role of the age-related white matter changes as an inde-
pendent factor in the transition to disability, and in cognitive 
performance of an independent elderly population. A com-
prehensive neuropsychological battery was constructed in 
order to harmonize the cognitive assessment across coun-
tries. Patients were evaluated at baseline and during the 3-
year follow-up with the Mini-Mental State Examination, a 
modified version of the VADAS-Cog (Alzheimer’s Dementia 
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portant variables influencing test performance. In the LADIS 
population baseline data, older age and lower educational 
levels negatively influence neuropsychological perfor-
mance.  Copyright © 2006 S. Karger AG, Basel 
 Introduction 
 The relationship between age-related white matter 
changes (ARWMC) and cognitive impairment has been 
described in several studies in different population sam-
ples  [1, 2] . 
 In community-dwelling and independent elderly sub-
jects, some studies reported an association between the 
presence of ARWMC and deficits in global mental func-
tioning, speed of mental processing and memory  [3–9] . 
However, others failed to find a relationship between the 
presence of ARWMC and cognitive performance  [10–
12] . 
 There are a number of factors that can explain the in-
consistency of these results. They may be related to the 
design of the studies, the type of analysis performed on 
imaging and the neuropsychological evaluation. Further, 
regarding cognitive performance, the variability of re-
sults can be due to the use of different instruments and 
measures to assess cognition, the use of different criteria 
to define cognitively impaired performance, and the use 
of nonsensitive instruments, such as global measures of 
cognition, or tests sensitive to memory decline but not to 
executive functioning. 
 Despite the recent interest and effort to analyze the 
impact of ARWMC on cognition, there are still several 
issues that need to be explored. How is cognitive func-
tioning influenced by ARWMC? Is there a threshold of 
ARWMC needed to affect cognition? Which cognitive 
domains are mainly affected by the presence of ARWMC 
and which domains are more sensitive to decline in par-
allel to the progression of ARWMC? Is there a neuropsy-
chological profile related to the location of ARWMC? 
 The Leukoaraiosis and Disability in the Elderly study 
 (LADIS) aims to assess the role of ARWMC as an inde-
pendent predictor of disability in the elderly  [13] , contrib-
uting with answers to the above-mentioned issues. The 
LADIS study involves 11 centers of 10 European coun-
tries (appendix 1). 
 The assessment of cognitive functions is a difficult 
task, starting with the selection of the appropriate tests to 
evaluate specific domains. The difficulty increases in 
multinational studies since the performance in majority 
of the tests is dependent on educational, language, cul-
tural and demographic variables. 
 The aims of the present work were to describe the de-
velopment of the LADIS neuropsychological battery, to 
present LADIS neuropsychological baseline data, and to 
discuss the methodological problems and limitations of 
the cognitive assessment within the LADIS study. 
 Methods 
 LADIS organization and methodology have already been re-
ported elsewhere  [13] . 
 Construction of the Neuropsychological Battery 
 The construction of the LADIS neuropsychological battery 
took into consideration that: (1) selected tests had to be available 
and familiar in the majority of the centers; (2) the tests had to be 
sensitive to cognitive decline; (3) the battery had to be innovative, 
comprehensive, easy to administer, but not too long; (4) all centers 
had to use the same version of each test; (5) the original English 
version of tests had to be translated into each local language. 
 In order to construct the neuropsychological battery for the 
LADIS study, we performed a review of the studies investigating 
elderly samples with ARWMC using comprehensive cognitive as-
sessments published until 2001, and selected the most frequently 
used instruments. In this review, we also retrieved the criteria for 
the definition of abnormal performance on the neuropsychologi-
cal tests used in each study. A list of tests was made according to 
the frequency they appeared in the studies. All participating cen-
ters received a questionnaire in which, for each test of the list, 
several questions were asked: (a) if the test was available at their 
center; (b) if it was routinely used for cognitive assessment; (c) if 
it had local/national validation norms; (d) if the original or other 
versions were used. 
 Of the eight tests initially selected, the Mini-Mental State Ex-
amination (MMSE)  [14] and the Stroop test  [15, 16] were the only 
tests available and in use for assessment in all centers. However, 
the versions used were slightly different from center to center and 
normative values existed in only 62% (MMSE) and 69% (Stroop) 
of the countries. Verbal fluency tests were also available in all cen-
ters, with normative values for 92% of the countries. Nevertheless, 
the variability of versions was wide: some centers used semantic 
fluency (animals, colors, fruits, cities, or supermarket goods), 
others used only controlled oral word association tests (using dif-
ferent letters such as FAS, PFL or LPS). The Wisconsin Card Sort-
ing Test  [17] was available in almost all the centers, but with dif-
ferent versions (original and modified). Further, in half of the 
centers it was not used on a regular basis. 
 The following tests were initially selected for inclusion in the 
LADIS neuropsychological battery: the MMSE to assess global 
mental status, the Stroop and Trail making tests  [18] to assess ex-
ecutive functions. In the absence of any frequently used battery, 
we added the VADAS-Cog  [19] which is a recently developed in-
strument used to assess the cognitive performance of patients 
with vascular dementia. It is composed by the well-known Alz-
heimer’s Disease Assessment Scale (ADAS-Cog)  [20] , which as-
sesses memory, orientation, language, ideational and construc-
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tional praxis in addition to other specific tests that evaluate mem-
ory with interference, attention and executive functions (Delayed 
recall, Symbol digit, Digit span, Maze, Digit cancellation, Verbal 
fluency). The psychometric properties of these tests have been 
previously described with elderly populations  [21, 22] .  Table 1 
tabulates the neuropsychological tests composing the initial 
LADIS battery and the cognitive domains they assess. 
 In order to reduce the time needed to administer the VADAS-
Cog, only one trial was used on subtest 1 (Word recall) and subtest 
8 (Word recognition), instead of the original three. On the 
VADAS-Cog, the translation of the words on subtests 1 and 8 was 
made according to the frequency of the words in each language 
 [23] . On subtest 5 (Naming objects), we used drawings instead of 
real objects, as it was the best way to reduce the heterogeneity of 
administration. The subtest ‘Delayed recall’ of the words of sub-
test 1 was also included in the ADAS-Cog. This subtest is scored 
as the other items of the ADAS-Cog (higher score representing 
worse performance). Because of these modifications, we will use 
the designation ADAS-Mod instead of ADAS-Cog. Finally, part 
B of Trail making (original version) was locally adapted to the al-
phabet of each country. 
 The original English version of all tests was collected by the 
center responsible for the neuropsychological assessment work 
package and mailed to each center to be locally translated. A 
handbook with the instructions of all the tests was also distrib-
uted to the centers in order to guarantee that each instrument 
would be used in the same way. 
 For the 2nd year of follow-up, two additional tests were in-
cluded: the 9-Word California Verbal Learning Test (CVLT)  [24] 
and the Constructional praxis delayed recall, based on the CERAD 
battery  [25] , in order to improve the assessment of memory de-
cline. Both these tests and the instrument used to assess partici-
pants who were unable to come to the visits – the Telephone In-
terview for Cognitive Status  [26] – will be described and analyzed 
elsewhere, along with the results of the last follow-up. 
 Analysis of Neuropsychological Data 
 Neuropsychological data were analyzed as follows: (1) analysis 
of the test score distribution; (2) analysis of the differences on the 
neuropsychological performance related to the demographic 
variables and center; (3) analysis of the influence of demographic 
variables on cognitive performance; (4) analysis of the influence 
of other potential confounding variables such as visual deficit, 
previous stroke, or center of inclusion on the neuropsychological 
performance. 
 MMSE was used only as a global measure of cognitive func-
tioning and analyzed either as a continuous variable or catego-
rized using the cut-off of  ^  23 (for dementia), or  ! 25 (for cogni-
tive deficit)  [27] . The Stroop test was considered a measure of 
executive function, and the analyzed measure was time used to 
perform Stroop 3 minus the time to perform Stroop 2. The Trail 
making test was considered a measure of executive functions us-
ing the score ‘time needed to perform part B minus the time to 
perform part A’. Trail making/A score was also used as a measure 
of speed and motor control. Higher scores on both the Stroop and 
Trail making tests represented worse performance. VADAS-Cog 
was analyzed in two ways: (a) as a global measure, consisting of 
the scores of ADAS-Mod items Word recall, Commands, Con-
structional praxis, Delayed recall, Naming, Ideational praxis, 
Orientation, Word recognition, Remembering instructions, Spo-
ken language ability, Word finding difficulty, Comprehension, 
and Concentration/distractibility. Higher scores represented 
worse performance; (b) the 5 additional subtests Digit span back-
wards, Maze task, Digit cancellation, Symbol digit and Verbal flu-
ency were evaluated independently. In all the tests except for 
Maze (where the score is the time to complete the task), higher 
scores represent better performance. 
 Depending on the aim of the study performed on the LADIS 
sample, cognitive variables will be analyzed as continuous or cat-
egorical using specific cut-offs (e.g. MMSE) or the quartiles of the 
distribution of the LADIS sample ( table 2 ). For the present paper, 
all the test scores were analyzed as continuous variables. 
 Table 1. LADIS neuropsychological battery 
MMSE ADAS-
Mod
VADAS Trail making Stroop
Symbol
digit
Digit
span
Maze Digit 
cancellation
Verbal 
fluency
A B
Global mental functioning + +
Orientation +
Memory + +
Attention + + + +
Language +
Constructional abilities +
Executive functions + + + +
Praxis +
Speed and motor control + + +
MMSE = Mini-Mental State Examination; ADAS-Mod = Alzheimer’s Disease Assessment Scale, Modified; VADAS = ADAS-Mod 
plus timed tests.
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 The distribution of the test scores was analyzed for each vari-
able. Non-normal distributions with marked skewness ( 1 2) were 
transformed into normal or less skewed distributions using a log-
arithmic transformation of the scores. Data analysis was conduct-
ed using both the raw and the transformed scores. As the results 
of raw and transformed scores were similar, the results based on 
raw scores were presented. 
 To compare performances across tests and by cognitive do-
main, we used Z-standard scores, using the distribution of the 
LADIS sample. To analyze performances by domain, compound 
measures were calculated using standard scores. Three main do-
mains were analyzed: (1) memory = z-scores of (Immediate word 
recall + Delayed recall + Word recognition + Digit span)/4;
(2) executive functions = z-scores of [(Stroop 3 – 2) + (Trail mak-
ing/B – Trail making/A) + Symbol digit + Verbal fluency]/4;
(3) speed and motor control = z-scores of (Trail making/A + Maz-
es + Digit cancellation)/3. Z-scores of the tests that had higher 
scores representing worse performance were inverted (–Z) in or-
der to calculate the compound measure score. A preliminary ex-
ploratory factor analysis was performed to evaluate the validity of 
the neuropsychological battery and the aforementioned com-
pound measures using Principal Component Analysis as extrac-
tion method and Varimax Rotation. The obtained solution was 
compared with the theoretically derived dimensions. 
 The degree of ARWMC severity on MRI was rated into mild, 
moderate and severe using the visual scale of Fazekas et al.  [28] , 
taking only deep and subcortical white matter lesions into ac-
count. 
 The demographic variables considered for the present analysis 
were age, education, gender, living conditions (alone or with oth-
ers), and employment status (retired, working). Age and educa-
tion were analyzed as continuous variables, except when compar-
ing demographic variables and neuropsychological performance 
where they were dichotomized using the median of the LADIS 
sample (74 years and 9 years, respectively). 
 There were several reasons for referral to the LADIS study, in-
cluding minor cognitive or neurological complaints, stroke or 
other neurological disturbances  [13] . Therefore, sources of refer-
ral were analyzed as variables that could influence the perfor-
mance on neuropsychological testing. Other possible confound-
ers for the analysis of cognitive performance, such as visual or 
hearing deficits, were also considered in data analysis. 
 Statistical Analysis 
 Descriptive statistics was performed to analyze the quality and 
distribution of the neuropsychological data. The distribution of 
demographic characteristics and test scores among centers was 
performed using box and whiskers plots. Differences among cen-
ters were calculated using one-way ANOVAs with Bonferroni or 
Tamhane’s (equal variance not assumed) post-hoc analyses for 
multiple comparisons. 
 The neuropsychological performance in each test and domain 
was compared across demographic characteristics (age, sex, edu-
cation, living conditions, employment status) using t tests. Per-
formance across cognitive tests was also compared according to 
the sources of referral using one-way ANOVA with Bonferoni 
post-hoc analysis. In order to study the influence of demographic 
variables on cognitive performance, linear regression models (in-
cluding all the significant variables in the previous comparisons, 
p  ! 0.05) were performed for each neuropsychological test and 
domain. Possible confounding variables that could influence the 
results of neuropsychological performance, such as presence of 
visual or hearing deficits, previous stroke or center of origin, were 
also included in an additional linear regression model. 
 Results 
 Baseline Neuropsychological Data 
 Six hundred and thirty-nine patients were enrolled in 
the LADIS study. Baseline demographic and WMC char-
acteristics, as well as the reasons for referral of the pa-
tients are shown in  table 3 . Neuropsychological examina-
tion was performed on 638 (99.8%) patients. 
 Quality of Data and Distribution of the Test Scores  
 The highest number of missing values (33 patients, 
5%) was observed on Trail making/part B (mental flexi-
bility) and Stroop test/part 3 (3%). Five-hundred and sev-
enty-eight patients (91%) had no missing values on the 
neuropsychological evaluation. Skewed distributions 
with a ceiling effect were observed in the subtests Com-
mand, Naming, Ideational praxis, Orientation, Mazes, 
 Table 2. Quartiles of the distribution of the neuropsychological tests scores 
MMSE Stroop 
1
Stroop 
2
Stroop 
3
Stroop 
3 – 2
Trail 
A
Trail 
B
Trail 
B – A
ADAS-
TOTAL
Symbol
digit
Digit
span
Maze Digit
cancel
Verbal
fluency
Valid 638 628 626 619 618 633 605 605 633 627 635 632 626 631
Missing 2 12 14 21 22 7 35 35 7 13 5 8 14 9
Mean 27.3 12.0 17.0 50.9 34.1 63.5 177.3 116.8 16.6 26.8 5.4 7.4 19.5 18.9
Median 28.0 11.0 15.0 43.0 27.0 52.0 143.0 91.0 16.0 27.0 5.0 6.0 20.0 19.0
Percentiles 25 26.0 9.0 13.0 32.0 18.0 41.0 106.0 59.0 12.0 19.0 4.0 4.0 14.0 14.0
50 28.0 11.0 15.0 43.0 27.0 52.0 143.0 91.0 16.0 27.0 5.0 6.0 20.0 19.0
75 29.0 14.0 19.0 60.0 42.0 72.5 233.5 154.0 20.0 35.0 6.0 8.7 24.0 23.0
Skewness –1.36 2.44 3.49 3.25 3.66 2.78 2.19 2.93 1.10 0.32 0.31 3.90 0.14 0.22
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Remembering instructions, Spoken language, Word 
finding difficulties, Comprehension and Concentration 
( fig. 1 ), which were transformed using the logarithmic of 
the scores. There were no differences in the results either 
using transformed or raw scores (data available on re-
quest). 
 Preliminary Exploratory Factor Analysis  
 Factor analysis of principal components with varimax 
rotation extracted three factors. The eigenvalues for the 
3 factors were 5.90, 1.44 and 1.41, explaining 48.6% of the 
total variance. For factor 1, the most salient tests were 
Trail A, Trail B, Trail B – A, Symbol digit, Digit cancella-
tion, Maze task and Verbal fluency. We denominated this 
factor as executive functions. Factor 2 was designated as 
Selective Attention because only Stroop 3 and Stroop 
3 – 2 were loaded saliently. Factor 3 was designated as 
memory because the loadings of the tests of memory, i.e. 
Immediate word recall, Delayed word recall, Word rec-
ognition and Orientation, were the most salient. For the 
compound measure scores, we excluded the simplest 
timed tests, i.e. Trail A, Maze task and Digit cancellation 
from the executive functions, and added the Stroop test, 
for theoretical and interpretability reasons. The timed 
tests were grouped into a speed/motor control measure. 
 Distribution of the Test Scores by Center  
 Significant differences among centers were observed 
for all tests (one-way ANOVAs). Post-hoc analysis (Bon-
ferroni’s analysis was employed for all tests, except for 
Symbol digit and Verbal fluency which were analyzed 
with Tamanhe’s test) showed that differences were ran-
domly distributed, and no consistent pattern was found 
(there was no center always better or worse than the oth-
ers).  Figure 1 shows the distribution of the test scores by 
center. 
 The distribution of age and education by center was 
analyzed, as they are important variables for neuropsy-
chological performance. No significant differences were 
found among centers with respect to age (F 10, 628  = 1.27; 
p = 0.24). Education had a normal distribution with sig-
nificant differences among centers (F 10,627  = 11.76; p  ! 
0.001). Using Bonferroni post-hoc test, we found that Lis-
bon and Florence centers differed systematically from the 
other centers as they had the lowest mean educational 
levels (p  ! 0.01 for both). 
 Mean Differences regarding Demographic Variables 
 Table 4  shows the differences in neuropsychological 
performance according to the demographic variables. 
 Age . Older subjects ( 1 74 years) performed significant-
ly worse than younger subjects on the ADAS-Mod Total 
based on the differences found on ADAS-Mod subtests 
Constructional praxis (t 513  = –3.09; p  ! 0.01) and Delayed 
recall (t 607  = –3.12; p  ! 0.01). Older subjects also showed 
worse performances on Stroop part 3 (t 617  = –2.63; p  ! 
0.01), Trail making A (t 537  = –3,16; p  ! 0.01) and B (t 456  = 
–3.40; p  ! 0.01), Symbol digit (t 625  = 3,72; p  ! 0.01), Digit 
cancellation (t 631  = 4.94; p  ! 0.001) and verbal fluency 
(t 629  = –2.83; p  ! 0.01). Comparing the performance by 
cognitive domain, older subjects performed worse than 
younger subjects on executive functions (t 581  = 4.68; p  ! 
0. 01), memory (t 631  = 3.25; p  ! 0. 01) and speed/motor 
control (t 587  = 4.01; p  ! 0.01). 
 Gender . Women performed significantly worse on the 
ADAS-Mod subtest Constructional praxis (t 635  = 3.18; 
p  ! 0. 01) and Maze (t 630  = 2.54; p  ! 0.01). There were no 
gender differences considering the three cognitive do-
mains: executive functions (t 581  = –0.99; p = 0.31), mem-
ory (t 628  = –0.18; p = 0.85) and speed/motor control
(t 621  = –1.46; p = 0.14). 
 Table 3. Baseline demographic WMC characteristics and reasons 
for referral of the patients 
Study population (n = 638)
Demographic factors
Age, mean 8 SD, years 74.185 
Female/male 351 (55%)/287(45%)
Education, mean 8 SD, years 9.683.8
Living alone/with other 205 (32%)/434 (68%)
Working/retired 24 (4%)/610 (96%)
Married/not married 401 (63%)/237 (37%)
WMC characteristics
Mild 284 (44.5%)
Moderate 196 (30.7%)
Severe 158 (24.8%)
Reasons for referral
Minor cognitive complaints 168 (26.3%)
Minor stroke 122 (19.1%)
Motor complaints 28 (4.4%)
Psychic complaints 13 (2%)
Incidental CT/MRI findingsa 107 (16.7%)
Other neurological disturbances 129 (20.2%)
Controls in other studies or volunteers 72 (11.3%)
a Subjects undergoing a neuroimaging study for nonspecific 
reasons such as tension headache, dizziness, minor trauma, hear-
ing complaints.
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 Fig. 1. Distribution of the test scores of the whole sample and by center. Box and whiskers represent the upper 
quartile (top of the box) and the lower quartile (bottom); bar represents the median; the largest value is on the 
superior whisker; the smallest value is on the inferior whisker. Open circles and asterisks signify outliers and 
extreme scores, respectively. 
 (For figure 1 see next pages.) 
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 Education . Significant differences between subjects 
with higher ( 1 8 years of school) and lower educational 
level ( ! 9 years) were observed on all tests, except on 
ADAS-Mod Orientation (t 555  = 1.93; p = 0.05, not shown 
in  table 4 ), Immediate word recall (t 635  = 1.59; p = 0.11), 
Word recognition (t 633  = 1.93; p = 0.05), and Commands 
(t 577  = 1.94; p = 0.05). Considering the compound 
 measures of cognitive domains, subjects with lower ed-
ucational level had worse performances on executive 
functions (t 581  = –10.74; p  ! 0.01), memory (t 631  = –4.99; 
p  ! 0.01), and speed/motor control (t 381  = –8.36; p  ! 
0.01). 
 Living Conditions . Participants who lived alone tended 
to perform better on Trail making A (t 568  = 2.19; p  ! 0.05). 
However, there were no differences on the other tests, or 
on the cognitive domains executive functions (t 581  = 0.52; 
p = 0.60), memory (t 631  = 0.46; p = 0.64) and speed/motor 
control (t 530  = –1.20; p = 0.22). As it was not a significant 
variable, it was not included in the regression models. 
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 Employment Status . Participants who were still work-
ing performed worse on the ADAS-Mod Commands
(t 29  = –3.28; p  ! 0.01). No differences were found in other 
tests, or on cognitive domains executive functions (t 576  = 
1.48; p = 0.14), memory (t 626  = 1.05; p = 0.29) and speed/
motor control (t 616  = 1.02; p = 0.31). As participants still 
working represented only 4% of the LADIS population, 
this variable was also not included in the regression mod-
els. 
 Neuropsychological performance was also compared 
by sources of referral. Using a one-way ANOVA, we 
found significant differences in all the cognitive tests, 
except for the MMSE (F 6, 631  = 0.72; p = 0.63), ADAS-
Mod subtests Word recall (F 6, 630  = 1.93; p = 0.07), Com-
mands (F 6, 630  = 1.33; p = 0.24) and Constructional prax-
is (F 6, 630  = 1.67; p = 0.12). Post-hoc analysis showed that 
healthy volunteers performed better in all the cognitive 
tests compared with patients with previous stroke or oth-
er complaints. 
 Multiple Regression Analysis 
 Multiple linear regression models were used to ana-
lyze the influence of the demographic variables on the 
neuropsychological performance.  Table 5 shows the anal-
yses performed with model 1, that included the variables 
age, education and gender; model 2, with added possible 
confounders, such as previous stroke, and any complaint 
or visual deficit, and model 3, in which center origin was 
added as a covariable. Age remained an important vari-
able influencing the performance on ADAS-Mod Total 
(R 2  = 0.10; F 2, 630  = 35.41;   = 0.17; p  ! 0.001) and cogni-
tive domains executive functions (R 2  = 0.22; F 2, 580  = 
79.99;   = –0.22, p  ! 0.001), and speed/motor control 
(R 2  = 0.16; F 2, 619  = 59.68;   = –0.17, p  ! 0.001). 
 There was no other significant influence of gender on 
neuropsychological performance except on ADAS-Mod 
Constructional praxis (R 2change  = 0.004; F 6, 629  = 10.62; 
  = –0.10, p  ! 0.01). 
 Education remained an important variable influencing 
the performance on all the tests and domains of executive 
functions, memory, and speed/motor control ( table 5 ). 
 Variables that might work as confounders of cognitive 
performance, such as ‘referral for any complaint’ (vs. 
healthy volunteers), and previous stroke and visual prob-
lems, were included on the second linear regression mod-
el. To have any complaint remained an important vari-
able influencing the performance on Trail making A (R 2 
change  = 0.02; F 6, 625  = 19.48;   = 0.12, p  ! 0.01), Trail mak-
ing B – A (R 2 change  = 0.10; F 16, 587  = 11.81;   = 0.10, p  ! 
0.01), Symbol digit (R 2 change  = 0.03; F 6, 619  = 44.90;
  = –0.13, p  ! 0.001), Digit cancellation (R 2 change  = 0.06; 
F 6, 618  = 31.90;   = –0.21, p  ! 0.001), Digit span (R 2 change  
= 0.01; F 6, 627  = 18.62;   = –0.10, p  ! 0.01) and compound 
measures speed/motor control (R 2 change  = 0.03; F 6, 615  = 
24.03;   = –0.12, p  ! 0.001) and executive functions (R 2 
change  = 0.02; F 6, 576  = 30.32;   = –0.10, p  ! 0.01). When 
visual impairment was included on the linear regression 
models, its influence was observed on the performance 
in Trail making B – A (R 2 change  = 0.10; F 16, 587  = 11.81;
  = 0.10, p  ! 0.01), Maze task (R 2 change  = 0.03; F 6, 624  = 
14.57;   = 0.15, p  ! 0.001) and Delayed recall (R 2 change  = 
0.03; F 6, 628  = 10.34;   = –0.12, p  ! 0.01). 
 On the third step of the models, center of origin was 
included as covariable. We found that centers influenced 
the performance of all the tests, but again the findings 
were randomly distributed and there was no center influ-
encing systematically all the dependent variables in the 
same way ( table 5 ). 
 In all the models, age and education remained impor-
tant factors for neuropsychological performance. 
 Discussion 
 The LADIS Battery 
 The LADIS neuropsychological battery was construct-
ed with the purpose to evaluate the cognitive perfor-
mance of a cohort of independent subjects with ARWMC, 
during a period of 3 years of follow-up. It is a comprehen-
sive but not too long instrument that can be administered 
on a single visit, making it less unpleasant and intrusive 
for older patients. This battery was chosen based on the 
familiarity of the tests and the validity of the instruments 
to assess the decline of cognitive functions of patients 
with vascular disease. The LADIS battery explores a 
whole range of cognitive functions. Along with widely 
known and validated instruments (MMSE, Stroop and 
Trail making tests), it included the recently developed 
VADAS-Cog, which provides detailed information on 
cognitive global and selective functioning. Although 
based on the Alzheimer’s Disease Assessment Scale 
(ADAS), the inclusion of time-dependent tasks on VADAS 
(Symbol digit substitution, Maze tracing, Digit cancella-
tion and Verbal fluency) complemented the evaluation of 
attention, speed of mental processing and motor control. 
These cognitive functions, along with executive func-
tioning, are possibly more likely to be affected by white 
matter changes  [29] . 
 The inclusion of memory-specific measures, particu-
larly the 9-word CVLT, during the 2nd and 3rd year of 
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 Table 4. Influence of demographic variables on neuropsychological performance (t test results)  
MMSE Executive functions Attention Speed and motor control
Stroop
3
Stroop
3 – 2
Verbal
fluency
TM
B – A
TM B EXEC DC Sy
Dig
TM A Maze speed
Age NS –2.63a –2.55a –2.83a –2.86b –3.40a 4.68a 4.94a 3.72a –3.16a –2.21b 4.01a
Gender –2.31b NS NS NS NS NS NS NS NS NS 2.54b NS
Education –6.66a 6.01a 5.14a –7.37a 6.93a 8.33a –10.74a –9.80a –13.48a 7.84a 5.87a –8.36a
Living conditions NS NS NS NS NS NS NS NS NS 2.19b NS NS
Employment status NS NS NS NS NS NS NS NS NS NS NS NS
a p < 0.01; b p < 0.05. TM = Trail making; EXEC = executive functions compound measure; DC = Digit cancellation; Sy Dig = Symbol digit; Dig Sp = 
Digit span; Im WR = Immediate word recall; Del WR= Delayed word recall; Word recog. = Word recognition; MEM = memory compound measure;
Com = Commands; VC = visuoconstructional; Id = ideational. 
 
 
 Table 5. Influence of demographic variables on neuropsychological performance (linear regression analysis) 
MMSE Executive functions EXEC Attention Speed and motor control
Stroop
3
Stroop
3 – 2
Verbal
fluency
TM
B – A
TM
B
DC Sy
Dig
TM A Maze speed
Model 1
R2 0.12a 0.07a 0.05a 0.12a 0.12a 0.18a 0.22a 0.18a 0.27a 0.14a 0.10a 0.16a
Age NS NS NS –0.14a 0.15a 0.18a –0.23a –0.23a –0.18a 0.13a NS –0.17a
Education 00.33a –0.24a –0.20a 0.31a –0.31a –0.38a 0.40a 0.34a 0.49a –0.34a 0.27a 0.36a
Gender NS NS NS NS NS NS NS NS NS NS NS NS
Model 2
R2 change NS 0.02b NS NS 0.02b 0.03a 0.02a 0.06a 0.03a 0.02b 0.03a 0.03a
Age NS 0.15a 0.17a –0.22a –0.22a –0.17a 0.12b NS –0.15a
Education –0.22a –0.29a –0.36a 0.38a 0.32a 0.46a –0.33a –0.26a 0.34a
Gender NS NS NS NS NS NS NS NS NS
Any complaint NS NS NS –0.10b –0.21a –0.13a 0.12b NS –0.12b
Stroke NS NS NS NS NS NS NS NS NS
Visual deficit NS NS 0.10b NS NS NS NS 0.15a NS
Model 3
R2 change 0.07a 0.05a 0.05b 0.09a 0.10a 0.13a 0.10a 0.07a 0.08a 0.10a 0.11a 0.10a
Age NS NS NS –0.16a 0.16a 0.18a –0.22a –0.22a –0.18a 0.12a 0.12b –0.17a
Education 0.37a –0.20a –0.17a 0.29a –0.30a –0.33a 0.37a 0.26a 0.43a –0.25a –0.21a 0.27a
Gender NS NS NS NS NS NS NS NS NS NS NS NS
Any complaint NS NS NS NS 0.15b 0.14b –0.12b –0.12b NS NS NS NS
Stroke NS NS NS NS NS NS NS NS NS NS NS NS
Visual deficit NS NS NS NS 0.10b 0.11b NS NS NS NS NS NS
Center HU CO –0.20b CO –0.14a CO 0.20a CO –0.18a CO –0.22b AM –0.14b CO 0.13b CO 0.19a CO –0.21a all all
–0.18a GO –0.17b GO –0.15b HE 0.13b HU –0.13b FL 0.13b CO 0.14b FL –0.12b HU 0.16a GO –0.14b centers except
GO –0.16b FL –0.18b GO 0.13b NC 0.15b GR –0.14b PA and
HU –0.20a NC 0.21a HE –0.13b FL
HU –0.22a
MA –0.15b
NC –0.21a
Values are standardized . a p < 0.001; b p < 0.01; NS = p > 0.05. TM = Trail making; EXEC = executive functions compound measure; DC = Digit 
cancellation; Sy Dig = Symbol digit; Dig Sp = Digit span; Im WR = Immediate word recall; Del WR = Delayed word recall; Word recog. = Word recogni-
tion; MEM = memory compound measure; Com = Commands; VC = visuoconstructional; Id = ideational; AM = Amsterdam; CO = Copenhagen; FL = 
Florence; GO = Goteborg; GR = Graz; HE = Helsinki; HU = Huddinge; LS = Lisbon; MA = Mannheim; NC = Newcastle; PA = Paris.
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Memory Language Praxis ADAS-Total
Dig
Sp
Im WR Del WR Word
recog.
MEM Com Naming VC Id
NS NS –3.12a –2.14b 3.25a NS NS –3.09a NS –3.84a
NS NS NS NS NS NS NS 3.18a NS NS
–9.41a NS 5.83a NS –4.99a NS 6.7a 5.39a 2.97a 5.69a
NS NS NS NS NS NS NS NS NS NS
NS NS NS NS NS –3.28a NS NS NS NS
 
 
 
Memory MEM Language Praxis ADAS-Total
Dig
Sp
Im WR Del WR Word recog. Com Naming VC Id 
0.14a 0.02a 0.06a 0.04a 0.08a NS 0.09b 0.10a 0.02b 0.10a
NS 0.15a 0.11b –0.15a NS 0.10b NS 0.15a
0.38a –0.12b –0.18a –0.15a 0.24a –0.30a –0.25a –0.13b –0.27a
NS NS NS NS –0.10b NS NS
NS NS 0.03a NS NS NS NS NS NS NS
0.16a
–0.17a
NS
NS
NS
–0.12b
0.06a 0.10a 0.29a 0.09a 0.14b NS 0.12a 0.07a 0.06a 0.15a
NS 0.11b 0.17a 0.11b –0.17a NS NS 0.16a
0.36a –0.17a –0.21a –0.15a 0.27a –0.26a –0.11b –0.29a
NS NS NS NS NS –0.12b NS NS
NS NS NS NS NS NS NS NS
NS NS NS NS NS NS NS NS
NS NS NS NS NS NS NS
CO 0.13b AM 0.13b AM 0.14b AM 0.17b AM –0.20a CO –0.20a AM 0.19a GO –0.14b AM 0.30a
NC 0.19b GO –0.15b GO –0.19a FL 0.15b GR –0.25a FL 0.15b FL 0.23a HU –0.14b FL 0.21a
PA 0.12b GR 0.27a GR 0.29a PA –0.15b GO –0.16b GO 0.17b NC –0.17b GR 0.19a
HE 0.14b HU –0.18a HU 0.21a
HU –0.23a MA –0.21a MA 0.19a
NC –0.22a NC –0.19b NC 0.18b
PA 0.21a
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follow-up, was adopted as a way to improve the evalua-
tion of memory decline minimizing the learning effect 
that might occur if the memory test or the VADAS word 
recall subtest were administered four times instead of 
two. 
 The use of the same version and guidelines for admin-
istration of the tests in all the centers reduced the hetero-
geneity of the cognitive evaluation and allowed the ap-
propriate evaluation of the whole sample of the LADIS 
cohort. 
 Nevertheless, the neuropsychological battery adopt-
ed in the LADIS study has some limitations: (1) when 
trying to reduce the time to administer the cognitive 
battery by using one trial instead of three, as described 
in the original version of the VADAS subtest Word re-
call, we did not include any measure of learning memo-
ry on the baseline assessment and compromised the pos-
sibility of comparing the results of the LADIS sample 
with other studies that use the same instrument. How-
ever, this limitation was minimized by the inclusion of 
the 9-word CVLT during the second and third follow-up 
visits; (2) the test versions adopted were not validated in 
each center/country and there is no control group to 
compare the results of the LADIS sample. The absence 
of a control group is due to the fact that it would be nec-
essary to perform MRI on normal volunteers and that 
would increase enormously the costs of the study; (3) us-
ing a handbook with all the administration norms for 
each test, we tried to reduce the differences concerning 
the training of the examiners that could lead to differ-
ences on the results. 
 Neuropsychological Data Analysis 
 Differences among centers were observed for almost 
all the tests except Naming and Ideational praxis. How-
ever, the differences were randomly distributed and no 
consistent pattern was found. Cultural and educational 
variables might explain some of the differences between 
centers. Despite that, when Florence and Lisbon (which 
had the lowest mean education level) were excluded from 
the analysis, differences among centers remained. 
 We found that, when compared with younger subjects, 
older subjects performed significantly worse on Trail 
making, Symbol digit, Digit cancellation tests and on ex-
ecutive functions and memory compound measures. Age 
remained an independent variable influencing the per-
formance in memory and executive function domains 
even when controlling for ARWMC severity. The effect 
of age on neuropsychological performance of healthy 
subjects with ARWMC was also reported by Ylikoski et 
al.  [6] , who found that cognitive performance decreased 
on memory tests, constructional abilities, language, 
timed tests and speed of mental processing. Our results 
are similar to those found in that work. 
 Education was the most consistent factor influencing 
the performance in all the neuropsychological tests and 
domains. The association between education and cogni-
tive performance remained significant in the presence of 
ARWMC. Memory performance seems to be indepen-
dent of the effect of education. This could be explained 
by the fact that in the baseline assessment of our study, 
memory was mainly evaluated verbally (Word recall, De-
layed recall, Word recognition, Digit span), reducing the 
influence of education on pencil/paper tests. Education 
seems to play a more important role on complex tasks 
such as executive functions. One study evaluating main-
ly speed and executive functions  [30] reported the influ-
ence of education on the cognitive performance of a sam-
ple of elderly subjects with ARWMC. Dufouil et al. [30] 
found no relationship between WMC severity and cogni-
tive performance in participants with a high level of edu-
cation, reinforcing the hypothesis of the cognitive reserve 
 [31] . Independent of the way it influences cognition, edu-
cation should be considered as a covariate variable in an-
alyzing the effect of ARWMC on neuropsychological 
performance. 
 In the LADIS sample, women performed worse on 
MMSE, Constructional praxis and Mazes. Female gender 
has been associated with difficulties performing visuo-
constructional tasks and spatial orientation, which could 
explain the difficulties in performing both Construction-
al praxis and Maze task. Although some studies  [9, 32] 
reported a prevalence of earlier and more severe  ARWMC 
in women, in our sample the prevalence and severity of 
ARWMC was similar for both sexes. In our study, women 
tended to have less years of education, which might ex-
plain the difference on the MMSE. Ott et al. [33] in a large 
populational study, reported a stronger association be-
tween low education and dementia in women than in 
men. However, in a recent study, Ruitenberg et al.  [34] 
found that this association was mainly significant among 
people over 90 years old and that the incidence of demen-
tia was similar for both sexes before this high age. 
 In our study, the analysis of the baseline neuropsycho-
logical data showed a significant influence of demo-
graphic variables on cognitive performance. Neuropsy-
chological performance in patients with ARWMC was 
influenced by age and education. Higher educational lev-
el was consistently associated with better performances 
on cognitive tasks, while older age was associated with 
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difficulties in memory and executive functions. The 
analysis performed on neuropsychological data in the 
LADIS study will, thus, have to use age and education as 
modifiers, and therefore as covariables. 
 Acknowledgements 
 The LADIS study is supported by the European Union within 
the 5th European Framework Program ‘Quality of Life and Man-
agement of Living Resources’ (1998–2002), contract QLRT-2000-
00446 as a concerted action. 
 Appendix 1 
 List of Participating Centers and Personnel 
 Helsinki, Finland  (Memory Research Unit, Department of 
Clinical Neurosciences, Helsinki University): Timo Erkinjuntti, 
MD, PhD, Tarja Pohjasvaara, MD, PhD, Pia Pihanen, MD, Raija 
Ylikoski, PhD, Hanna Jokinen, LPsych, Meija-Marjut Somerkos-
ki, MPsych;  Graz, Austria  (Department of Neurology and MRI 
Institute, Karl Franzens University): Franz Fazekas, MD, Rein-
hold Schmidt, MD, Stefan Ropele, PhD, Brigitte Rous, MD, Katja 
Petrovic, MagPsychol, Ulrike Garmehi;  Lisboa, Portugal  (Serviço 
de Neurologia, Centro de Estudos Egas Moniz, Hospital de Santa 
Maria): José M. Ferro, MD, PhD, Ana Verdelho, MD, Sofia Ma-
dureira, PsyD;  Amsterdam, The Netherlands  (Department of 
Neurology, VU Medical Center): Philip Scheltens, MD, PhD, Ilse 
van Straaten, MD, Frederik Barkhof, MD, PhD;  Göteborg, Sweden 
 (Institute of Clinical Neuroscience, Göteborg University): Anders 
Wallin, MD, PhD, Michael Jonsson, MD, Karin Lind, MD, Arto 
Nordlund, PsyD, Sindre Rolstad, PsyD, Kerstin Gustavsson, RN; 
 Huddinge, Sweden  (Karolinska Institute, Department of Clinical 
Neuroscience and Family Medicine, Huddinge University Hospi-
tal): Lars-Olof Wahlund, MD, PhD, Militta Crisby, MD, PhD, 
Anna Pettersson, physiotherapist, Kaarina Amberla, PsyD;  Paris, 
France  (Department of Neurology, Hopital Lariboisière): Hugues 
Chabriat, MD, PhD, Ludovic Benoit, MD, Karen Hernandez, 
Solene Pointeau, Annie Kurtz, Daniel Reizine, MD;  Mannheim, 
Germany  (Department of Neurology, University of Heidelberg, 
Klinikum Mannheim): Michael Hennerici, MD, Christian Bla-
hak, MD, Hansjörg Baezner, MD, Martin Wiarda, PsyD, Susanne 
Seip, RN;  Copenhagen, Denmark  (Memory Disorders Research 
Unit, Department of Neurology, Copenhagen University Hospi-
tal): Gunhild Waldemar, MD, DMSc, Egill Rostrup, MD, MSc; 
 Newcastle-upon-Tyne, UK  (Institute for Ageing and Health, Uni-
versity of Newcastle): John O’Brien, DM, Sanjeet Pakrasi, MRC-
Psych, Thais Minnet, PhD, Michael Firbank, PhD, Jenny Dean, 
PhD, Pascale Harrison, BSc, Philip English, DCR. The Coordi-
nating Center is in  Florence, Italy  (Department of Neurological 
and Psychiatric Sciences, University of Florence): Domenico Inzi-
tari, MD (study coordinator); Leonardo Pantoni, MD, PhD, Anna 
Maria Basile, MD, Michela Simoni, MD, Giovanni Pracucci, MD, 
Monica Martini, MD, Luciano Bartolini, PhD, Emilia Salvadori, 
PhD, Marco Moretti, MD, Mario Mascalchi, MD, PhD, Giovanna 
Carlucci, MD, PhD, Anna Poggesi, MD, Eliana Magnani, MD. 
The LADIS Steering Committee is formed by Domenico Inzitari, 
MD (study coordinator), Timo Erkinjuntti, MD, PhD, Philip 
Scheltens, MD, PhD, Marieke Visser, MD, PhD, and Kjell Asplund, 
MD, PhD. 
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batteries was compared according to the clinical diagnosis 
of dementia.  Results: From the initially enrolled 639 sub-
jects, 480 were evaluated at year 3. Dementia was diagnosed 
in 90 participants. The demented subjects had worse perfor-
mance in almost all the baseline cognitive tests. Using re-
ceiver operating characteristic curves, we found that the 
Vascular Dementia Assessment Scale (VADAS) battery had 
higher sensitivity and specificity rates (area under the
curve = 82%) to identify dementia compared with the Mini-
Mental State Examination (MMSE) and Alzheimer’s Disease 
Assessment Scale. Worse performance on baseline MMSE
(  = 0.33; p  ! 0.001) and VADAS (  = –0.07; p = 0.02) were 
predictors of dementia (regression analyses).  Conclusion: 
Performance on the MMSE and the VADAS battery were im-
portant predictors of dementia at a 3-year period. 
 Copyright © 2010 S. Karger AG, Basel 
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 Abstract 
 Background: White matter changes (WMC) are related to 
cognitive deficits and dementia. Our aim was to determine 
the extent to which the performance in neuropsychological 
tests would be able to predict the clinical diagnosis of de-
mentia.  Methods: The LADIS (Leukoaraiosis and Disability) is 
a prospective study that evaluates the impact of WMC on the 
transition of independent elderly to disability. The subjects 
were evaluated at baseline and yearly during 3 years with a 
comprehensive clinical, functional and neuropsychological 
protocol. At each visit, dementia was classified according to 
clinical criteria. The performance in the neuropsychological 
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 Introduction 
 Age-related white matter changes (ARWMC) have 
been associated with cognitive impairment and dementia 
and represent a form of cerebrovascular disease. How-
ever, the relation between severity of ARWMC and pro-
gression to dementia or other forms of vascular cognitive 
impairment (VCI), which include vascular dementia and 
other cognitive impairment without dementia, is still not 
completely understood.
 The Leukoaraiosis and Disability (LADIS) study is a 
large multinational 3-year longitudinal study  [1] that 
aims to identify the importance of the presence of
ARWMC on the transition to disability in a nondisabled 
elderly population. For this pan-European study, a spe-
cific neuropsychological battery was constructed in or-
der to include instruments sensitive to changes related to 
the presence of ARWMC, mainly executive and speed of 
mental processing functions  [2, 3] . 
 The importance of the use of sensitive measures for the 
cognitive evaluation of this specific population was de-
scribed by Ylikoski et al.  [3] . Their results showed that the 
inclusion of tests reflecting mental speed and executive 
functions, the Vascular Dementia Assessment Scale – 
cognitive extension (VADAS-Cog) of the Alzheimer’s 
Disease Assessment Scale – cognitive subscale (ADAS-
Cog)  [4] , was an important tool differentiating patients 
with mild to moderate and severe ARWMC. Although 
several instruments have been used in the assessment of 
cognitive dysfunction (including VADAS-Cog in clinical 
trials), it is important to validate sensitive tools for spe-
cific populations as it is the case of vascular patients, since 
different patterns of neuropsychological functioning are 
expected.
 In addition, in a previously reported cross-sectional 
analysis of the neuropsychological baseline LADIS data, 
we identified the importance of other demographic (old-
er age, lower educational level) and clinical (presence of 
diabetes, hypertension, previous stroke) factors on cog-
nitive performance  [2, 5] along with the presence of
ARWMC. 
 Several studies performed with patients and healthy 
elderly have also associated specific cognitive deficits 
with ARWMC, such as speed of mental processing and 
executive functions  [6–8] . However, there is less informa-
tion regarding the way these deficits progress over time. 
 Recent studies  [9, 10] tried to identify neuropsycho-
logical predictors of VCI, differentiating them from those 
frequently associated with Alzheimer’s disease (AD). In-
gles et al.  [9] reported that low baseline scores on tests of 
free recall, similarities, comprehension, block design and 
verbal fluency were associated with incident VCI 5 years 
after the inclusion. Also a trend toward an association 
between low baseline scores on the similarities subtest 
and incident VCI was found, in comparison with incident 
AD.  
 The aim of this paper is to determine the extent to 
which in the LADIS population, the baseline perfor-
mance in specific neuropsychological tests was able to 
predict the clinical diagnosis of dementia 3 years later. 
 Methods 
 Participants and Methods 
 The rationale and methodology of the LADIS study have been 
extensively reported elsewhere  [1, 2] . Briefly, the LADIS is a lon-
gitudinal multinational study involving 11 centers from 10 Euro-
pean countries (see Appendix) which aims to evaluate the impact 
of white matter changes (WMC) on the transition to disability. 
Inclusion criteria were: (a) age 65–84 years, (b) WMC of any de-
gree according to the modified Fazekas visual rating scale  [11] , (c) 
no or mild impairment (none or 1 item affected) on the instru-
mental activities of daily living scale  [12] , and (d) presence of a 
contactable informant and agreement to sign an informed con-
sent. We excluded participants with: (a) severe illness likely lead-
ing to dropout, (b) severe unrelated neurological disease, (c) leu-
koencephalopathy of nonvascular origin, (d) severe psychiatric 
disorders, and (e) inability or refusal to undergo brain MRI. Pa-
tients were enrolled due to minor neurological, cognitive or motor 
complaints or incidental finding on cranial imaging due to non-
specific reasons (incidental finding in brain imaging)  [1] .
 The participants were submitted to a comprehensive clinical, 
functional, motor and neuropsychological examination that was 
repeated yearly during a 3-year follow-up period. Clinical and 
functional assessment included: (1) standard cardiovascular and 
neurological examination; (2) functional status measured by 
means of the instrumental activities of daily living scale and the 
Disability Assessment for Dementia scale  [13] , and (3) health-re-
lated quality of life measured using the Euro-QoL 5D  [14] . 
 MRI was performed at baseline and at the 3-year follow-up 
visit using a standard protocol  [1] . White matter rating and volu-
metric analysis was carried out by a single center (Amsterdam) 
 [15] .
 A total of 639 participants were included at baseline and 638 
performed the complete baseline assessment. In the 3rd year of 
the study, 475 (75%) came to the last follow-up visit.
 Neuropsychological Evaluation 
 The participants were submitted to a standardized cognitive 
evaluation every year. The construction of the neuropsychologi-
cal battery was described in detail in a previous paper  [2] . The 
battery included: the Mini-Mental State Examination (MMSE) 
 [16, 17] as a measure of global cognitive status; the ADAS-Cog to 
assess memory, orientation, language, ideational and construc-
tional praxis  [18, 19] used in the original version (except on the 
words list recall item, where we used 1 trial instead of 3); the 
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VADAS-Cog, which includes delayed recall of the ADAS’s 10 
word lists, a symbol digit test, a digit span backwards, a maze task, 
a digit cancellation task and a verbal fluency task (animal nam-
ing), and the Trail-Making  [20] and Stroop tests  [21] used to assess 
executive functions. The VADAS-Cog total score was calculated 
according to Ylikoski et al.  [3] . The scores applied as measures of 
executive functions were ‘time used to perform Stroop part 3
minus the time to perform Stroop part 2’ and ‘time needed to
perform Trail-Making part B minus the time to perform Trail-
Making part A’. As described in detail in a previous paper  [2] , 
compound measures were calculated in order to analyze perfor-
mances by domain. Three main domains were considered: (1) 
memory, using the z-scores of immediate word recall, delayed re-
call, word recognition and digit span; (2) executive functions, us-
ing z-scores of Stroop 3 – 2, Trail-Making B-Trail-making A, sym-
bol digit and verbal fluency; (3) speed and motor control, using 
z-scores of Trail-Making A, maze and digit cancellation. 
 Criteria of Dementia and Cognitive Impairment No Dementia 
 At each follow-up visit, a questionnaire for the clinical diag-
nosis of dementia and dementia subtypes included in the LADIS 
protocol was completed by the clinician. 
 The criteria used to define dementia, dementia subtypes and 
cognitive impairment no dementia (CIND) are described in detail 
in a previous paper  [1] . For the current study, we used the clinical 
diagnosis of dementia defined according to the DSM-IV criteria 
 [22] and CIND according to Wentzel et al.  [23] .
 When analyzing the participants according to the clinical di-
agnosis, we used the last observation carried forward method to 
classify the participants who did not come to the 3-year follow-up 
visit. The diagnosis observed on the last visit of the participant 
was then considered as the final diagnosis and analyzed accord-
ingly. The last observation carried forward method was used to 
reduce the number of missing values. 
 Statistical Analysis 
 Reasons of referral, as well as demographic (age, gender, years 
of education), clinical (WMC severity) and cognitive (scores on 
neuropsychological tests) baseline characteristics were compared 
between the participants who came to the 3-year follow-up visit 
with those who did not, using bivariate analysis (t test and   2 ). The 
same procedure was used to compare participants with and with-
out the diagnosis of dementia at the last follow-up. 
 When comparing the baseline characteristics of the partici-
pants with dementia, CIND and no cognitive impairment, we 
used ANOVA with multiple-comparison analyses.
 In order to ascertain the sensitivity and specificity of each neu-
ropsychological test to predict diagnosis of dementia and CIND 
in the 3-year period, we used receiver operating characteristic 
(ROC) analyses.
 Multinomial logistic regression models adjusted for the con-
found variables were then used to identify the neuropsychological 
baseline predictors of dementia at the last follow-up visit.
 In order to reduce the chance of type I error, Bonferroni post 
hoc analyses were used for ANOVA comparisons. A more conser-
vative p level of 0.01 was applied for single tests.
 Results 
 Descriptive and Comparative Analysis 
 Baseline demographic and clinical characteristics of 
the LADIS population have been described elsewhere  [2] . 
 From the 639 participants enrolled in the LADIS 
study, 480 (75%) could be evaluated in the last follow-up 
visit 3 years later. The patients who came to the last eval-
uation were younger ( t = 3.68; p  ! 0.001), had a higher 
level of education ( t = –2.94; p = 0.004) and presented 
better performance in the baseline MMSE ( t = –4.30;
p  ! 0.001), ADAS-Cog ( t = 4.24; p  ! 0.001) and VADAS-
Cog ( t = 5.80; p  ! 0.001), Stroop test ( t = 4.53; p  ! 0.001) 
and Trail-Making ( t = 6.17; p  ! 0.001) tests, when com-
pared to those who were not able to come to the last fol-
low-up. No differences were found considering WMC 
severity (  2 = 5.39; p = 0.07) and reasons of referral (  2 = 
7.44; p = 0.28). 
 480 participants had the clinical diagnosis at the third-
year visit of follow-up. Using the last observation carried 
forward method we had a total of 588 participants with 
clinical diagnosis. A total of 90 (14%) out of these 588 par-
ticipants had a clinical diagnosis of dementia: 12 partici-
Table 1.  Comparisons between participants with dementia and those with no dementia concerning demograph-
ic and clinical data
Demographic and
clinical characteristics
Dementia N o dementia t test p
valuen mean 8 SD n mean 8 SD 
Age, years 90 75.984.7 498 73.785.0 –3.71 <0.001
Education, years 90 8.883.5 497 9.883.9 2.57 <0.002
WMC
Severe grade (2) 90 47% 498 20% <0.001
Volume 88 34.182.9 480 18.782.0 –4.73 <0.001
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pants with diagnosis at the 1-year follow-up visit, 7 with 
diagnosis at the 2nd-year visit and 71 with the diagnosis 
at the 3rd-year visit. 
 When comparing demographic and clinical charac-
teristics of the participants diagnosed as having dementia 
and those without dementia on the last follow-up ( ta-
ble 1 ), we found that the patients with dementia were old-
er ( t = 3.71; p  ! 0.001), had a lower educational level ( t = 
–2.38; p  ! 0.02), severer WMC (  2 = 39.07; p  ! 0.001) and 
a higher volume of WMC ( t = 4.73; p  ! 0.001). Concern-
ing baseline cognitive performance ( table 2 ), the partici-
pants with dementia had had lower scores in all the neu-
ropsychological tests, except for the ADAS-Cog follow-
ing the command subtest ( t = 2.56; p  ! 0.02). The 
participants with dementia had also had significantly 
lower scores in executive functioning ( t = –8.21; p  ! 
0.001), memory ( t = –9.68; p  ! 0.001), speed and motor 
control ( t = –9.55; p  ! 0.001) than the participants without 
dementia at the end of follow-up ( table 2 ). 
 Demographic and Neuropsychological Predictors of 
Dementia  
 We performed ROC analyses to ascertain the sensitiv-
ity and specificity of each neuropsychological test and 
battery to identify participants with dementia following 
a 3-year period. On the single test analyses, we identified 
( table 3 ) symbol digit and verbal fluency as having the 
higher scores of sensitivity and specificity (AUC 78 and 
Table 2.  Comparisons between participants with dementia and those with no dementia concerning neuropsy-
chological baseline performance and compound measures
Dementia N o dementia t test p
valuen mean 8 SD n mean 8 SD
Performance
MMSE 90 2583 497 2882 –8.57 <0.001
ADAS-Cog total1 88 2388 496 1586 8.50 <0.001
Word recall 89 681.8 497 581.6 6.01 <0.001
Command 89 0.580.7 498 0.380.6 2.23 <0.03
Construction 89 0.880.7 498 0.580.7 3.49 <0.001
Naming 89 0.380.6 498 0.180.4 2.67 <0.001
Ideational praxis 89 0.480.8 498 0.180.5 2.98 <0.001
Orientation 89 1.181.6 498 0.280.8 5.43 <0.001
Word recognition 88 4.382.8 498 2.582.2 5.48 <0.001
Remembering instructions 89 0.586.9 498 0.280.6 3.24 <0.001
Spoken difficulties 89 0.380.8 498 0.180.4 2.28 <0.001
Word finding 89 0.580.9 497 0.280.5 3.28 <0.001
Comprehension 89 0.680.9 498 0.280.6 4.16 <0.001
Concentration 89 0.781.1 498 0.380.7 3.20 <0.001
VADAS-Cog total1 78 57811.6 483 41812.5 10.38 <0.001
Delayed recall 89 7.382.1 497 5.582.3 6.68 <0.001
Digit span 89 4.681.6 497 7.382.1 –5.15 <0.001
Verbal fluency 87 14.485.6 495 2086.1 –8.25 <0.001
Symbol digit 84 18.289.2 495 28.7810.5 –8.68 <0.001
Digit cancellation 84 15.287 495 20.586.5 –6.91 <0.001
Maze 84 11.9810.9 495 6.684.6 4.36 <0.001
Stroop (3 – 2)1 84 51840 487 31823 4.47 <0.001
Trail-Making (B – A)1 85 144864 485 99859 5.93 <0.001
Compound measures
Memory 88 –0.680.6 496 0.180.6 –9.52 <0.001
Executive functions 68 –0.680.6 472 0.280.7 –8.16 <0.001
Speed and motor control 80 –0.781 490 0.280.7 –7.10 <0.001
t t est: non-parametric analysis was also conducted due to the skewness of the distribution of some tests. The 
results were similar. 1 Higher scores represent worse performance.
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75%, respectively), although fair. Concerning the neuro-
psychological batteries, MMSE and ADAS-Cog obtained 
the same rate (79%) but VADAS-Cog had a good rate 
(82%) of sensitivity and specificity on identifying de-
mentia at 3 years ( fig.  1 ). VADAS extension alone ob-
tained 79% of sensitivity and specificity for dementia at 
3 years.
 Using logistic regression analyses to identify neuro-
psychological predictors of dementia while controlling 
for age, education and WMC severity (as they are known 
predictors; see  table 4 ), we found that worse performance 
on MMSE (  = 0.33; OR = 1.39, 95% CI = 1.19–1.62; p  ! 
0.001) and VADAS-Cog (  = –0.07; OR = 0.93, 95% CI = 
0.88–1.0; p = 0.02) were independent predictors of de-
mentia. In order to know which component of the 
VADAS (ADAS or the VADAS extension) was the stron-
ger predictor of dementia, we repeated the logistic re-
gression model separating the ADAS score from the 
VADAS-extension total score (data not shown). In this 
model, VADAS extension was an independent predictor 
of dementia (  = –0.08; OR = 1.09, 95% CI = 1.02–1.15;
p  ! 0.01).
 Concerning the neuropsychological baseline com-
pound scores, both memory (  = 1.2; OR = 3.33, 95%
CI = 1.9–5.9; p  ! 0.001) and executive functions (  = 0.69; 
OR = 2.0, 95% = CI 1.15–3.46; p  ! 0.01) were independent 
predictors of dementia at the third year ( table 5 ). 
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 Fig. 1. ROC curves of the 3 batteries.  a MMSE total (AUC = 79%).  b ADAS-Cog total (AUC = 79%).  c VADAS-
Cog (AUC = 82%). 
Table 3.  ROC analyses, sensitivity and specificity of neuropsycho-
logical batteries and single tests
Batteries and tests AUC
%
Sensi-
tivity, %
Speci-
ficity, %
Batteries
MMSE 79 29 87
ADAS-Cog 79 20 84
VADAS
VADAS extension
82
79
25
8
88
82
Single tests
Trail making (part B – A) 70 – 86
Stroop (part 3 – 2) 69 62 86
Word immediate recall 68 71 85
Delayed recall 71 20 85
Word recognition 69 54 85
Constructional praxis 62 – 85
Ideational praxis 59 40 85
Naming 56 – 84
Orientation 70 65 84
Symbol digit 78 68 87
Digit span 64 50 85
Digit cancellation 73 55 86
Maze 71 58 86
Verbal fluency 75 45 86
– = No positive cases were identified.
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 Demographic and Neuropsychological Predictors 
of Cognitive Impairment (Dementia and Cognitive 
Impairment No Dementia) 
 We compared participants who were diagnosed as 
having dementia (DEM; n = 90) with those diagnosed as 
having CIND (n = 147) and those with no cognitive im-
pairment (NCI) (n = 351) as clinically classified. Using 
ANOVAs with Bonferroni’s multiple-comparison anal-
yses (data not shown), we found that age was signif-
icantly different when comparing NCI participants
with those with DEM (mean age NCI = 73.4  8 5 years, 
DEM = 75.8  8 5; p  ! 0.001) but not when comparing 
NCI with CIND patients (mean age NCI = 73.4  8 5 
years, CIND = 74.2  8 5; p = 0.41) nor CIND with par-
ticipants with DEM (p = 0.05). Differences in education-
al level were significant when comparing NCI with 
CIND (mean educational level NCI = 10.3  8 4 years, 
CIND = 8.8  8 4; p  ! 0.001) and DEM (mean = 8.8  8 4, 
p = 0.003) but not when comparing CIND with DEM
(p  1 0.05). The volume of WMC was significantly dif-
ferent in the 3 groups (mean WMC volume NCI = 16.5, 
CIND = 23.9; DEM = 33.8; p  ! 0.001). 
 Concerning baseline scores of the neuropsychological 
tests, there were significant differences between the 3 
groups in the global measures ( fig. 2 ), compound scores 
( fig. 3 ) and in all the single tests, except for ADAS-Cog’s 
subtest following command. Multiple-comparison anal-
yses (data not shown) allowed us to conclude that for the 
ADAS-Cog subtests word recall, delayed recall, word 
recognition, orientation, construction, naming, idea-
Dementia
CIND
No impairment
–1.0
Memory
Executive
Speed
–0.5 0 0.5 1.0
 Fig. 3. Comparisons between participants with no impairment, 
CIND and dementia concerning baseline neuropsychological 
compound scores (mean z-scores). All differences were signifi-
cant (t test with p  ! 0.001).  
28
27
25
MMSE
15
39
16
46
23
57
ADAS total*
VADAS total*
Dementia
CIND
No impairment
 Fig. 2. Comparisons between participants with no impairment, 
CIND and dementia concerning baseline neuropsychologi-
cal batteries (mean scores). All differences were significant
(t test with p  ! 0.001). * Higher scores represent worse perfor-
mance. 
Table 4.  Baseline neuropsychological predictors of dementia in a 
3-year period (logistic regression analysis)
 p value OR
Age –0.069 0.03 0.93 (0.88–0.99)
Education –0.116 0.01 0.89 (0.81–0.98)
WMH grade –0.264 n.s. 0.77 (0.53–1.11)
MMSE total 0.328 <0.001 1.39 (1.19–1.62)
ADAS total 0.020 n.s. 1.02 (0.93–1.11)
VADAS total –0.070 0.02 0.93 (0.88–0.99)
Trail B – A –0.002 n.s. 1.00 (0.99–1.00)
Stroop 3 – 2 –0.002 n.s. 1.00 (0.99–1.01)
R 2 = 0.34. Figures in parentheses are 95% CI.
Table 5. B aseline compound measure predictors of dementia in a 
3-year period (logistic regression analysis)
 p value OR (95% CI)
Age –0.07 0.02 0.93 (0.87–0.99)
Education –0.09 0.03 0.91 (0.84–0.99)
WMH severity 0.87 0.03 2.36 (1.10–5.07)
Executive functions 0.69 0.01 2.00 (1.15–3.46)
Memory 1.20 0.001 3.33 (1.88–5.90)
Speed and motor control 0.47 0.04 1.61 (1.01–2.55)
F igures in parentheses are 95% CI. 
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tional praxis, remembering instructions, spoken, word 
finding, comprehension and concentration, the differ-
ences were significant only when the participants with 
DEM were compared with those with NCI. In these tests, 
in the MMSE and in the Stroop ‘time to perform part 3 
minus time to perform part 2’, the participants with NCI 
did not differ significantly from the group with CIND. 
When comparing the group of CIND with DEM, we 
found significant differences in all the tests except in the 
ADAS-Cog subtests construction, naming and ideation-
al praxis. 
 When using ROC analyses to assess sensitivity and 
specificity of the neuropsychological tests and batteries 
in identifying participants with CIND at the third year 
(excluding participants with DEM), we found that none 
of the tests, batteries or compound measures had good 
rates (data available when requested).   
 In the multinomial logistic analysis model (R 2 = 0.28), 
we included baseline global measures of MMSE, ADAS-
Cog, VADAS-Cog, the Stroop and Trail-Making test, and 
used age, education and WMC (categorized) as covariates 
( table 6 ). MMSE [  = –0.311; OR = 1.36 (1.16–1.60); p = 
0.001] and VADAS-Cog [  = –0.093; OR = 0.911 (0.858–
0.968); p = 0.003] were independent predictors of demen-
tia at a 3-year period of follow-up.
 Discussion 
 The participants included in the LADIS study were 
followed during a 3-year period and assessed with a com-
plete clinical and neuropsychological evaluation each 
year. At each visit, a clinical diagnosis of the mental status 
was made, which was defined as ‘dementia’, ‘cognitive 
impairment no dementia’ and ‘no cognitive impairment’. 
When we analyzed the baseline results of these 3 groups, 
and despite the fact that the participants were all func-
tionally independent at the time of inclusion, we found 
that those clinically diagnosed as having dementia at the 
end of the 3-year follow-up period had had lower scores 
in almost all the baseline neuropsychological tests, when 
compared with the participants without dementia. This 
is consistent with the understanding of dementia as a pro-
gressive disease that starts insidiously, usually without 
evident signs besides subtle differences in cognitive tests 
scores. In the LADIS study, the differences were observed 
in all the baseline tests and not only in those previously 
reported as sensitive enough to predict cognitive decline 
in normal individuals, such as episodic memory, execu-
tive functions or abstract reasoning and verbal fluency  [9, 
24] . Differences were also observed in the total scores of 
the MMSE, ADAS-Cog and VADAS-Cog batteries be-
tween the participants who developed dementia during a 
3-year period and those who did not, showing that gen-
eral cognitive capacities are also affected by ARWMC. 
 The participants with dementia were also older, had 
lower educational levels and severer ARWMC than the 
participants without the diagnosis of dementia. These re-
sults are in line with previous reported data on the LADIS 
study. Increasing age and low educational levels have 
been identified as risk factors for lower cognitive perfor-
mance even in the presence of ARWMC  [2] .
 Besides older age and lower educational levels, base-
line scores in the MMSE were important predictors of the 
diagnosis of dementia at the end of follow-up. This had 
also been reported in previous studies that had tried to 
identify preclinical markers of vascular dementia and AD 
 [9, 10] . Backman and Small  [10] reviewed the data from a 
community-based, longitudinal study and reported the 
presence of preclinical deficits 3 years before the diagno-
sis of vascular dementia in the total score, delayed recall 
and orientation of the MMSE, used as an outcome mea-
sure. The MMSE is a common instrument assessing glob-
al functions and detecting cognitive impairment. How-
ever, its sensitivity and specificity decrease when used to 
assess mild cognitive impairment, at least when applying 
the original cutoff values. Nevertheless, in the LADIS 
Table 6.  Baseline n tests predictors of no impairment, CIND and 
dementia (multinomial logistic regression)
 p value OR
No impairment
Age –0.076 0.02 0.93 (0.87–0.99)
Education –0.101 0.04 0.90 (0.82–0.99)
WMH grade –0.36 0.06 0.70 (0.48–1.02)
MMSE total 0.311 <0.001 1.37 (1.16–1.60)
ADAS total 0.037 0.40 1.04 (0.95–1.13)
VADAS total –0.090 0.01 0.91 (0.86–0.97)
Trail B – A –0.001 0.66 1.00 (0.99–1.00)
Stroop 3 – 2 –0.003 0.68 1.00 (0.98–1.01)
CIND
Age –0.054 0.12 0.95 (0.88–1.01)
Education –0.144 0.01 0.87 (0.78–0.96)
WMH grade –0.121 0.55 0.89 (0.59–1.32)
MMSE total 0.36 <0.001 1.43 (1.20–1.70)
ADAS total 0.023 0.62 0.97 (0.89–1.07)
VADAS total –0.023 0.48 0.97 (0.90–1.07)
Trail B – A –0.004 0.25 0.99 (0.99–1.00)
Stroop 3 – 2 –0.002 0.73 1.00 (0.98–1.01)
T he reference category is dementia. Accuracy rate: 63% (>57%).
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study, the median baseline score for MMSE of partici-
pants who developed dementia during the 3-year period 
(median = 26) was higher than the original MMSE pro-
posed cutoff for dementia ( ! 25). This is also consistent 
with the reports of the importance of using different cut-
off scores for the MMSE according to age and level of 
education. In a recent paper  [25] , it is proposed that a 
higher cutoff score should be used for detecting dementia 
among patients with higher educational levels. This 
change might also increase the rates of sensitivity and 
specificity of the MMSE for mild cognitive impairment.
 Concerning sensitivity and specificity rates, we found 
the MMSE to have lower scores compared with the 
VADAS-Cog battery. VADAS-Cog had previously been 
reported to be a more sensitive instrument to evaluate 
patients with WMC when compared with ADAS-Cog  [3] . 
The authors identified that 5 (out of the 6) tests that com-
pound the VADAS-Cog extension (namely, delayed re-
call, symbol-digit, maze, digit cancellation and verbal 
fluency) were able to differentiate among mild, moderate 
and severe WMC. Most of these 5 tests are used to assess 
speed of mental processing and executive functions, cog-
nitive capacities shown to be impaired in patients with 
vascular disease or WMC  [6] . However, in the LADIS 
population, none of the specific tests used to assess ex-
ecutive functions (Stroop and Trail-Making tests) were 
baseline predictors of dementia at the end of follow-
up. Some studies have found no relationship between
ARWMC and specific tests for the assessment of execu-
tive functions  [26, 27] . Nevertheless, in our study, the 
compound score of executive functions that, besides the 
Stroop and Trail-Making tests, includes scores on sym-
bol-digit and verbal fluency tests, was an independent 
predictor of dementia at the end of follow-up. 
 Memory baseline compound scores were also inde-
pendent predictors of dementia. An association between 
WMC and memory impairment had been previously re-
ported. Jokinen et al.  [6] found that memory impairment 
was mediated by executive functions and mental speed. 
They suggest that executive dysfunction causes second-
ary deficits such as memory impairment. In the LADIS 
population, dementia at the end of follow-up might be 
related with other causes rather than a direct effect of 
ARWMC. The heterogeneity of the type of dementia 
(vascular dementia, AD with vascular component, oth-
ers) might explain this multidomain pattern of cognitive 
impairment. 
 In this paper we also compared participants with no 
impairment (NI) with those with CIND and dementia at 
the end of follow-up. We found that performance on the 
baseline neuropsychological tests was distinctively dif-
ferent for the 3 groups clinically diagnosed at the end of 
the follow-up period, showing a consistent relation be-
tween clinical criteria and neuropsychological assess-
ment.  
 We found that the patients with CIND were older than 
the patients with NI and younger than those with demen-
tia. This group of patients also had a lower educational 
level when compared with the participants with NI but 
did not differ from those with dementia. Concerning 
cognitive performance at baseline, the patients with 
CIND differed from the patients with dementia in almost 
all the tests and global measures. When compared with 
those with NI, the patients with CIND had no significant 
differences on the baseline performance of MMSE, 
Stroop and ADAS-Cog. These findings show the hetero-
geneity of this particular group, which seems to be in the 
continuous line between ‘no impairment’ and ‘dementia’. 
In the CIND group, we found participants with similar 
performances to those with no impairment but also to 
those with dementia, along with more risk factors for de-
mentia such as older age. These results illustrate the dif-
ficulty of identifying predictors in the CIND group, since 
it is very heterogeneous. 
 A possible limitation of this study is related to the use 
of dichotomized or categorized variables such as demen-
tia/no dementia or NCI/CIND, including patients with 
different types of dementia in the same group. However, 
splitting these groups would reduce the statistical power 
and compromise the results. Also the absence of sensitive 
measures of memory, such as verbal learning and cued 
recall, limits our interpretation of the baseline results. 
However, the introduction of these tests during the fol-
low-up of the LADIS study will permit us to analyze the 
evolution of memory performance over time in further 
studies. 
 The present study contributes to the identification of 
sensitive measures to assess participants with ARWMC 
and to evaluate the risk of progression for dementia in a 
population with no functional or major cognitive impair-
ment in initial evaluations. It also enhances the impor-
tance of the neuropsychological assessment to the study 
of subtle changes on progression to dementia.
 Neuropsychological Predictors of 
Dementia  
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 Abstract 
 Aims: To describe the contribution of white matter lesions to the long-term neuropsycho-
logical profiles of different groups of clinical diagnoses, and to identify neuropsychological 
predictors of cognitive impairment in a 10-year follow-up.  Methods: The Lisbon subcohort of 
the Leukoaraiosis and Disability (LADIS) study was re-evaluated performing a clinical, func-
tional and cognitive evaluation [including Mini-Mental State Examination (MMSE), Alzhei-
mer’s Disease Assessment Scale – Cognition (ADAS-Cog) and ADAS-Cog with the extension 
for vascular impairment (VADAS-Cog), the 9-word version of the California Verbal Learning 
Test (CVLT-9), the Trail-Making test and the Stroop test] as well as an MRI scan. Using clinical 
diagnostic criteria, participants were identified as having no cognitive impairment (NI), cogni-
tive impairment but no dementia (CIND) or dementia (DEM), and the effect of time on clinical 
diagnosis and neuropsychological profiles was analyzed.  Results: From the initial group of 66 
participants, 37 out of 41 survivors (90%) were re-evaluated (mean age 81.40 years, 57% wom-
en). Fifteen patients (41%) had DEM, 12 (32%) CIND and 10 (27%) NI. Over time, the three 
groups presented distinct profiles in the MMSE [F 2, 62 = 15.85, p = 0.000], ADAS [F 2, 62 = 15.85, 
p = 0.000] and VADAS [F 2, 48 = 5.87, p = 0.008]. Logistic regression analysis identified higher 
scores on MMSE (β = 1.14, p = 0.03, OR = 3.13, 95% CI 1.09–8.97) as predictors of NI after
10 years of follow-up.  Conclusion: Higher scores on baseline MMSE were the only neuropsy-
chological predictors of NI after 10 years.  © 2016 S. Karger AG, Basel 
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 Introduction 
 Longitudinal studies in the general population of cognitively intact participants have 
demonstrated that increasing volume and increased progression of white matter lesions 
(WMLs) are related to lower global cognitive performance and conversion to mild cognitive 
impairment and dementia  [1, 2] . In the 3-year follow-up of the Leukoaraiosis and Disability 
(LADIS) study, WMLs and lacunae were found to progress over time, appearing mostly in the 
subcortical white matter. Progression was related to more severe WMLs and a higher number 
of lacunae at baseline as well as to several vascular risk factors  [3] . The impact of diabetes 
and severity of WMLs on the decline of cognitive performance was also reported by Verdelho 
et al. in the LADIS study  [4] . In the same sample, neuropsychological predictors of dementia 
(DEM) and cognitive impairment but no dementia (CIND) were both identified, above and 
beyond clinical and demographic factors  [5] . Patients who developed CIND or DEM 3 years 
after the inclusion already presented lower scores on cognitive baseline performance in 
global measures such as the Mini-Mental State Examination (MMSE) and the Vascular De-
mentia Assessment Scale (VADAS) compared with those who had no cognitive impairment 
(NI) or CIND at the 3-year follow-up, despite the fact that they were all functionally inde-
pendent at baseline. Very long-term follow-up studies on the impact of WMLs on the tran-
sition to dementia are still rare  [6–8] , and none of them followed a group of initially nonde-
pendent participants with WMLs. Furthermore, prediction of no impairment is particularly 
less common in the literature and, hence, it is one of our foci using both global batteries and 
subtests scores.
 In the present study we aimed to evaluate a subcohort of the LADIS study after 10 years 
of follow-up who had been functionally independent at baseline in order to (1) locate the 
cognitive evolution of different groups of cognitive clinical diagnoses and (2) identify neuro-
psychological predictors of NI, CIND and DEM.
 Methods 
 Participants and Methods 
 For the purpose of this study, we included all the 66 participants of the Lisbon center who had previ-
ously been enrolled in the longitudinal European multinational LADIS study. The rationale and methodology 
of the LADIS project has been extensively reported in other papers  [9, 10] . Briefly, the LADIS study started 
in 2001 and aimed to evaluate the impact of WMLs on the transition to disability during a follow-up of 3 years. 
Each of the eleven European centers involved had to include participants with (a) age 65–84 years, (b) WMLs 
of any degree according to the modified Fazekas visual rating scale  [11] , (c) no or mild impairment (none or 
one item affected) on the instrumental activities of daily living scale  [12] , and (d) presence of a contactable 
informant and agreement to give written informed consent. Patients were enrolled due to minor neuro-
logical, cognitive or motor complaints or incidental findings on brain imaging due to nonspecific grounds 
(controls in other studies and volunteers)  [9] . The participants were submitted to a comprehensive clinical, 
functional, motor and neuropsychological examination that was repeated yearly, and MRI was performed at 
baseline and at the end of the 3-year period.
 For the current study, all the surviving Lisbon participants were contacted by a neuropsychologist 
(S.M.) and invited to come to an extra evaluation in the 10th year of follow-up. This visit consisted of the 
following: (1) A clinical and functional evaluation performed by a neurologist (A.V.), according to the LADIS 
protocol  [9] . (2) A neuropsychological assessment which included the LADIS battery consisting of: the 
MMSE  [13] , a measure of global cognitive status; the Alzheimer’s Disease Assessment Scale – Cognition 
(ADAS-Cog) to assess memory, orientation, language, and ideational and constructional praxis  [14, 15] , with 
the extension for vascular impairment (VADAS-Cog)  [16] , which adds the delayed recall of the ADAS’s 
10-word lists, a symbol digit test, a digit span backwards, a maze task, a digit cancellation task and an animal 
naming verbal task; the Trail-Making  [17] and Stroop tests  [18] to assess executive functions; and the 
9-word version of the California Verbal Learning Test (CVLT-9)  [19] to assess memory and learning (for a 
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more detailed description of the battery, see Madureira et al.  [10] ). (3) An MRI scan was performed according 
to the LADIS protocol  [9] , at the same center and with the same equipment which had previously been used 
in the LADIS study. The severity of WMLs was rated visually by a neurologist (A.V.), who was blind to neuro-
psychological data, using the Fazekas scale  [11] . CD copies of the MRI scans were sent by mail to the same 
researcher who had rated the follow-up MRI evaluation in the LADIS study (A.G.) and who was blind to 
clinical details and neuropsychological data. Progression of the WMLs and presence of new lacunae were 
visually rated in a side-by-side fashion; the entire procedure is described elsewhere  [3] . Briefly, WML 
progression was rated on FLAIR images according to the modified Rotterdam Progression Scale (range 0–9) 
 [20] , in which ‘no progression’ or ‘progression’ (0 and 1, respectively) was rated in three periventricular 
regions (frontal caps, occipital caps, bands), four subcortical white matter regions (frontal, parietal, occipital, 
temporal), the basal ganglia and the infratentorial region. Progression was also classified as ‘no progression’, 
‘mild’ (progression in one to three regions) or ‘severe’ (progression in more than three regions)  [3] . New 
lacunae were also visually assessed according to the number and location in five brain regions (frontal, 
parieto-occipital, temporal, basal ganglia, and infratentorial). New cortical/lobar infarcts were also iden-
tified according to number and location  [3] .
 For participants who were unable to come to the hospital for assessment, home visits were conducted 
for clinical and neuropsychological evaluation. Information concerning nonsurviving participants was 
collected in a face-to-face or telephone interview with the caregivers/informants. This interview included a 
dropout/death questionnaire used in the LADIS study which collects clinical and functional data.
 The study was submitted to and approved by the Ethics Committee of Santa Maria University Hospital, 
Lisbon.
 Neuropsychological Data and Cognitive Status 
 For the purpose of this study, neuropsychological battery scores were analyzed as previously described 
in detail  [10] . Briefly, we used both subtest scores and total raw scores of ADAS and VADAS-Cog, the latter 
calculated according to Ylikoski et al.  [21] . We considered ‘time used to perform Stroop part 3 minus time to 
perform Stroop part 2’ and ‘time needed to perform Trail-Making part B minus time to perform Trail-Making 
part A (raw scores)’ as measures of executive functions. CVLT-9 scores used for the purpose of this study 
were the total raw score of the five learning trials and the raw score of both short and long delayed free recall 
tasks, as measures of verbal learning and retrieval.
 The participants’ cognitive status was evaluated clinically and classified into three groups accordingly 
to previously established sets of criteria  [22] by a neurologist (A.V.) who had access to MRI results but was 
blind to neuropsychological data: (1) NI, (2) CIND and (3) DEM. Briefly, for CIND two types were considered: 
(1) amnestic mild cognitive impairment  [23] and (2) vascular cognitive impairment without dementia  [24] . 
For dementia the following subtypes were considered: probable Alzheimer’s disease (AD)  [25] , probable 
vascular dementia (VD)  [26] , frontotemporal dementia  [27] and dementia with Lewy bodies (DLB)  [28] .
 Statistical Analyses 
 To test associations of clinical diagnosis or progression of WMLs with different variables as well as 
differences between participant groups, bivariate analyses were used: (a) comparing survivors and nonsur-
vivors and (b) those who came to the follow-up evaluation at 10 years with those who did not, to assess 
potential selection bias, using nonparametric tests (Mann-Whitney test, χ 2 test); (c) comparing groups of 
diagnosis (NI, CIND, DEM) concerning neuropsychological performance using nonparametric statistics such 
as the Mann-Whitney test and Kruskal-Wallis test for multiple groups. Repeated measures ANOVA was 
performed in order to study how test scores changed across the three time points (baseline, 3rd and 10th 
years of follow-up), exploring the effect of time, clinical diagnosis group and the interaction between them. 
In these series, time and clinical diagnosis at 10 years (NI vs. CIND vs. DEM) were used as independent vari-
ables. We also performed regression analyses (linear and logistic) to identify predictors of clinical decline 
using the most significant demographic, clinical and neuropsychological data as independent variables. For 
each analysis, age and education were included in step 1 as independent variables, since they are known to 
influence cognitive performance. Baseline WML severity (mild, moderate or severe) was added in step 2 and 
cognitive baseline performance was included in step 3. No more than four variables were included in each 
model to avoid type I errors. Specifically we tested the effects of known clinical predictors (diabetes and 
stroke) and global neuropsychological measures. A 0.05 level of significance was used except when comparing 
multiple tests with multiple variables, where a more conservative level of 0.01 or 0.001 (Bonferroni’s 
correction) was adopted. Data analyses were performed using the SPSS 21.0 software.
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 Results 
 From the initial group of 66 Portuguese elderly participants who had been enrolled in the 
LADIS study in 2001–2002, 41 (62%) were still alive at the 10-year follow-up visit ( fig. 1 ). 
Twenty-three participants had died during the 10-year period (1 during the first year of the 
study, 1 in 2004 and 21 between 2005 and 2012). The most frequent cause of death was 
stroke (4 patients) and heart failure (4 patients). Two participants were lost to follow-up and 
we were unable to obtain any further information. One of them was lost during the first year 
of the study.
 There were no significant differences between survivors (n = 41) and nonsurvivors (n = 
23) concerning sex (χ 2 (1) = 0.03, p = 0.88), educational level (U = 368, p = 0.11) and WML 
severity (χ 2 (2) = 2.56, p = 0.28) or WML volume (U = 590, p = 0.10) at baseline. Nonsurvivors 
(mean age at baseline 74.7 ± 4.8 years) tended to be older than survivors (mean age at baseline 
72.1 ± 5.1 years; U = 691, p = 0.04). Concerning the cognitive clinical diagnosis at the third 
year of evaluation, survivors and nonsurvivors showed no significant differences (χ 2 (2) = 4.66, 
p = 0.10).
 Of the 41 participants who were alive 10 years after enrollment in the LADIS study, 3 
refused to participate, and 1 was living in a nursing home far from Lisbon and it was not 
possible to evaluate him in the new residence. Thus 37 (90%) could be evaluated at the 
10-year follow-up. Participants who came to this evaluation (n = 37), when compared with 
all those who did not come (n = 29), had a higher level of education (U = 377, p = 0.02), but 
Baseline group
of participants
(2001–2002)
n = 66
Known survivors
(2011–2012)
n = 41
10-year
follow-up
n = 37
Complete NP and
MRI evaluation
n = 32
Nonsurvivors: 23
Cause of death: heart failure, 4;
stroke, 4; multiorgan failure, 3;
pneumonia, 4; sudden death, 2;
cancer, 1; dementia, 2; unknown, 3
No information: 2
Refusal to participate: 3
Unable to attend: 1
Refusal to undergo MRI: 3
Unable to undergo MRI: 2
With complete
NP evaluation
n = 37
With MRI
n = 32
 Fig. 1. Schematic representation of participants assessed at year 10. NP = Neuropsychological. 
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were not different concerning sex, age, baseline WML severity or clinical diagnosis at the 
3rd year. There were also no differences concerning MMSE scores at baseline (U = 434, p = 
0.18) and at the 3-year follow-up (U = 275, p = 0.08), as illustrated in  table 1 . Of the 37 
participants who came to the 10-year follow-up, 5 refused (n = 3) or had contraindications 
(n = 2) to repeating the MRI scan. Thus, a final group of 32 (78%) participants underwent 
the complete neuropsychological assessment and also had MRI evaluation at the 10-year 
follow-up.
 In the sample at the 10-year follow-up there were 37 participants (21 women, 57%), with 
a mean age of 81 years (range 74–92 years) and a mean educational level of 8.2 years (range 
4–26 years). Of those who underwent MRI, severe WMLs at follow-up were observed in 16 
(43%), moderate WMLs in 7 (19%) and mild WMLs in 9 (24%).
 Fifteen patients (41%) were clinically diagnosed with DEM (VD = 10, AD = 4, DLB = 1), 
12 (32%) with CIND, and 10 (27%) with NI.
 Compared to the clinical diagnosis in the 3rd year of follow-up, 14 participants had cog-
nitively declined: 6 participants (16%) had changed from NI to CIND (mild cognitive impair-
ment = 2, vascular cognitive impairment without dementia = 1) and DEM (VD = 1, AD = 1,
DLB = 1), and 8 participants (22%) had changed from CIND to DEM (VD = 6, AD = 2).
 Cognitive performance for the total sample as well as for the groups of participants with 
NI and participants with any impairment (CIND or DEM) at the 10-year follow-up is presented 
in  table 2 . Overall the data showed that, as expected, neuropsychological performance after 
10 years was statistically better for NI participants than for those who had CIND or DEM.
 Changes in Cognitive Performance across the 10-Year Period 
 Regarding general scores of neuropsychological measures, we used repeated measures 
ANOVA to evaluate the main effect of time and group in each battery or test. For MMSE scores, 
the main effect of time was significant [F 2, 66 = 21.52, p = 0.000], with performance decreasing 
 Table 1.  Comparison between participants who attended the 10-year follow-up and those who did not
Participants who 
attended (n = 37)
Participants who did 
not attend (n = 29)
p value
Mean age at baseline, yearsa 72.35 74.28 n.s.
Mean age at 10-year follow-up, years 81.30 – –
Mean education, yearsa 8.2 5.6 0.02
Sexb
Female 21 17 n.s.
Male 16 12 n.s.
Baseline WMLsb
Mild 20 14 n.s.
Moderate 9 6 n.s.
Severe 8 9 n.s.
Mean baseline WML volume, mla 19.11 18.65 n.s.
Third-year clinical diagnosisb
NI 16 10 n.s.
CIND 17 11 n.s.
DEM 4 7 n.s.
Mean MMSE scorea
Baseline  27.57 26.69 n.s.
Three-year follow-up 27.28 25.81 n.s.
 n.s. = Nonsignificant. a Mann-Whitney test. b χ2 test.
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after the 3rd year; the main effect of participant group (NI, CIND, DEM) was also significant 
[F 2, 66 = 17.65, p = 0.001], with the DEM group demonstrating the lowest results; the inter-
action effect of time × group was significant [F 4, 66 = 14.24, p = 0.000]. A steeper decline was 
found among DEM participants even though all three groups showed decreased performance 
over time ( fig. 2 ).
 A similar analysis was performed for ADAS-Cog, in which we also found a significant main 
effect of time [F 2, 62 = 37.88, p = 0.000], of group [F 2, 62 = 15.85, p = 0.000], and of time × group 
interaction [F 4, 62 = 8.97, p = 0.000]. Cognitive performance also decreased with time, espe-
cially after year 3, and the group whose results had worsened most was the DEM group 
( fig. 2 ).
 Table 2. Neuropsychological performance at the 10-year follow-up (raw test scores)
Neuropsychological 
performance
No impairment Any impairment  Total Mann-Whitney 
U valuen mean ± SD n mean ± SD  n mean ± SD
MMSE 10 28.20 ± 1.62 27 21.19 ± 7.98 37 23.08 ± 7.52 214**
ADAS-Cog
Totala 10 17.00 ± 5.67 25 28.92 ± 12.78 35 28.77 ± 17.47 51**
Word recalla 10 5.00 ± 1.41 26 6.69 ± 2.21 36 6.22 ± 2.14 n.s.
Commanda 10 0.20 ± 0.63 26 0.69 ± 1.26 36 0.56 ± 1.13 n.s.
Constructiona 10 0.70 ± 0.95 25 0.96 ± 1.21 35 0.89 ± 1.13 n.s.
Naminga 10 0.30 ± 0.48 25 1.52 ± 1.61 35 1.17 ± 1.48 52.5**
Ideational praxisa 10 0.80 ± 1.03 26 1.96 ± 1.48 36 1.64 ± 1.46 n.s.
Orientationa 10 0.10 ± 0.32 26 2.31 ± 2.43 36 1.69 ± 2.29 47.0**
Word recognitiona 10 3.00 ± 2.26 25 6.24 ± 3.92 35 5.31 ± 3.79 n.s.
Remembering instructionsa 10 0.00 ± 0.00 27 1.37 ± 1.90 37 1.00 ± 1.72 75.0*
Speaking difficultiesa 10 0.00 ± 0.00 27 1.07 ± 1.71 37 0.78 ± 1.53 n.s.
Word findinga 10 0.00 ± 0.00 27 1.04 ± 1.63 37 0.76 ± 1.46 n.s.
Comprehensiona 10 0.10 ± 0.32 27 0.81 ± 1.50 37 0.62 ± 1.32 n.s.
Concentrationa 10 0.10 ± 0.32 27 0.63 ± 1.15 37 0.49 ± 1.02 n.s.
VADAS-Cog
Totala 10 49.30 ± 11.10 22 66.72 ± 16.44 32 61.28 ± 16.92 40.5**
Delayed recall 10 6.90 ± 2.28 26 8.23 ± 1.90 36 7.86 ± 2.07 n.s.
Digit span 10 4.00 ± 2.11 25 3.24 ± 1.86 35 3.46 ± 1.93 n.s.
Verbal fluency 10 19.60 ± 4.14 26 11.23 ± 6.31 36 13.56 ± 6.88 224.5**
Symbol digit 10 18.40 ± 9.83 23 10.57 ± 9.71 33 12.95 ± 10.27 n.s.
Digit cancellation 10 16.60 ± 7.30 24 10.00 ± 6.74 34 11.94 ± 7.46 n.s.
Mazea 10 12.20 ± 6.34 23 16.00 ± 11.05 33 14.85 ± 9.92 n.s.
Stroop
Stroop 3-2a 10 34.00 ± 31.78 19 47.79 ± 29.14 29 43.03 ± 30.25 n.s.
Stroop 1a 10 10.70 ± 4.30 21 27.76 ± 16.63 31 22.26 ± 15.99 20.5**
Stroop 2a 10 18.20 ± 4.24 21 37.05 ± 30.02 31 30.97 ± 26.20 41.0**
Stroop 3a 10 52.20 ± 32.93 20 77.50 ± 34.69 30 69.07 ± 35.67 n.s.
Trail-Making
Trail-Making B-Aa 10 124.7 ± 55.16 19 143.50 ± 73.63 29 137.00 ± 67.42 n.s.
Trail-Making Aa 10 67.90 ± 35.46 23 150.43 ± 90.89 33 125.42 ± 86.70 44.5**
Trail-Making Ba 10 192.60 ± 77.25 19 273.63 ± 47.32 29 245.69 ± 69.96 24.0**
CVLT-9
Total 10 36.20 ± 6.70 27 21.63 ± 10.73 37 25.57 ± 11.7 236.5**
Short delay 10 7.30 ± 1.8690 27 2.70 ± 2.63 37 3.95 ± 3.18 241.0**
Long delay 10 6.80 ± 2.15 27 3.11 ± 2.47 37 4.11 ± 2.88 232.0**
Recognition 10 7.80 ± 2.82 27 6.93 ± 2.95 37 7.16 ± 2.90 n.s.
a Tests in which higher scores indicate worse performance. * p < 0.01; ** p < 0.001.
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 The VADAS-Cog was also explored in terms of the change across the 10-year period. The 
main effect of time [F 2, 48 = 41.35, p = 0.000], the main effect of group [F 2, 48 = 5.87, p = 0.008], 
and the interaction effect [F 4, 48 = 3.430, p = 0.018] were significant as well ( fig. 2 ).
 When changes across time were explored for the executive measures of both the Trail-
Making and Stroop tests, only a significant effect of time [F 2, 46 = 6.95, p = 0.002] and group 
[F 2, 46 = 5.98, p = 0.008] was found for Trail-Making B-A, but the time × group interaction was 
not significant.
 WML Progression, Cognitive Performance and Clinical Diagnosis 
 Four (13%) out of the 32 participants who underwent MRI showed no WML progression 
from the baseline assessment. Mild WML progression was observed in 11 (34%) participants, 
and 17 (53%) had severe WML progression ( fig. 3 illustrates an example of WML progression 
from baseline to the 10-year follow-up). Presence of at least one new lacuna was identified in 
9 (28%) participants. Participants with severe WML progression had a tendency to have 
lower education compared with those who did not progress or had mild progression (U = 
178.5, p = 0.05). No other differences were found concerning age (U = 170, p = 0.11) or WML 
volume at baseline (U = 142, p = 0.58). There were no significant differences between partic-
ipants with NI and those with any impairment concerning WML progression (U = 102.5, p = 
0.96) or presence of new lacunae (U = 90, p = 0.47). Concerning WML severity at the 10-year 
follow-up, participants with NI had less severe WMLs than participants with any impairment 
(χ 2 (2) = 9.21, p = 0.01).
 Predictors of Clinical Diagnosis at the 10-Year Follow-Up 
 Participants with NI at 10 years also had no significant differences concerning the volume 
of WMLs at baseline when compared with participants with CIND or DEM (U = 72, p = 0.031), 
the presence of medial temporal lobe atrophy (U = 86, p = 0.08) or WML progression rated at 
year 3 (U = 104, p = 0.60). Regarding the presence of new stroke (n = 4) or lacunae (n = 9) 
during the long-term follow-up, the effect also failed to reach statistical significance comparing 
participants with NI or any cognitive impairment.
 A logistic regression was performed in order to determine the ability to predict NI 
after 10 years based on the cognitive measures that appeared to distinguish participants 
with NI from those with any cognitive impairment. For each analysis, step 1 included the 
demographic variables of age and education, given their known association with cognitive 
performance, in order to control for their effect. Step 2 entered the baseline WMLs, and in 
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 Fig. 2. MMSE, ADAS-Cog and VADAS-Cog scores over 10 years for participants with NI, CIND and DEM.
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step 3 cognitive scores were included as dependent variables. Only MMSE (β = 1.14, p = 
0.03, OR = 3.13, 95% CI 1.09–8.97) and ADAS (β = 0.61, p = 0.02, OR = 0.54, 95% CI 0.32–
0.91) scores at baseline were found to be significant predictors of NI after 10 years of 
follow-up, with both models (MMSE χ 2 = 14.66, R 2 = 0.48; ADAS χ 2 = 21.20, R 2 = 0.63) able 
to make correct predictions for 87% of the participants. No effects were found for age and 
education.
 Discussion 
 In this study, the Lisbon group of functionally independent elderly people with age-
related WMLs who had been included in the multinational European LADIS study was 
followed during a period of 10 years. The long-term follow-up allowed the identification of 
different profiles of evolution of the three groups of clinical diagnoses. As expected, the 
group of participants with DEM showed more prominent decline over time, while the group 
with a clinical diagnosis of CIND revealed a profile closer to that of NI participants, even after 
such a long period of time. Differences between groups of diagnoses were observed in the 
main batteries MMSE, ADAS-Cog and VADAS-Cog, but not in executive measures when 
composed scores (Stroop 3-2 and Trail-Making B-A) were used: in both the Stroop and Trail-
Making tests, only the effect of time was significant. The absence of differences in composed 
executive measures could be explained (1) by the fact that age-related decline in processing 
speed might contribute to an increase in time needed to perform the task in less complex 
parts (reading words, naming colors and connecting ordered numbers), reducing the 
a b
 Fig. 3. MRI axial FLAIR images of 
one patient at baseline ( a ) and 10 
years after ( b ) show clear pro-
gression of WMLs in the frontal 
caps and bands of the periventric-
ular region. 
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magnitude of the difference between both tasks  [29] , and (b) by the increasing number of 
persons who performed the first part of the tests but were not able to perform the more 
complex parts. Considering these findings, the best discriminative measures in long-term 
follow-up evaluations seemed to be the individual scores of each task and not the differences 
between them.
 When baseline clinical and neuropsychological variables were analyzed, we found that 
the only predictor of NI at the end of the 10 years was the baseline MMSE score. MMSE baseline 
scores had already been identified as predictors of dementia in a sample of independent 
elderly participants with WMLs after a 3-year follow-up period  [5] . Moreover, MMSE mean 
scores were relatively high and suggestive of the importance of establishing high cut-off 
scores for early identification of CIND. Another study has also reported the importance of 
using higher cut-off scores on MMSE to detect people at risk of dementia in a group of highly 
educated elderly subjects  [30] .
 More than half of the participants showed progression of WMLs in more than three 
regions, which was consistent with what had been previously described in a similar group of 
patients  [3] . However, in our cohort, we did not find an association between severe progression 
of WMLs and demographic factors, vascular risk factors or baseline severity of WMLs. It has 
already been described that some factors related to progression of WMLs in a medium follow-
up period might disappear in the longer run  [31] , which might explain the absence of these 
associations in our study. On the other hand, in the visual rating of some MRI scans obtained 
at the 10-year follow-up, white matter atrophy with prominent ventricular enlargement 
could be seen in the absence of an expressive WML increase. This could lead us to the 
hypothesis that the disease might have a different expression of progression after such a long-
term process.
 The interpretation of these results might be limited by some aspects of the present 
research. Such long-term periods of follow-up in elderly populations are associated with high 
rates of attrition, either due to death or the presence of other diseases that might interfere 
with the natural progression of WMLs. Moreover, the small number of patients did not allow 
more specific analysis, for instance regarding what type of dementia could be better predicted. 
Nevertheless, we were able to evaluate a group of older adults with severe vascular risks and/
or vascular disease for a period of 10 years. The small sample, an intrinsic risk in long-term 
follow-up studies performed in elderly populations, contributes to a loss of statistical power 
in some analyses. The use of a conservative level of significance in order to reduce type I error 
can also explain the absence of associations regarding some variables that are consistently 
reported as related to cognitive decline in this population (e.g. age or educational level). Still, 
this procedure allowed us to identify some significant findings, such as the identification of a 
global battery like the MMSE as a potential predictor of nonimpairment in this very long 
follow-up period. However these findings, as well as the absence of a clear association between 
WML progression and cognitive performance, reflect the importance of the present data and 
of replication of the study with a larger population.
 In this study we presented different longitudinal profiles of cognitive performance in 
a cohort of independent elderly participants with WMLs, and identified higher scores on 
baseline MMSE cognitive performance as the strongest predictor of long-term clinical diag-
nosis of no cognitive impairment. Higher cut-off points on global batteries such as the 
MMSE should be used to identify participants at risk of cognitive decline over long-term 
periods.
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